Substituted oxadiazoles for combating phytopathogenic fungi

The present invention relates to novel oxadiazoles of the formula I, or an N-oxide and/or their agriculturally useful salts and to their use for controlling phytopathogenic fungi, or to a method for combating phytopathogenic harmful fungi, which process comprises treating the fungi or the materials, plants, the soil or seeds to be protected against fungal attack, with an effective amount of at least one compound of the formula I, or an N-oxide, or an agriculturally acceptable salt thereof; the present invention also relates to mixtures comprising at least one such compound of the formula I and at least one further pesticidally active substance selected from the group consisting of herbicides, safeners, fungicides, insecticides, and plant growth regulators; and to agrochemical compositions comprising at least one such compound of the formula I and to agrochemical compositions further comprising seeds.

EP 276432 A2 relates to 3-phenyl-5-trifluoromethyloxadiazole derivatives and to their use to combat phytopathogenic microorganisms. WO 2013/008162 describes trifluoromethyl- oxadiazole derivatives with HDAC4 inhibitory activity and their medical use, particularly in the treatment of Huntington's disease, muscle atrophy and diabetes/metabolic syndrome. WO 2015/185485 was published after the date of filing of the present application and describes the use of certain substituted oxadiazoles for combating phytopathogenic fungi.

In many cases, in particular at low application rates, the fungicidal activity of known fungicidal compounds is unsatisfactory. Based on this, it was an objective of the present invention to provide compounds having improved activity and/or a broader activity spectrum against phytopathogenic fungi. This objective is achieved by the oxadiazoles of the formula I and/or their agriculturally useful salts for controlling phytopathogenic fungi.

The compounds according to the invention differ from those described in state of the art documents mentioned above in that the R ³ R ⁴ moiety forms a cycle.

Accordingly, the present invention rel the formula I

A is phenyl or a 5- or 6-membered aromatic heterocycle, wherein the ring member atoms of the heterocyclic ring include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from N, O and S as ring member atoms; and wherein the cyclic groups A are unsubstituted or substituted by 1 , 2, 3 or 4 identical or different groups R ^A ; wherein

R ^A is halogen, cyano, NO2, OH, NH ₂ , SH, did-Ce-alkylamino, Ci-Ce-alkyl, d-Ce-alkoxy, Ci-C6-alkylthio, Ci-C6-alkylsulfinyl, Ci-C6-alkylsulfonyl, C2-C6-alkenyl, C2-C6-alkynyl, C3-C8-cycloalkyl or Cs-Cs-cycloalkoxy; and wherein any of the aliphatic or cyclic moieties are unsubstituted or substituted by 1 , 2, 3 or 4 identical or different groups R ^a ; wherein

R ^a is halogen, cyano, N0 ₂ , OH, SH, NH ₂ , C C ₆ -alkyl, C C ₆ -haloalkyl,

Ci-C6-alkoxy, Ci-C6-haloalkoxy, Ci-C6-alkylthio, Ci-C6-haloalkylthio or C3-C8- cycloal ky I , Ci -C ₄ -a I koxy-Ci -C ₄ -a I ky I ; R ¹ , R ² independently of each other are hydrogen, Ci-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, Cs-Ce-cycloalkyl, C ₃ -C ₆ -cycloalkenyl, C(=0)-(Ci-C ₆ -alkyl), C(=0)-(Ci-C ₆ -alkoxy), phenyl- Ci-C4-alkyl, heteroaryl-Ci-C4-alkyl, phenyl, naphthyl or a 3- to 10-membered saturated, partially unsaturated or aromatic mono- or bicyclic heterocycle, wherein the ring member atoms of said mono- or bicyclic heterocycle include besides carbon atoms further 1 , 2, 3 or 4 heteroatoms selected from N, O and S as ring member atoms and wherein 1 or 2 carbon ring member atoms of the heterocycle may be replaced by 1 or 2 groups independently selected from C(=0) and C(=S); and wherein the heteroaryl group in heteroaryl-Ci-C4-alkyl is a 5- or 6-membered aromatic heterocycle, wherein the ring member atoms of the heterocyclic ring include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from N, O and S as ring member atoms; and wherein any of the above-mentioned aliphatic or cyclic groups are unsubstituted or substituted by 1 , 2, 3 or up to the maximum possible number of identical or different groups R ^1a ;

or R ¹ and R ² together with the nitrogen atom to which they are bound form a saturated or

partially unsaturated mono- or bicyclic 3- to 7-membered heterocycle, wherein the heterocycle includes beside one nitrogen atom and one or more carbon atoms no further heteroatom or 1 , 2 or 3 further heteroatoms independently selected from N, O and S as ring member atoms; and wherein one or two CH ₂ groups of the heterocycle may be replaced by one or two groups independently selected from the group of C(=0) and C(=S); and wherein the heterocycle is unsubstituted or carries 1 , 2, 3, 4 or up to the maximum possible number of identical or different groups R ^1a ; wherein

R ^1a is halogen, cyano, N0 ₂ , OH, SH, NH ₂ , d-C ₆ -alkyl, Ci-C ₆ -haloalkyl, Ci-C ₆ -alkoxy, d-Ce-haloalkoxy, Ci-C ₆ -alkylthio, Ci-C ₆ -haloalkylthio, C ₃ -C ₈ -cycloalkyl, NHS0 ₂ - Ci-C ₄ -alkyl, (C=0)-Ci-C ₄ -alkyl, C(=0)-Ci-C ₄ -alkoxy or Ci-C ₆ -alkylsulfonyl;

R ³ and R ⁴ together with the carbon atom to which they are bound form 3- to 7-membered

carbocycle or a saturated 3- to 6-membered heterocycle, wherein the heterocycle includes beside carbon atoms 1 , 2 or 3 heteroatoms independently selected from N-R ^N , S, S(=0), S(=0)2 and O as ring member atoms; wherein

R ^N is H, d-Ce-alkyl, S0 ₂ CH ₃ , S0 ₂ C ₆ H ₄ CH ₃ S0 ₂ -aryl;

and wherein one or two CH ₂ groups of the cycle may be replaced by one or two groups independently selected from the group of C(=0) and C(=S);

and wherein the carbocycle, heterocycle and aryl is unsubstituted or carries 1 , 2, 3, 4 or up to the maximum possible number of identical or different groups R ^3a ; wherein

R ^3a is halogen, cyano, N0 ₂ , OH, SH, NH ₂ , Ci-C ₆ -alkyl, Ci-C ₆ -haloalkyl, Ci-C ₆ -alkoxy, Ci-Ce-haloalkoxy, Ci-C ₆ -alkylthio, Ci-C ₆ -haloalkylthio, C ₃ -C ₈ -cycloalkyl, NHS0 ₂ - CrC ₄ -alkyl, -(C=0)-Ci-C ₄ -alkyl, C(=0)-C C ₄ -alkoxy or C C ₆ -alkylsulfonyl; or the N-oxides, or the agriculturally acceptable salts thereof.

Agriculturally acceptable salts of the compounds of the formula I encompass especially the salts of those cations or the acid addition salts of those acids whose cations and anions, respectively, have no adverse effect on the fungicidal action of the compounds I. Suitable cations are thus in particular the ions of the alkali metals, preferably sodium and potassium, of the alkaline earth metals, preferably calcium, magnesium and barium, of the transition metals, preferably manganese, copper, zinc and iron, and also the ammonium ion which, if desired, may carry one to four Ci-C4-alkyl substituents and/or one phenyl or benzyl substituent, preferably

diisopropylammonium, tetramethylammonium, tetrabutylammonium, trimethylbenzylammonium, furthermore phosphonium ions, sulfonium ions, preferably tri(Ci-C4-alkyl)sulfonium, and sulfoxonium ions, preferably tri(Ci-C4-alkyl)sulfoxonium.

Anions of acceptable acid addition salts are primarily chloride, bromide, fluoride,

hydrogensulfate, sulfate, dihydrogenphosphate, hydrogenphosphate, phosphate, nitrate, bicarbonate, carbonate, hexafluorosilicate, hexafluorophosphate, benzoate, and the anions of Ci-C4-alkanoic acids, preferably formate, acetate, propionate and butyrate. They can be formed by reacting a compound I with an acid of the corresponding anion, preferably of hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid or nitric acid.

Compounds of the formula I can exist as one or more stereoisomers. The various stereoisomers include enantiomers, diastereomers, atropisomers arising from restricted rotation about a single bond of asymmetric groups and geometric isomers. They also form part of the subject matter of the present invention. One skilled in the art will appreciate that one stereoisomer may be more active and/or may exhibit beneficial effects when enriched relative to the other stereoisomer(s) or when separated from the other stereoisomer(s). Additionally, the skilled artisan knows how to separate, enrich, and/or to selectively prepare said stereoisomers. The compounds of the invention may be present as a mixture of stereoisomers, e.g. a racemate, individual

stereoisomers, or as an optically active form.

Compounds of the formula I can be present in different crystal modifications whose biological activity may differ. They also form part of the subject matter of the present invention.

In respect of the variables, the embodiments of the intermediates obtained during preparation of compounds I correspond to the embodiments of the compounds of formula I. The term

"compounds I" refers to compounds of formula I.

In the definitions of the variables given above, collective terms are used which are generally representative for the substituents in question. The term "C _n -C _m " indicates the number of carbon atoms possible in each case in the substituent or substituent moiety in question.

The moieties having two ore more possibilities to be attached apply following:

The moieties having no brackets in the name are bonded via the last moiety e.g. C2-C6- alkenyloxyimino-Ci-C4-alkyl is bonded via Ci-C4-alkyl, heteroaryl-Ci-C4-alkyl is bonded via Ci- C4-alkyl etc.

The moieties having brackets in the name are bonded via the first moiety e.g. C(=0)-(Ci-C6- alkyl) is bonded via C=0, etc.

The term "halogen" refers to fluorine, chlorine, bromine and iodine.

The term "Ci-C6-alkyl" refers to a straight-chained or branched saturated hydrocarbon group having 1 to 6 carbon atoms, for example methyl, ethyl, propyl, 1 -methylethyl, butyl, 1 - methylpropyl, 2-methylpropyl, and 1 ,1 -dimethylethyl.

The term "Ci-C6-haloalkyl" refers to a straight-chained or branched alkyl group having 1 to 6 carbon atoms (as defined above), wherein some or all of the hydrogen atoms in these groups may be replaced by halogen atoms as mentioned above, for example chloromethyl,

bromomethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl, chlorofluoromethyl, dichlorofluoromethyl, chlorodifluoromethyl, 1-chloroethyl, 1 -bromoethyl, 1 - fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 2-chloro-2-fluoroethyl, 2-chloro- 2,2-difluoroethyl, 2,2-dichloro-2-fluoroethyl, 2,2,2-trichloroethyl and pentafluoroethyl, 2- fluoropropyl, 3-fluoropropyl, 2,2-difluoropropyl, 2,3-difluoropropyl, 2-chloropropyl, 3- chloropropyl, 2,3-dichloropropyl, 2-bromopropyl, 3-bromopropyl, 3,3,3-trifluoropropyl, 3,3,3- trichloropropyl, CH2-C2F5, CF2-C2F5, CF(CF ₃ ) ₂ , 1-(fluoromethyl)-2-fluoroethyl, l -(chloromethyl)- 2-chloroethyl, 1 -(bromomethyl)-2-bromoethyl, 4-fluorobutyl, 4-chlorobutyl, 4-bromobutyl or nonafluorobutyl.

The term "Ci-C6-alkoxy" refers to a straight-chain or branched alkyl group having 1 to 6 carbon atoms (as defined above) which is bonded via an oxygen, at any position in the alkyl group, for example methoxy, ethoxy, n-propoxy, 1 -methylethoxy, butoxy, 1-methylpropoxy, 2- methylpropoxy or 1 ,1-dimethylethoxy.

The term "Ci-C6-haloalkoxy" refers to a Ci-C6-alkoxy group as defined above, wherein some or all of the hydrogen atoms may be replaced by halogen atoms as mentioned above, for example, OCH2F, OCH F2, OCF3, OCH2CI, OCHCI2, OCCI3, chlorofluoromethoxy, dichlorofluoromethoxy, chlorodifluoromethoxy, 2-fluoroethoxy, 2-chloroethoxy, 2-bromoethoxy, 2-iodoethoxy, 2,2- difluoroethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2-fluoroethoxy, 2-chloro-2,2-difluoroethoxy, 2,2- dichloro-2-fluoroethoxy, 2,2,2-trichloroethoxy, OC2F5, 2-fluoropropoxy, 3-fluoropropoxy, 2,2- difluoropropoxy, 2,3-difluoropropoxy, 2-chloropropoxy, 3-chloropropoxy, 2,3-dichloropropoxy, 2-bromopropoxy, 3-bromopropoxy, 3,3,3-trifluoropropoxy, 3,3,3-trichloropropoxy, OCH2-C2F5, OCF2-C2F5, 1-(CH ₂ F)-2-fluoroethoxy, 1 -(CH ₂ CI)-2-chloroethoxy, 1-(CH2Br)-2-bromo-"ethoxy, 4-fluorobutoxy, 4-chlorobutoxy, 4-bromobutoxy or nonafluorobutoxy.

The terms "phenyl-Ci-C4-alkyl or heteroaryl-Ci-C4-alkyl" refer to alkyl having 1 to 4 carbon atoms (as defined above), wherein one hydrogen atom of the alkyl radical is replaced by a phenyl or hetereoaryl radical respectively.

The term "Ci-C4-alkoxy-Ci-C4-alkyl" refers to alkyl having 1 to 4 carbon atoms (as defined above), wherein one hydrogen atom of the alkyl radical is replaced by a Ci-C4-alkoxy group (as defined above). Likewise, the term "Ci-C4-alkylthio-Ci-C4-alkyl" refers to alkyl having 1 to 4 carbon atoms (as defined above), wherein one hydrogen atom of the alkyl radical is replaced by a Ci-C4-alkylthio group.

The term "Ci-Ce-alkylthio" as used herein refers to straight-chain or branched alkyl groups having 1 to 6 carbon atoms (as defined above) bonded via a sulfur atom. Accordingly, the term "Ci-C6-haloalkylthio" as used herein refers to straight-chain or branched haloalkyi group having 1 to 6 carbon atoms (as defined above) bonded through a sulfur atom, at any position in the haloalkyi group.

The term "Ci-C6-alkylsulfinyl" refers to straight-chain or branched alkyl groups having 1 to 6 carbon atoms (as defined above) bonded through a -S(=0)- moiety, at any position in the alkyl group, for example methylsulfinyl and ethylsulfinyl, and the like. Accordingly, the term "C1-C6- haloalkylsulfinyl" refers to straight-chain or branched haloalkyi group having 1 to 6 carbon atoms (as defined above), bonded through a -S(=0)- moiety, at any position in the haloalkyi group. The term "Ci-C6-alkylsulfonyl" refers to straight-chain or branched alkyl groups having 1 to 6 carbon atoms (as defined above), bonded through a -S(=0)2- moiety, at any position in the alkyl group, for example methylsulfonyl. Accordingly, the term "Ci-C6-haloalkylsulfonyl" refers to straight-chain or branched haloalkyi group having 1 to 6 carbon atoms (as defined above), bonded through a -S(=0)2- moiety, at any position in the haloalkyi group. The term "hydroxyCi-C4-alkyl" refers to alkyl having 1 to 4 carbon atoms, wherein one hydrogen atom of the alkyl radical is replaced by a OH group.

The term "aminoCi-C4-alkyl" refers to alkyl having 1 to 4 carbon atoms, wherein one hydrogen atom of the alkyl radical is replaced by a Nh group.

The term "Ci-C4-alkylamino-Ci-C4-alkyl" refers to refers to alkyl having 1 to 4 carbon atoms (as defined above), wherein one hydrogen atom of the alkyl radical is replaced by a CrC4-alkyl-NH- group which is bound through the nitrogen. Likewise the term "diCi-C4-alkylamino-Ci-C4-alkyl" refers to refers to alkyl having 1 to 4 carbon atoms (as defined above), wherein one hydrogen atom of the alkyl radical is replaced by a (Ci-C4-alkyl)2N- group which is bound through the nitrogen.

The term "aminocarbonyl-Ci-C4-alkyl" refers to alkyl having 1 to 4 carbon atoms, wherein one hydrogen atom of the alkyl radical is replaced by a -(C=0)-NH2 group.

The term "C2-C6-alkenyl" refers to a straight-chain or branched unsaturated hydrocarbon radical having 2 to 6 carbon atoms and a double bond in any position, such as ethenyl, 1-propenyl, 2- propenyl (allyl), 1 -methylethenyl, 1 -butenyl, 2-butenyl, 3-butenyl, 1 -methyl-1 -propenyl, 2-methyl-

1- propenyl, 1 -methyl-2-propenyl, 2-methyl-2-propenyl.

The term "C2-C6-alkynyl" refers to a straight-chain or branched unsaturated hydrocarbon radical having 2 to 6 carbon atoms and containing at least one triple bond, such as ethynyl, 1-propynyl,

2- propynyl (propargyl), 1 -butynyl, 2-butynyl, 3-butynyl, 1 -methyl-2-propynyl.

The term "Cs-Cs-cycloalkyl" refers to monocyclic saturated hydrocarbon radicals having 3 to 8 carbon ring members such as cyclopropyl (C3H5), cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl or cyclooctyl.

The term "C ₃ -C8-cycloalkyloxy" refers to a cycloalkyl radical having 3 to 8 carbon atoms (as defined above), which is bonded via an oxygen.

The term "C(=0)-Ci-C4-alkyl" refers to a radical which is attached through the carbon atom of the C(=0) group as indicated by the number valence of the carbon atom.

The term "aliphatic" refers to compounds or radicals composed of carbon and hydrogen and which are non-aromatic compounds. An alicyclic compound or radical is an organic compound that is both aliphatic and cyclic. They contain one or more all-carbon rings which may be either saturated or unsaturated, but do not have aromatic character.

The term "aryl" refers to aromatic monocyclic or polycyclic ring systems incuding besides carbon atoms no heteroatom or 1 , 2, 3 or 4 heteroatoms independently selected from the group consisting of N, O and S.

The term "heteroaryl" refers to aromatic monocyclic or polycyclic ring systems incuding besides carbon atoms, 1 , 2, 3 or 4 heteroatoms independently selected from the group consisting of N, O and S.

The terms "cyclic moiety" or "cyclic group'Yefer to a radical which is an alicyclic ring or an aromatic ring, such as, for example, phenyl or heteroaryl.

The term "and wherein any of the aliphatic or cyclic groups are unsubstituted or substituted by 1 , 2, 3, 4 or up to the maximum possible number of identical or different groups R ^1a " refers to aliphatic groups, cyclic groups and groups, which contain an aliphatic and a cyclic moiety in one group, such as in, for example, phenyl-Ci-C4-alkyl; therefore a group which contains an aliphatic and a cyclic moiety both of these moieties may be substituted or unsubstituted independently of each other. The term "phenyl" refers to an aromatic ring system incuding six carbon atoms (commonly referred to as benzene ring). In association with the group A the term "phenyl" is to be interpreted as a benzene ring or phenylene ring, which is attached to both, the oxadiazole moiety and the -R ³ R ⁴ - group.

The term "saturated or partially unsaturated 3-, 4-, 5-, 6- or 7-membered carbocycle" is to be understood as meaning both saturated or partially unsaturated carbocycles having 3, 4, 5, 6 or 7 ring members. Examples include cyclopropyl, cyclopentyl, cyclopentenyl, cyclopentadienyl, cyclohexyl, cyclohexenyl, cyclohexadienyl, cycloheptyl, cycloheptenyl, cycloheptadienyl, and the like.

The term "3- to 10-membered saturated, partially unsaturated or aromatic mono- or bicyclic heterocycle, wherein the ring member atoms of said mono- or bicyclic heterocycle include besides carbon atoms further 1 , 2, 3 or 4 heteroatoms selected from N, O and S as ring member atoms", is to be understood as meaning both, aromatic mono- and bicyclic

heteroaromatic ring systems, and also saturated and partially unsaturated heterocycles, for example:

a 3- or 4-membered saturated heterocycle which contains 1 or 2 heteroatoms from the group consisting of N, O and S as ring members such as oxirane, aziridine, thiirane, oxetane, azetidine, thiethane, [1 ,2]dioxetane, [1 ,2]dithietane, [1 ,2]diazetidine;

and a 5- or 6-membered saturated or partially unsaturated heterocycle which contains 1 , 2 or 3 heteroatoms from the group consisting of N, O and S as ring members such as 2-tetrahydro- furanyl, 3-tetrahydrofuranyl, 2-tetrahydrothienyl, 3-tetrahydrothienyl, 2-pyrrolidinyl, 3-pyrrolidinyl, 3-isoxazolidinyl, 4-isoxazolidinyl, 5-isoxazolidinyl, 3-isothiazolidinyl, 4-isothiazolidinyl,

5-isothiazolidinyl, 3-pyrazolidinyl, 4-pyrazolidinyl, 5-pyrazolidinyl, 2-oxazolidinyl, 4-oxazolidinyl, 5-oxazolidinyl, 2-thiazolidinyl, 4-thiazolidinyl, 5-thiazolidinyl, 2-imidazolidinyl, 4-imidazolidinyl, 1 ,2,4-oxadiazolidin-3-yl, 1 ,2,4-oxadiazolidin-5-yl, 1 ,2,4-thiadiazolidin-3-yl, 1 ,2,4-thiadiazolidin-5- yl, 1 ,2,4-triazolidin-3-yl, 1 ,3,4-oxadiazolidin-2-yl, 1 ,3,4-thiadiazolidin-2-yl, 1 ,3,4-triazolidin-2-yl, 2,3-dihydrofur-2-yl, 2,3-dihydrofur-3-yl, 2,4-dihydrofur-2-yl, 2,4-dihydrofur-3-yl, 2,3-dihydrothien-

2- yl, 2,3-dihydrothien-3-yl, 2,4-dihydrothien-2-yl, 2,4-dihydrothien-3-yl, 2-pyrrolin-2-yl, 2-pyrrolin-

3- yl, 3-pyrrolin-2-yl, 3-pyrrolin-3-yl, 2-isoxazolin-3-yl, 3-isoxazolin-3-yl, 4-isoxazolin-3-yl, 2- isoxazolin-4-yl, 3-isoxazolin-4-yl, 4-isoxazolin-4-yl, 2-isoxazolin-5-yl, 3-isoxazolin-5-yl,

4- isoxazolin-5-yl, 2-isothiazolin-3-yl, 3-isothiazolin-3-yl, 4-isothiazolin-3-yl, 2-isothiazolin-4-yl, 3- isothiazolin-4-yl, 4-isoth iazoli n-4-y 1 , 2-isothiazolin-5-yl, 3-isothiazolin-5-yl, 4-isoth iazoli n-5-y 1 , 2,3- dihydropyrazol-1-yl, 2,3-dihydropyrazol-2-yl, 2,3-dihydropyrazol-3-yl, 2,3-dihydropyrazol-4-yl, 2,3-dihydropyrazol-5-yl, 3,4-dihydropyrazol-1-yl, 3,4-dihydropyrazol-3-yl, 3,4-dihydropyrazol-4- yl, 3,4-dihydropyrazol-5-yl, 4,5-dihydropyrazol-1-yl, 4,5-dihydropyrazol-3-yl, 4,5-dihydropyrazol- 4-yl, 4,5-dihydropyrazol-5-yl, 2,3-dihydrooxazol-2-yl, 2,3-dihydrooxazol-3-yl, 2,3-dihydrooxazol- 4-yl, 2,3-dihydrooxazol-5-yl, 3,4-dihydrooxazol-2-yl, 3,4-dihydrooxazol-3-yl, 3,4-dihydrooxazol-4- yl, 3,4-dihydrooxazol-5-yl, 3,4-dihydrooxazol-2-yl, 3,4-dihydrooxazol-3-yl, 3,4-dihydrooxazol-4- yl, 2-piperidinyl, 3-piperidinyl, 4-piperidinyl, 1 ,3-dioxan-5-yl, 2-tetrahydropyranyl, 4- tetrahydropyranyl, 2-tetrahydrothienyl, 3-hexahydropyridazinyl, 4-hexahydropyridazinyl,

2-hexahydropyrimidinyl, 4-hexahydropyrimidinyl, 5-hexahydropyrimidinyl, 2-piperazinyl, 1 ,3,5- hexahydrotriazin-2-yl and 1 ,2,4-hexahydrotriazin-3-yl and also the corresponding -ylidene radicals; and a 7-membered saturated or partially unsaturated heterocycle such as tetra- and

hexahydroazepinyl, such as 2,3,4,5-tetrahydro[1 H]azepin-1-,-2-,-3-,-4-,-5-,-6- or-7-yl, 3,4,5,6- tetrahydro[2H]azepin-2-,-3-,-4-,-5-,-6- or-7-yl, 2,3,4,7-tetrahydro[1 H]azepin-1 -,-2-,-3-,-4-,-5-,-6- or-7-yl, 2,3,6,7-tetrahydro[1 H]azepin-1 -,-2-,-3-,-4-,-5-,-6- or-7-yl, hexahydroazepin-1 -,-2-,-3- or- 4-yl, tetra- and hexahydrooxepinyl such as 2,3,4,5-tetrahydro[1 H]oxepin-2-,-3-,-4-,-5-,-6- or-7-yl, 2,3,4,7-tetrahydro[1 H]oxepin-2-,-3-,-4-,-5-,-6- or-7-yl, 2,3,6,7-tetrahydro[1 H]oxepin-2-, -3-,-4-,-5- ,-6- or-7-yl, hexahydroazepin-1 -,-2-,-3- or-4-yl, tetra- and hexahydro-1 ,3-diazepinyl, tetra- and hexahydro-1 ,4-diazepinyl, tetra- and hexahydro-1 ,3-oxazepinyl, tetra- and hexahydro-1 ,4- oxazepinyl, tetra- and hexahydro-1 , 3-dioxepinyl, tetra- and hexahydro-1 ,4-dioxepinyl and the corresponding -ylidene radicals; and

the term "5- or 6-membered heteroaryl" or the term "5- or 6-membered aromatic heterocycle" refer to aromatic ring systems incuding besides carbon atoms, 1 , 2, 3 or 4 heteroatoms independently selected from the group consisting of N, O and S, for example, a 5-membered heteroaryl such as pyrrol-1-yl, pyrrol-2-yl, pyrrol-3-yl, thien-2-yl, thien-3-yl, furan-2-yl, furan-3-yl, pyrazol-1-yl, pyrazol-3-yl, pyrazol-4-yl, pyrazol-5-yl, imidazol-1 -yl, imidazol-2-yl, imidazol-4-yl, imidazol-5-yl, oxazol-2-yl, oxazol-4-yl, oxazol-5-yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, thiazol-2-yl, thiazol-4-yl, thiazol-5-yl, isothiazol-3-yl, isothiazol-4-yl, isothiazol-5-yl, 1 ,2,4-triazolyl- 1-yl, 1 ,2,4-triazol-3-yl 1 ,2,4-triazol-5-yl, 1 ,2,4-oxadiazol-3-yl, 1 ,2,4-oxadiazol-5-yl and 1 ,2,4- thiadiazol-3-yl, 1 ,2,4-thiadiazol-5-yl; or

a 6-membered heteroaryl, such as pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyridazin-3-yl, pyridazin-4-yl, pyrimidin-2-yl, pyrimidin-4-yl, pyrimidin-5-yl, pyrazin-2-yl and 1 ,3,5-triazin-2-yl and 1 ,2,4-triazin-3-yl.

In respect of the variables, the embodiments of the intermediates correspond to the

embodiments of the compounds I. Preference is given to those compounds I and, where applicable, also to compounds of all sub-formulae provided herein, wherein all variables have independently of each other or more preferably in combination (any possible combination of 2 or more substituents as defined herein) the following meanings:

In one aspect of the invention A is phenyl which is unsubstituted or substituted by 1 , 2, 3 or 4 identical or different groups R ^A as defined or preferably defined herein and wherein the group - C(R ³ R ⁴ )-NR ¹ R ² is attached to the phenyl ring in para-pos\t\on with regard to the

trifluoromethyloxadiazole group.

In one aspect of the invention A is phenyl which is unsubstituted or substituted by 1 , 2, 3 or 4 identical or different groups R ^A as defined or preferably defined herein and wherein the group - C(R ³ R ⁴ )-NR ¹ R ² is attached to the phenyl ring in /^e/a-position with regard to the

trifluoromethyloxadiazole group.

In a further aspect of the invention A is phenyl which is substituted by 1 or 2 identical or different groups R ^A as defined or preferably defined herein and wherein the group -C(R ³ R ⁴ )-NR ¹ R ² is attached to the phenyl ring in para-pos\t\on with regard to the trifluoromethyloxadiazole group. In another aspect of the invention A is phenyl which is unsubstituted and wherein the group - C(R ³ R ⁴ )-NR ¹ R ² is attached to the phenyl ring in para-pos\t\on with regard to the

trifluoromethyloxadiazole group. In a preferred embodiment of the invention A is phenyl substituted by R ^A selected from halogen, Ci-C6-alkyl. In a further preferred embodiment of the invention A is phenyl substituted by halogen. In a special preferred embodiment of the invention A is phenyl substituted by F. In a further special preferred embodiment of the invention A is phenyl substituted by CI. In a further preferred embodiment of the invention A is phenyl substituted by In a special preferred embodiment of the invention A is phenyl substituted by S(=0)2NH2.

In a further preferred embodiment of the invention A is phenyl substituted by Ci-C6-alkyl. In a special preferred embodiment of the invention A is phenyl substituted by CH3. In a further special preferred embodiment of the invention A is phenyl substituted by CH ₂ CH ₃ . In a further special preferred embodiment of the invention A is phenyl which is unsubstituted.

In one embodiment A is a 6-membered aromatic heterocycle, wherein the ring member atoms of the aromatic heterocycle include besides carbon atoms 1 or 2 nitrogen atoms as ring member atoms; and wherein the aromatic heterocyclic ring is unsubstituted or substituted by 1 or 2 identical or different groups R ^A as defined or preferably defined herein.

In a further embodiment A is a 6-membered aromatic heterocycle, wherein the ring member atoms of the aromatic heterocycle include besides carbon atoms 1 or 2 nitrogen atoms as ring member atoms; and wherein the aromatic heterocycle is unsubstituted or substituted by 1 or 2 identical or different groups R ^A as defined or preferably defined herein and wherein the group -

C(R ³ R ⁴ )-NR ¹ R ² is attached to the 6-membered aromatic heterocycle in para-pos\t\on with regard to the trifluoromethyloxadiazole group.

In a further embodiment A is a 6-membered aromatic heterocycle, wherein the ring member atoms of the aromatic heterocycle include besides carbon atoms 1 or 2 nitrogen atoms as ring member atoms; and wherein the aromatic heterocycle is unsubstituted or substituted by 1 or 2 identical or different groups R ^A as defined or preferably defined herein and wherein the group - C(R ³ R ⁴ )-NR ¹ R ² is attached to the 6-membered aromatic heterocycle in /77ete-position with regard to the trifluoromethyloxadiazole group.

In a further embodiment A is a 6-membered aromatic heterocycle, wherein the ring member atoms of the aromatic heterocycle include besides carbon atoms 1 or 2 nitrogen atoms as ring member atoms; and wherein the aromatic heterocycle is unsubstituted or substituted by 1 or 2 identical or different groups R ^A as defined or preferably defined herein and wherein the group -C(R ³ R ⁴ )-NR ¹ R ² is attached to the 6-membered aromatic heterocycle in with regard to the trifluoromethyloxadiazole group.

In a further embodiment A is a 6-membered aromatic heterocycle, wherein the ring member atoms of the aromatic heterocycle include besides carbon atoms 1 or 2 nitrogen atoms as ring member atoms; and wherein the aromatic heterocycle is unsubstituted and wherein the group - C(R ³ R ⁴ )-NR ¹ R ² is attached to the 6-membered aromatic heterocycle in para-pos\t\on with regard to the trifluoromethyloxadiazole group.

In a further preferred embodiment A is a 5-membered aromatic heterocycle, wherein the ring member atoms of the heterocycle include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from N, O and S as ring member atoms; and wherein the cyclic groups A are unsubstituted or substituted by 1 or 2 identical or different groups R ^A as defined or preferably defined herein. In a further preferred embodiment A is a 5-membered aromatic heterocycle, wherein the ring member atoms of the heterocycle include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from N, O and S as ring member atoms; and wherein the cyclic groups A are unsubstituted. In one embodiment the invention relates to compounds of the formula I, or the N-oxides, or the agriculturally acceptable salts thereof, wherein the cyclic moiety A is defined as in subformulae (A.1 ) to (A.12),

(A.1 ) (A.2) (A3) (A.4)

(A.9) (A.10) (A1 1 ) (A 12)

wherein #1 denotes the position which is bound to the trifluoromethyloxadiazole moiety and #2 denotes the position, which is connected to the -C(R ³ R ⁴ )-NR ¹ R ² group of compounds of the formula I; and wherein the cyclic moiety A is unsubstituted or substituted by 1 or 2 identical or different groups R ^A and wherein R ^A is as defined or preferably defined herein. In another embodiment the cyclic moieties A as defined in any one of subformulae (A.1 ) to (A.12) is unsubstituted or substituted by 1 or 2 identical or different groups R ^A ; and wherein R ^A is chlorine, fluorine or methyl. In a preferred embodiment the cyclic moiety A as defined in any one of subformulae (A.1 ) to (A.12) is unsubstituted.

In a preferred embodiment of the invention R ^A is halogen, cyano, Ci-C6-alkyl, Ci-C6-alkoxy, C2-C6-alkenyl, C2-C6-alkynyl or Cs-Cs-cycloalkyl; and wherein any of the aliphatic and cyclic moieties are unsubstituted or substituted by 1 , 2, 3, 4 or up to the maximum possible number of identical or different groups R ^a as defined or preferably defined herein.

In another preferred embodiment of the invention R ^A is halogen, cyano, Ci-C6-alkyl, Ci-C6-alk- oxy, C2-C6-alkenyl, C2-C6-alkynyl or Cs-Cs-cycloalkyl; and wherein any of the the aliphatic and cyclic moieties are unsubstituted or substituted by 1 , 2, 3, 4 or up to the maximum possible number of identical or different groups selected from halogen, cyano, Ci-C6-alkyl, Ci-C6-alkoxy and C3-Cs-cycloalkyl; in particular fluorine. More preferably R ^A is halogen, cyano, Ci-C6-alkyl, Ci-C6-haloalkyl, Ci-C6-alkoxy or C1-C6- haloalkoxy; in particular halogen, Ci-C6-alkyl. In a more preferable embodiment R ^A is chlorine, fluorine or methyl.

R ^a according to the invention is halogen, cyano, NO2, OH, SH, NH2, Ci-C6-alkyl, Ci-C6-haloalkyl, Ci-C6-alkoxy, Ci-C6-haloalkoxy, Ci-C6-alkylthio, Ci-C6-haloalkylthio or Cs-Cs-cycloalkyl. In a preferred embodiment of the invention R ^a is halogen, cyano, Ci-C6-alkyl, Ci-C6-alkoxy or Cs-Cs- cycloalkyl. More preferably R ^a is halogen, in particular fluorine.

According to one embodiment R ¹ is H. According to one embodiment R ¹ is Ci-C6-alkyl, preferably methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, t-butyl, in particular methyl, ethyl. According to a further embodiment R ¹ is C2-C6-alkenyl, preferably ethylene. According to a further embodiment R ¹ is C2-C6-alkynyl, preferred ethynyl, 1 -propynyl. According to a further embodiment R ¹ is Cs-Cs- cycloalkyl, preferrably cyclopropyl, cyclobutyl, cyclopentyl, in particular cyclopropyl, cyclopentyl or cyclohexyl.

According to one embodiment R ¹ is Ci-C6-alkyl substituted by halogen, preferably methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, t-butyl, in particular methyl, ethyl. In a special embodiment of the invention, R ¹ CF3.

According to one embodiment R ¹ is C(=0)-(Ci-C6-alkyl). According to one embodiment R ¹ is

C(=0)-(Ci-C6-alkyl), wherein alkyl is preferably methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, t- butyl, in particular methyl, ethyl. According to one embodiment R ¹ is C(=0)-(Ci-C6-alkoxy), wherein alkoxy is preferrably methoxy, ethoxy, n-propoxy, i-propoxy, n-butoxy, i-butoxy, t-butoxy. According to one embodiment R ¹ is phenyl-Ci-C4-alkyl, wherein alkyl is preferably methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, t-butyl, in particular methyl, ethyl.

According to one embodiment R ¹ is heteroaryl-Ci-C4-alkyl, wherein alkyl is preferably methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, t-butyl, in particular methyl, ethyl and wherein heteroaryl is furan, thiophen, pyrazol, isoxazol, imidazole, oxazol, thiazol, triazol, oxydiazol, pyrol, pyrimidin.

According to one embodiment R ¹ is phenyl. According to a further embodiment R ¹ is benzyl.

According to a further embodiment R ¹ is naphthyl. According to one embodiment R ¹ is a 3- to 10-membered saturated, partially unsaturated or aromatic mono- or bicyclic heterocycle, wherein the ring member atoms of said mono- or bicyclic heterocycle include besides carbon atoms further 1 , 2, 3 or 4 heteroatoms selected from N, O and S as ring member atoms and wherein 1 or 2 carbon ring member atoms of the heterocycle may be replaced by 1 or 2 groups independently selected from C(=0) and C(=S); and wherein the heteroaryl group in heteroaryl-Ci-C4-alkyl is a 5- or 6-membered aromatic heterocycle, wherein the ring member atoms of the heterocyclic ring include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from N, O and S as ring member atoms especially, furan, thiophen, pyrazol, isoxazol, imidazole, oxazol, thiazol, triazol, oxydiazol, pyrol, pyriminin.

According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of methyl, ethyl, propyl, butyl, preferably methyl. According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of partially or fully halogenated methyl, ethyl, propyl, butyl, preferably partially or fully

halogenated methyl, in particular CF3. According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of methoxy, ethoxy, propoxy, butoxy, preferably methoxy. According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of partially or fully halogenated methoxy, ethoxy, propoxy, butoxy, preferably partially or fully halogenated methoxy, in particular OCF ₃ . In a special embodiment of the invention, R ¹ is phenyl. In a further special embodiment of the invention, R ¹ is phenyl substituted by CI, F, Br, I , CH ₃ , OCH ₃ , CF ₃ or OCF ₃ . In a further special embodiment of the invention, R ¹ is benzyl substituted by CI, F, Br, I , CH3, OCH3, CF3 or OCF3. In a further special embodiment R ¹ is naphtyl substituted by CI, F, Br, I , CH3, OCH3, CF3 or OCF3. In a further special embodiment of the invention, R ¹ is thiophene substituted by CI, F, Br, I, CH3, OCH3, CF3 or OCF3. In a further special embodiment of the invention, R ¹ is pyrol substituted by CI, F, Br, I , CH3, OCH3, CF3 or OCF3. In a further special embodiment of the invention, R ¹ is pyrazol substituted by CI, F, Br, I , CH3, OCH3, CF3 or OCF3. In a further special embodiment of the invention, R ¹ is pyrimidin substituted by CI, F, Br, I , CH ₃ , OCH ₃ , CF ₃ or OCF3. In a further special embodiment of the invention, R ¹ is oxydiazol substituted by CI, F, Br, I, CH ₃ , OCH3, CF ₃ or OCF ₃ .

In a preferred embodiment R ¹ is H, Ci-C6-alkyl, C3-C6-cycloalkyl. In a special preferred

embodiment R ¹ is H, CH3, cyclopropyl.

According to one embodiment R ² is H. According to one embodiment R ² is Ci-C6-alkyl, preferably methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, t-butyl, in particular methyl, ethyl. According to a further embodiment R ² is C2-C6-alkenyl, preferably ethylene. According to a further embodiment R ² is C2-C6-alkynyl, preferred ethynyl, 1 -propynyl. According to a further embodiment R ² is C ₃ -C8- cycloalkyl, preferrably cyclopropyl, cyclobutyl, cyclopentyl, in particular cyclopropyl, cyclopentyl or cyclohexyl.

According to one embodiment R ² is Ci-C6-alkyl substituted by halogen, preferably methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, t-butyl, in particular methyl, ethyl. In a special embodiment of the invention, R ² CF3.

According to one embodiment R ² is C(=0)-(Ci-C6-alkyl). According to one embodiment R ² is C(=0)-(Ci-C6-alkyl), wherein alkyl is preferably methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, t- butyl, in particular methyl, ethyl. According to one embodiment R ² is C(=0)-(CrC ₆ -alkoxy), wherein alkoxy is preferrably methoxy, ethoxy, n-propoxy, i-propoxy, n-butoxy, i-butoxy, t-butoxy. According to one embodiment R ² is phenyl-Ci-C4-alkyl, wherein alkyl is preferably methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, t-butyl, in particular methyl, ethyl.

According to one embodiment R ² is heteroaryl-Ci-C4-alkyl, wherein alkyl is preferably methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, t-butyl, in particular methyl, ethyl and wherein heteroaryl is furan, thiophen, pyrazol, isoxazol, imidazole, oxazol, thiazol, triazol, oxydiazol, pyrol, pyriminin.

According to one embodiment R ² is phenyl. According to a further embodiment R ² is benzyl.

According to a further embodiment R ² is naphthyl. According to one embodiment R ² 3- to

10-membered saturated, partially unsaturated or aromatic mono- or bicyclic heterocycle, wherein the ring member atoms of said mono- or bicyclic heterocycle include besides carbon atoms further 1 , 2, 3 or 4 heteroatoms selected from N, O and S as ring member atoms and wherein 1 or 2 carbon ring member atoms of the heterocycle may be replaced by 1 or 2 groups independently selected from C(=0) and C(=S); and wherein the heteroaryl group in heteroaryl-Ci-C4-alkyl is a 5- or 6-membered aromatic heterocycle, wherein the ring member atoms of the heterocyclic ring include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from N, O and S as ring member atoms especially, furan, thiophen, pyrazol, isoxazol, imidazole, oxazol, thiazol, triazol, oxydiazol, pyrol, pyriminin.

According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of methyl, ethyl, propyl, butyl, preferably methyl. According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of partially or fully halogenated methyl, ethyl, propyl, butyl, preferably partially or fully

halogenated methyl, in particular CF3. According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of methoxy, ethoxy, propoxy, butoxy, preferably methoxy. According to a further embodiment the above mentioned groups may carry one, two, three or four identical or different substituents selected from the group consisting of partially or fully halogenated methoxy, ethoxy, propoxy, butoxy, preferably partially or fully halogenated methoxy, in particular OCF3. In a special embodiment of the invention, R ² is phenyl. In a further special embodiment of the invention, R ² is phenyl substituted by CI, F, Br, I, CH3, OCH3, CF3 or OCF3. In a further special embodiment of the invention, R ² is benzyl substituted by CI, F, Br, I, CH3, OCH3, CF3 or OCF3. In a further special embodiment R ² is naphtyl substituted by CI, F, Br, I, CH3, OCH3, CF3 or OCF3. In a further special embodiment of the invention, R ² is thiophene substituted by CI, F, Br, I, CH3, OCH3, CF3 or OCF3. In a further special embodiment of the invention, R ² is pyrol substituted by CI, F, Br, I, CH ₃ , OCH ₃ , CF ₃ or OCF ₃ . In a further special embodiment of the invention, R ² is pyrazol substituted by CI, F, Br, I, CH ₃ , OCH ₃ , CF ₃ or OCF ₃ . In a further special embodiment of the invention, R ² is pyrimidin substituted by CI, F, Br, I, CH3, OCH3, CF3 or OCF3. In a further special embodiment of the invention, R ² is oxydiazol substituted by CI, F, Br, I, CH ₃ , OCH3, CF ₃ or OCF ₃ .

In a preferred embodiment R ² is H, Ci-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C3-C6-cycloalkyl, phenyl-Ci-C4-alkyl, heteroaryl-Ci-C4-alkyl, phenyl. In a special preferred embodiment R ² is H, Ci-C6-alkyl, C3-C6-cycloalkyl, phenyl-Ci-C4-alkyl, heteroaryl-Ci-C4-alkyl, phenyl. In a further special preferred embodiment R ² is H, Ci-C6-alkyl, C ₃ -C6-cycloalkyl, phenyl-Ci-C4-alkyl, phenyl. In a further special preferred embodiment R ² is H, CH ₃ , CH ₂ CH ₃ , cyclopropyl, phenyl, benzyl. In another preferred embodiment R ¹ is hydrogen, Ci-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C3-C6-cycloalkyl, C3-C6-cycloalkenyl, phenyl-Ci-C4-alkyl, heteroaryl-Ci-C4-alkyl, phenyl or a 3- to 10-membered saturated, partially unsaturated or aromatic mono- or bicyclic heterocycle, wherein the ring member atoms of said mono- or bicyclic heterocycle include besides carbon atoms further 1 , 2, 3 or 4 heteroatoms selected from N, O and S as ring member atoms and wherein 1 or 2 carbon ring member atoms of the heterocycle may be replaced by 1 or 2 groups independently selected from C(=0) and C(=S); and wherein the heteroaryl group in heteroaryl- Ci-C4-alkyl is a 5- or 6-membered aromatic heterocycle, wherein the ring member atoms of the heterocyclic ring include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from N, O and S as ring member atoms; and wherein any of the above-mentioned aliphatic or cyclic groups are unsubstituted or substituted by 1 , 2, 3 or up to the maximum possible number of identical or different groups R ^1a ; wherein R ^1a is halogen, cyano, NO2, OH, SH, NH2, Ci-C6-alkyl,

Ci-C6-haloalkyl, Ci-C6-alkoxy, Ci-C6-haloalkoxy, Ci-C6-alkylthio, Ci-C6-haloalkylthio, C3-C8- cycloalkyl, NHS0 ₂ -Ci-C ₄ -alkyl, (C=0)-(Ci-C ₄ -alkyl), C(=0)-(Ci-C ₄ -alkoxy) or d-Ce-alkylsulfonyl; and wherein R ² is C(=0)-(Ci-C ₆ -alkyl), C(=0)-(Ci-C ₆ -alkoxy), C(=0)-(Ci-C ₆ -haloalkyl),

C(=0)-(Ci-C6-haloalkoxy), Ci-C6-alkylsulfonyl or Ci-C6-haloalkylsulfonyl.

In a further embodiment R ¹ and R ² independently of each other are hydrogen, Ci-C6-alkyl, C ₂ -C ₆ -alkenyl, C ₂ -C ₆ -alkynyl, C ₃ -Ce-cycloalkyl, , C(=0)-(Ci-C ₆ -alkyl), C(=0)-(Ci-C ₆ -alkoxy), phenyl-Ci-C ₄ -alkyl or phenyl; and wherein the aliphatic and the cyclic groups are unsubstituted or substituted by 1 , 2, 3, 4 or up to the maximum possible number of identical or different groups R ^1a as defined herein.

In another embodiment R ¹ is hydrogen, Ci-C6-alkyl, C2-C6-alkenyl or C2-C6-alkynyl and R ² is hydrogen, Ci-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, Cs-Cs-cycloalkyI, phenyl-Ci-C ₄ -alkyl, heteroaryl-Ci-C ₄ -alkyl, phenyl or heteroaryl; and wherein the heteroaryl group is a 5- or 6- membered aromatic heterocycle, wherein the ring includes besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from N, O and S as ring member atoms; and wherein any of the aliphatic or cyclic groups are unsubstituted or substituted by 1 , 2, 3, 4 or up to the maximum possible number of identical or different groups R ^1a as defined herein.

In one aspect of the invention R ¹ and R ² independently of each other are hydrogen, Ci-C6-alkyl, C ₂ -C ₆ -alkenyl, C ₂ -C ₆ -alkynyl, C ₃ -C ₈ -cycloalkyl, C(=0)-(Ci-C ₆ -alkyl) or C(=0)-(Ci-C ₆ -alkoxy); and wherein any of the aliphatic or cyclic groups are unsubstituted or substituted by 1 , 2, 3, 4 or up to the maximum possible number of identical or different groups R ^1a as defined or preferably defined herein.

In another embodiment R ¹ is hydrogen, Ci-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl or C3-C8- cycloalkyl; preferably R ¹ is hydrogen or Ci-C6-alkyl; and R ² is C(=0)-(CrC ₆ -alkyl) or C(=0)- (Ci-C6-alkoxy); and wherein any of the aliphatic or cyclic groups are unsubstituted or substituted by 1 , 2, 3, 4 or up to the maximum possible number of identical or different groups R ^1a as defined or preferably defined herein.

In another embodiment R ¹ is hydrogen, Ci-C6-alkyl, C2-C6-alkenyl, C ₂ -C6-alkynyl or C3-C8- cycloalkyl; preferably R ¹ is hydrogen or Ci-C6-alkyl; and R ² is C(=0)-(Ci-C6-alkyl); and wherein any of the aliphatic or cyclic groups are unsubstituted or substituted by 1 , 2, 3, 4 or up to the maximum possible number of identical or different radicals selected from the group fluorine, chlorine and methyl.

In one aspect of the invention R ¹ and R ² independently of each other are hydrogen, Ci-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, Cs-Cs-cycloalkyI,; and wherein any of the aliphatic or cyclic groups are unsubstituted or substituted by 1 , 2, 3, 4 or up to the maximum possible number of identical or different groups R ^1a as defined or preferably defined herein.

In a further aspect of the invention R ¹ is hydrogen, Ci-C6-alkyl, C2-C6-alkenyl or C2-C6-alkynyl and R ² is phenyl-Ci-C ₄ -alkyl, heteroaryl-Ci-C ₄ -alkyl, phenyl or heteroaryl; and wherein the heteroaryl group is a 5- or 6-membered aromatic heterocycle wherein the ring includes besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from N, O and S as ring member atoms; and wherein any of the aliphatic or cyclic groups are unsubstituted or substituted by 1 , 2, 3, 4 or up to the maximum possible number of identical or different groups R ^1a as defined or preferably defined herein.

In a further aspect of the invention R ¹ is hydrogen, Ci-C6-alkyl, C2-C6-alkenyl or C2-C6-alkynyl and R ² is phenyl-Ci-C ₄ -alkyl, heteroaryl-Ci-C ₄ -alkyl or phenyl; and wherein the heteroaryl group is a 5- or 6-membered aromatic heterocycle wherein the ring includes besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from N, O and S as ring member atoms; and wherein any of the aliphatic or cyclic groups are unsubstituted or substituted by 1 , 2, 3, 4 or up to the maximum possible number of identical or different groups R ^1a as defined or preferably defined herein. In one embodiment R ¹ is hydrogen or Ci-C4-alkyl and R ² is Cs-Cs-cycloalkyl, wherein the cycloalkyl group is unsubstituted or carries 1 , 2, 3, 4 or up to the maximum possible number of identical or different groups R ^1a as defined or preferably defined herein.

In one embodiment R ¹ is hydrogen or Ci-C4-alkyl and R ² is Ci-C6-alkyl, C2-C6-alkenyl or C2-C6- alkynyl, wherein the aliphatic groups are unsubstituted or carry 1 , 2, 3, 4 or up to the maximum possible number of identical or different groups R ^1a as defined or preferably defined herein. In one embodiment R ¹ is hydrogen or Ci-C4-alkyl and R ² is phenyl, a 5- or 6-membered aromatic heterocycle, phenyl-Ci-C4-alkyl or heteroaryl-Ci-C4-alkyl, wherein the ring member atoms of the heterocyclic ring include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from N, O and S as ring member atoms; and wherein any of the cyclic groups are unsubstituted or substituted by 1 , 2, 3, 4 or up to the maximum possible number of identical or different groups R ^1a as defined or preferably defined herein.

In one embodiment R ¹ is hydrogen or Ci-C4-alkyl and R ² is phenyl-Ci-C4-alkyl or heteroaryl- Ci-C4-alkyl; wherein the heteroaryl group is a 5- or 6-membered aromatic heterocycle, wherein the ring member atoms of the aromatic heterocycle include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from N, O and S as ring member atoms; wherein any of the aliphatic or cyclic groups are unsubstituted or substituted by 1 , 2, 3, 4 or up to the maximum possible number of identical or different groups R ^1a as defined or preferably defined herein.

In one embodiment R ¹ is hydrogen or Ci-C4-alkyl and R ² is phenyl or a 5- or 6-membered aromatic heterocycle, wherein the ring member atoms of the heterocyclic ring include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from N, O and S as ring member atoms; and wherein any of the cyclic groups are unsubstituted or substituted by 1 , 2, 3, 4 or up to the maximum possible number of identical or different groups R ^1a as defined or preferably defined herein.

In another aspect of the invention R ¹ and R ² together with the nitrogen atom to which they are bound form a saturated or partially unsaturated 3- to 6-membered heterocycle, wherein the heterocycle includes beside one nitrogen atom and one or more carbon atoms no further heteroatoms or 1 , 2 or 3 further heteroatoms independently selected from N, O and S as ring member atoms; and wherein one or two CH2 groups of the heterocycle may be replaced by one or two groups independently selected from the group of C(=0) and C(=S); and wherein the heterocycle is unsubstituted or carries 1 , 2, 3, 4 or up to the maximum possible number of identical or different groups R ^1a as defined or preferably defined herein.

In still another aspect of the invention R ¹ and R ² together with the nitrogen atom to which they are bound form a saturated or partially unsaturated 3- to 6-membered heterocycle, wherein the heterocycle includes beside one nitrogen atom and one or more carbon atoms no further heteroatoms or one additional heteroatom selected from N, O and S as ring a member atom; and wherein the heterocycle is unsubstituted or carries 1 , 2, 3, 4 or up to the maximum possible number of identical or different groups R ^1a as defined or preferably defined herein. In a further embodiment R ¹ and R ² together with the nitrogen atom to which they are bound form a saturated or partially unsaturated monocyclic 5- to 7-membered heterocycle, wherein the heterocycle includes beside one nitrogen atom and one or more carbon atoms no further heteroatom or 1 or 2 heteroatoms independently selected from N, O and S as ring member atoms; and wherein one or two CH ₂ groups of the heterocycle are replaced by one or two groups independently selected from the group of C(=0) and C(=S); and wherein the heterocycle is unsubstituted or carries 1 , 2, 3, 4 or up to the maximum possible number of identical or different groups R ^1a as defined or preferably defined herein; particularly R ^1a is halogen or d-Ce-alkyl.

In a further embodiment R ¹ and R ² together with the nitrogen atom to which they are bound form a saturated or partially unsaturated monocyclic 5- or 6-membered heterocycle, wherein the heterocycle includes beside one nitrogen atom and one or more carbon atoms no further heteroatom or 1 further heteroatom independently selected from N, O and S as ring member atoms; and wherein one or two CH ₂ groups of the heterocycle may be replaced by one or two groups independently selected from the group of C(=0) and C(=S); and wherein the heterocycle is unsubstituted or carries 1 , 2, 3, 4 or up to the maximum possible number of identical or different groups R ^1a as defined or preferably defined herein; particularly R ^1a is halogen or d-Ce-alkyl.

In one embodiment of the invention R ^1a is halogen, cyano, Ci-C6-alkyl, Ci-C6-haloalkyl,

Ci-C6-alkoxy, Ci-C6-haloalkoxy or Cs-Cs-cycloalkyl. In another preferred aspect of the invention R ^1a is halogen, cyano, Ci-C6-alkyl, Ci-C6-haloalkyl, Ci-C6-alkoxy or Ci-C6-haloalkoxy. In another preferred aspect of the invention R ^1a is fluorine, chlorine, cyano, methyl, methoxy,

trifluoromethyl, trifluoromethoxy, difluoromethyl or difluoromethoxy. In a more preferred aspect of the invention R ^1a is halogen or Ci-C6-alkyl; particularly fluorine, chlorine or methyl.

In one embodiment of the invention R ¹ and R ² together with the nitrogen atom to which they are bound form a saturated or partially unsaturated mono- or bicyclic 3- to 7-membered heterocycle, wherein the heterocycle includes beside one nitrogen atom and one or more carbon atoms 1 , 2 or 3 heteroatoms independently selected from N, O and S as ring member atoms; and wherein one or two CH ₂ groups of the heterocycle may be replaced by one or two groups independently selected from the group of C(=0) and C(=S); and wherein the heterocycle is unsubstituted or carries 1 , 2, 3, 4 or up to the maximum possible number of identical or different groups R ^1a ; wherein R ^1a is halogen, cyano, N0 ₂ , OH, SH, NH ₂ , d-Ce-alkyl, C C ₆ -haloalkyl, C C ₆ -alkoxy, d-Ce-haloalkoxy, C C ₆ -alkylthio, C C ₆ -haloalkylthio, C ₃ -C ₈ -cycloalkyl, NHS0 ₂ -Ci-C ₄ -alkyl, (C=0)-Ci-C ₄ -alkyl, C(=0)-Ci-C ₄ -alkoxy or Ci-C ₆ -alkylsulfonyl.

In one embodiment of the invention R ¹ and R ² together with the N atom to which it is bound form a saturated or partially unsaturated 3- to 6-membered heterocycle, wherein the heterocycle includes beside one nitrogen atom and one or more carbon atoms no further heteroatoms. In one embodiment of the invention R ¹ and R ² together with the N to which it is bound form a saturated or partially unsaturated 3- to 6-membered heterocycle, wherein one or two CH ₂ groups of the heterocycle may be replaced by one or two groups independently selected from the group of C(=0) and C(=S).

In one special preferred embodiment of the invention R ¹ and R ² together with the N atom to which it is bound form a aziridinyl.

In one special preferred embodiment of the invention R ¹ and R ² together with the N atom to which it is bound form a azetidinyl.

In one special preferred embodiment of the invention R ¹ and R ² together with the N atom to which it is bound form a 1-pyrrolidinyl.

In one special preferred embodiment of the invention R ¹ and R ² together with the N atom to which it is bound form a 1-piperidinyl.

In one special preferred embodiment of the invention R ¹ and R ² together with the N atom to which it is bound form a 1-piperazinyl.

In one special preferred embodiment of the invention R ¹ and R ² together with the N atom to which it is bound form a 1-methyl-4-piperazinyl.

In one special preferred embodiment of the invention R ¹ and R ² together with the N atom to which it is bound form a 4-morpholinyl.

In one embodiment of the invention R ^1a is halogen, cyano, Ci-C6-alkyl, Ci-C6-haloalkyl,

Ci-C6-alkoxy, Ci-C6-haloalkoxy. In another preferred aspect of the invention R ^1a is fluorine, chlorine, cyano, methyl, methoxy, trifluoromethyl, trifluoromethoxy, difluoromethyl or

difluoromethoxy. In a more preferred aspect of the invention R ^1a is halogen or Ci-C6-alkyl;

particularly fluorine, chlorine or methyl.

In one embodiment R ³ and R ⁴ together with the carbon atom to which they are bound form a 3- to 7-membered carbocycle or a saturated 3- to 6-membered heterocycle, wherein the heterocycle includes beside carbon atoms 1 , 2 or 3 heteroatoms independently selected from

N-R ^N ,S, S(=0), S(=0)2 and O as ring member atoms; wherein

R ^N is H, d-Ce-alkyl, SO2CH3, SO2C6H4CH3 S0 ₂ -aryl;

and wherein one or two CH2 groups of the cycle may be replaced by one or two groups independently selected from the group of C(=0) and C(=S);

and wherein the carbocycle, heterocycle and aryl is unsubstituted or carries 1 , 2, 3, 4 or up to the maximum possible number of identical or different groups R ^3a ; wherein

R ^3a is halogen, cyano, N0 ₂ , OH, SH, NH ₂ , Ci-C ₆ -alkyl, Ci-C ₆ -haloalkyl, Ci-C ₆ -alkoxy, d-Ce-haloalkoxy, Ci-C ₆ -alkylthio, Ci-C ₆ -haloalkylthio, C ₃ -C ₈ -cycloalkyl, NHS0 ₂ -Ci-C ₄ -alkyl, - (C=0)-Ci-C ₄ -alkyl, C(=0)-Ci-C ₄ -alkoxy or Ci-C ₆ -alkylsulfonyl.

In a preferred embodiment R ^N is hydrogen, Ci-C6-alkyl or SO2CH3; more preferably R ^N is hydrogen or Ci-C6-alkyl; particularly hydrogen or CH3. In another embodiment R ³ and R ⁴ together with the carbon atom to which they are bound form a 3- to 7-membered carbocycle which is unsubstituted. In one special preferred embodiment of the invention R ³ and R ⁴ together with the carbon atom to which they are bound form

cyclopropyl. In one further special preferred embodiment of the invention R ³ and R ⁴ together with the carbon atom to which they are bound form cyclobutyl. In one special preferred embodiment of the invention R ³ and R ⁴ together with the carbon atom to which they are bound form cyclopentyl. In one special preferred embodiment of the invention R ³ and R ⁴ together with the carbon atom to which they are bound form cyclohexyl.

In one embodiment R ³ and R ⁴ together with the carbon atom to which they are bound form a saturated 3- to 7-membered carbocycle, wherein one or two CH2 groups of the carbocycle may be replaced by one or two groups independently selected from the group of C(=0) and C(=S); and wherein the carbocycle is unsubstituted or carries 1 , 2, 3, 4 or up to the maximum possible number of identical or different groups R ^3a as defined or preferably defined herein. In a further embodiment of the invention R ³ and R ⁴ together with the carbon atom to which they are bound form a 3- to 7-membered carbocycle as defined above which carries 1 , 2, 3, 4 or up to the maximum possible number of identical or different groups R ^3a ; wherein

R ^3a is halogen, cyano, N0 ₂ , OH, SH, NH ₂ , Ci-C ₆ -alkyl, Ci-C ₆ -haloalkyl, Ci-C ₆ -alkoxy, d-Ce-haloalkoxy, Ci-C ₆ -alkylthio, Ci-C ₆ -haloalkylthio, C ₃ -C ₈ -cycloalkyl, NHS0 ₂ -Ci-C ₄ -alkyl, - (C=0)-Ci-C ₄ -alkyl, C(=0)-C C ₄ -alkoxy or C C ₆ -alkylsulfonyl.

In one special preferred embodiment of the invention R ^3a is halogen, Ci-C6-alkyl or C1-C6- alkylsulfonyl; specially CH3.ln a further embodiment of the invention R ³ and R ⁴ together with the carbon atom to which they are bound form a saturated 3- to 6-membered heterocycle which is unsubstituted and wherein the heterocycle includes beside carbon atoms 1 , 2 or 3 heteroatoms independently selected from N-R ^N ,S, S(=0), S(=0)2 and O as ring member atoms.

In one special preferred embodiment of the invention R ³ and R ⁴ together with the carbon atom to which they are bound form a 3-membered heterocycle wherein the heterocycle includes beside carbon atoms one heteroatom independently selected from N-R ^N ,S, S(=0), S(=0)2 and O as ring member atoms, wherein R ^N is as defined or preferably defined herein. In one special preferred embodiment of the invention R ³ and R ⁴ together with the carbon atom to which they are bound form a 3-membered heterocycle wherein the heterocycle includes beside carbon atoms oxygen atom as ring member atoms. In one special preferred embodiment of the invention R ³ and R ⁴ together with the carbon atom to which they are bound form a 3-membered heterocycle wherein the heterocycle includes beside carbon atoms N-R ^N as ring member atoms. In one special preferred embodiment of the invention R ³ and R ⁴ together with the carbon atom to which they are bound form a 4-membered heterocycle wherein the heterocycle includes beside carbon atoms one heteroatom independently selected from N-R ^N ,S, S(=0), S(=0)2 and O as ring member atoms, wherein R ^N is as defined or preferably defined herein. In one special preferred embodiment of the invention R ³ and R ⁴ together with the carbon atom to which they are bound form a 4-membered heterocycle wherein the heterocycle includes beside carbon atoms oxygen atom as ring member atoms. In one special preferred embodiment of the invention R ³ and R ⁴ together with the carbon atom to which they are bound form a 4-membered heterocycle wherein the heterocycle includes beside carbon atoms N-R ^N as ring member atoms, wherein R ^N is as defined or preferably defined herein.

In one special preferred embodiment of the invention R ³ and R ⁴ together with the carbon atom to which they are bound form a 5-membered heterocycle wherein the heterocycle includes beside carbon atoms one heteroatom independently selected from N-R ^N ,S, S(=0), S(=0)2 and O as ring member atoms, wherein R ^N is as defined or preferably defined herein. In one special preferred embodiment of the invention R ³ and R ⁴ together with the carbon atom to which they are bound form a 5-membered heterocycle wherein the heterocycle includes beside carbon atoms oxygen atom as ring member atoms. In one special preferred embodiment of the invention R ³ and R ⁴ together with the carbon atom to which they are bound form a 5-membered heterocycle wherein the heterocycle includes beside carbon atoms N-R ^N as ring member atoms, wherein R ^N is as defined or preferably defined herein.

In one special preferred embodiment of the invention R ³ and R ⁴ together with the carbon atom to which they are bound form a 6-membered heterocycle wherein the heterocycle includes beside carbon atoms one heteroatom independently selected from N-R ^N ,S, S(=0), S(=0)2 and O as ring member atoms, wherein R ^N is as defined or preferably defined herein. In one special preferred embodiment of the invention R ³ and R ⁴ together with the carbon atom to which they are bound form a 6-membered heterocycle wherein the heterocycle includes beside carbon atoms oxygen atom as ring member atoms. In one special preferred embodiment of the invention R ³ and R ⁴ together with the carbon atom to which they are bound form a 6-membered heterocycle wherein the heterocycle includes beside carbon atoms N-R ^N as ring member atoms, wherein R ^N is as defined or preferably defined herein.

In one embodiment the invention relates to the compounds of the formula I, or the N-oxides, or the agriculturally acceptable salts thereof, wherein R ³ and R ⁴ together with the carbon atom to which they are bound form a ring which is defined as in subformulae:

wherein # shall denote the carbon atom to which R ³ and R ⁴ are bound.

In one embodiment the present invention relates to compounds (1.1 ) of the formula I

wherein:

A is phenyl or a 5- or 6-membered aromatic heterocycle, wherein the ring member atoms of the heterocyclic ring include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from N, O and S as ring member atoms; and wherein the cyclic groups A are unsubstituted or substituted by 1 , 2, 3 or 4 identical or different groups R ^A ; wherein

R ^A is halogen, cyano, N0 ₂ , OH, NH ₂ , SH, S(=0) ₂ N(R ^b ) ₂ , Ci-C ₆ -alkyl, Ci-C ₆ -alkoxy,

Ci-C6-alkylthio, Ci-C6-alkylsulfinyl, Ci-C6-alkylsulfonyl, C ₂ -C6-alkenyl, C ₂ -C6-alkynyl, C3-C8-cycloalkyl or Cs-Cs-cycloalkoxy; and wherein any of the aliphatic or cyclic moieties are unsubstituted or substituted by 1 , 2, 3 or 4 identical or different groups R ^a ; wherein

R ^a is halogen, cyano, N0 ₂ , OH, SH, NH ₂ , d-Ce-alkyl, d-Ce-haloalkyl,

Ci-C6-alkoxy, Ci-C6-haloalkoxy, Ci-C6-alkylthio, Ci-C6-haloalkylthio or d-Cs- cycloalkyl;

R ^b is independently selected from hydrogen, halogen, cyano, NO2, OH, SH, NH ₂ , Ci-C6-alkyl, Ci-C6-haloalkyl, Ci-C6-alkoxy, Ci-C6-haloalkoxy, Ci-C6-alkylthio, Ci-C6-haloalkylthio and d-d-cycloalkyl;

R ¹ is hydrogen, Ci-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C3-C6-cycloalkyl,

C3-C6-cycloalkenyl, phenyl-Ci-C4-alkyl, heteroaryl-Ci-C4-alkyl, phenyl, naphthyl or a 3- to

10-membered saturated, partially unsaturated or aromatic mono- or bicyclic heterocycle, wherein the ring member atoms of said mono- or bicyclic heterocycle include besides carbon atoms further 1 , 2, 3 or 4 heteroatoms selected from N, O and S as ring member atoms and wherein 1 or 2 carbon ring member atoms of the heterocycle may be replaced by 1 or 2 groups independently selected from C(=0) and C(=S); and wherein the heteroaryl group in heteroaryl-Ci-C4-alkyl is a 5- or 6-membered aromatic heterocycle, wherein the ring member atoms of the heterocyclic ring include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from N, O and S as ring member atoms; and wherein any of the above-mentioned aliphatic or cyclic groups are unsubstituted or substituted by 1 , 2, 3 or up to the maximum possible number of identical or different groups R ^1a ; wherein

R ^1a is halogen, cyano, N0 ₂ , OH, SH, NH ₂ , C C ₆ -alkyl, d-Ce-haloalkyl, Ci-C ₆ -alkoxy, d-Ce-haloalkoxy, Ci-C ₆ -alkylthio, Ci-C ₆ -haloalkylthio, C ₃ -C ₈ -cycloalkyl, N HSO2- Ci-C ₄ -alkyl, (C=0)-Ci-C ₄ -alkyl, C(=0)-Ci-C ₄ -alkoxy or d-Ce-alkylsulfonyl; R2 is C(=0)-(Ci-C ₆ -alkyl), C(=0)-(Ci-C ₆ -alkoxy), (d-Ce-haloalkyl), C(=0)-(Ci-C ₆ -haloalkoxy), d-Ce-alkylsulfonyl or Ci-Ce-haloalkylsulfonyl;

or R ¹ and R ² together with the nitrogen atom to which they are bound form a saturated or

partially unsaturated mono- or bicyclic 3- to 7-membered heterocycle, wherein the heterocycle includes beside one nitrogen atom and one or more carbon atoms no further heteroatom or 1 , 2 or 3 further heteroatoms independently selected from N, O and S as ring member atoms; and wherein one or two CH ₂ groups of the heterocycle may be replaced by one or two groups independently selected from the group of C(=0) and C(=S); and wherein the heterocycle is unsubstituted or carries 1 , 2, 3, 4 or up to the maximum possible number of identical or different groups R ^1a as defined or preferably defined herein;

R ³ and R ⁴ together with the carbon atom to which they are bound form a saturated monocyclic 3- to 5-membered heterocycle or carbocycle; wherein the heterocycle includes beside one or more carbon atoms 1 or 2 heteroatoms independently selected from N, O and S as ring member atoms; and wherein the heterocycle or the carbocycle is unsubstituted or carries 1 , 2, 3, 4 or up to the maximum possible number of identical or different groups R ^3a ;

wherein R ^3a is hydrogen, halogen, cyano or Ci-C2-alkyl;

or the N-oxides, or the agriculturally acceptable salts thereof.

In a further embodiment the invention relates to compounds (1.1 ), wherein A is (A.2). In a further embodiment the invention relates to compounds (1.1 ), wherein A is (A.2), and wherein A is substituted by 1 group R ^A as defined or preferably defined herein. In yet another embodiment the invention relates to compounds (1.1 ), wherein A is (A.2), and wherein A is unsubstituted. In another embodiment the invention relates to compounds (1.1 ), wherein A is (A.8). In a further embodiment the invention relates to compounds (1.1 ), wherein A is (A.8), and wherein A is substituted by 1 group R ^A as defined or preferably defined herein. In yet another embodiment the invention relates to compounds (1.1 ), wherein A is (A.8), and wherein A is unsubstituted. In another embodiment the invention relates to compounds (1.1 ), wherein A is (A.4). In a further embodiment the invention relates to compounds (1.1 ), wherein A is (A.4), and wherein A is substituted by 1 group R ^A as defined or preferably defined herein. In yet another embodiment the invention relates to compounds (1.1 ), wherein A is (A.4), and wherein A is unsubstituted.

In one embodiment the present invention relates to compounds (1.2) of the formula I wherein:

A is phenyl or a 5- or 6-membered aromatic heterocycle, wherein the ring member atoms of the heterocyclic ring include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from

N, O and S as ring member atoms; and wherein the cyclic groups A are unsubstituted or substituted by 1 , 2, 3 or 4 identical or different groups R ^A ; wherein

R ^A is halogen, cyano, N0 ₂ , OH, NH ₂ , SH, S(=0) ₂ N(R ^b ) ₂ , Ci-C ₆ -alkyl, Ci-C ₆ -alkoxy,

Ci-C6-alkylthio, Ci-C6-alkylsulfinyl, Ci-C6-alkylsulfonyl, C ₂ -C6-alkenyl, C ₂ -C6-alkynyl, C3-C8-cycloalkyl or Cs-Cs-cycloalkoxy; and wherein any of the aliphatic or cyclic moieties are unsubstituted or substituted by 1 , 2, 3 or 4 identical or different groups R ^a ; wherein

R ^a is halogen, cyano, N0 ₂ , OH, SH, NH ₂ , Ci-C ₆ -alkyl, Ci-C ₆ -haloalkyl,

Ci-C6-alkoxy, Ci-C6-haloalkoxy, Ci-C6-alkylthio, Ci-C6-haloalkylthio or C3-C8- cycloalkyl;

R ^b is independently selected from hydrogen, halogen, cyano, N0 ₂ , OH, SH, NH ₂ , Ci-C6-alkyl, Ci-C6-haloalkyl, Ci-C6-alkoxy, Ci-C6-haloalkoxy, Ci-C6-alkylthio, Ci-C6-haloalkylthio and Cs-Cs-cycloalkyl;

R ¹ is hydrogen, Ci-C6-alkyl, C ₂ -C6-alkenyl, C ₂ -C6-alkynyl, C3-C6-cycloalkyl,

C3-C6-cycloalkenyl, phenyl-Ci-C4-alkyl, heteroaryl-Ci-C4-alkyl, phenyl or a 3- to

10-membered saturated, partially unsaturated mono- or bicyclic heterocycle, wherein the ring member atoms of said mono- or bicyclic heterocycle include besides carbon atoms further 1 , 2, 3 or 4 heteroatoms selected from N, O and S as ring member atoms and wherein 1 or 2 carbon ring member atoms of the heterocycle may be replaced by 1 or 2 groups independently selected from C(=0) and C(=S); and wherein the heteroaryl group in heteroaryl-Ci-C4-alkyl is a 5- or 6-membered aromatic heterocycle, wherein the ring member atoms of the heterocyclic ring include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from N, O and S as ring member atoms; and wherein any of the above-mentioned aliphatic or cyclic groups are unsubstituted or substituted by 1 , 2, 3 or up to the maximum possible number of identical or different groups R ^1a ; wherein R ^1a is halogen, cyano, N0 ₂ , OH, SH, NH ₂ , Ci-C ₆ -alkyl, Ci-C ₆ -haloalkyl, Ci-C ₆ -alkoxy, d-Ce-haloalkoxy, Ci-C ₆ -alkylthio, Ci-C ₆ -haloalkylthio, C ₃ -C ₈ -cycloalkyl, NHSO2- Ci-C ₄ -alkyl, (C=0)-Ci-C ₄ -alkyl, C(=0)-Ci-C ₄ -alkoxy or Ci-C ₆ -alkylsulfonyl; R ² is C(=0)-(Ci-C ₆ -alkyl) or C(=0)-(Ci-C ₆ -alkoxy);

or R ¹ and R ² together with the nitrogen atom to which they are bound form a saturated or

partially unsaturated monocyclic 5- to 7-membered heterocycle, wherein the heterocycle includes beside one nitrogen atom and one or more carbon atoms no further heteroatom or 1 or 2 further heteroatoms independently selected from N, O and S as ring member atoms; and wherein one or two CH2 groups of the heterocycle are replaced by one or two groups independently selected from the group of C(=0) and C(=S); and wherein the heterocycle is unsubstituted or carries 1 , 2, 3, 4 or up to the maximum possible number of identical or different groups R ^1a as defined or preferably defined herein; particularly R ^1a is halogen or Ci-C6-alkyl;

R ³ and R ⁴ together with the carbon atom to which they are bound form a saturated 3- or 4- membered carbocylic ring; and wherein the carbocyclic ring is unsubstituted;

or the N-oxides, or the agriculturally acceptable salts thereof.

In a further embodiment the invention relates to compounds (1.2), wherein A is (A.2). In a further embodiment the invention relates to compounds (1.2), wherein A is (A.2), and wherein A is substituted by 1 group R ^A as defined or preferably defined herein. In yet another embodiment the invention relates to compounds (1.2), wherein A is (A.2), and wherein A is unsubstituted.

In another embodiment the invention relates to compounds (I.2), wherein A is (A.8). In a further embodiment the invention relates to compounds (1.2), wherein A is (A.8), and wherein A is substituted by 1 group R ^A as defined or preferably defined herein. In yet another embodiment the invention relates to compounds (1.2), wherein A is (A.8), and wherein A is unsubstituted. In another embodiment the invention relates to compounds (I.2), wherein A is (A.4). In another embodiment the invention relates to compounds (1.2), wherein A is (A.4), and wherein R ⁴ is hydrogen or CH3. In a further embodiment the invention relates to compounds (1.2), wherein A is (A.4), and wherein A is substituted by 1 group R ^A as defined or preferably defined herein. In a further embodiment the invention relates to compounds (1.2), wherein A is (A.4), and wherein A is substituted by 1 group R ^A as defined or preferably defined herein, and wherein R ³ is hydrogen and R ⁴ is hydrogen or CH3. In yet another embodiment the invention relates to compounds (1.2), wherein A is (A.4), and wherein A is unsubstituted. In yet another embodiment the invention relates to compounds (1.2), wherein A is (A.4), and wherein A is unsubstituted, and wherein R ³ is hydrogen and wherein R ⁴ is hydrogen or CH3.

In one embodiment the present invention relates to compounds (1.3) of the formula I

wherein:

A is phenyl or a 5- or 6-membered aromatic heterocycle, wherein the ring member atoms of the heterocyclic ring include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from N, O and S as ring member atoms; and wherein the cyclic groups A are unsubstituted or substituted by 1 , 2, 3 or 4 identical or different groups R ^A ; wherein

R ^A is halogen, cyano, N0 ₂ , OH, NH ₂ , SH, S(=0) ₂ N(R ^b ) ₂ , Ci-C ₆ -alkyl, Ci-C ₆ -alkoxy,

Ci-C6-alkylthio, Ci-C6-alkylsulfinyl, Ci-C6-alkylsulfonyl, C ₂ -C6-alkenyl, C ₂ -C6-alkynyl, C3-C8-cycloalkyl or C3-Cs-cycloalkoxy; and wherein any of the aliphatic or cyclic moieties are unsubstituted or substituted by 1 , 2, 3 or 4 identical or different groups R ^a ; wherein

R ^a is halogen, cyano, N0 ₂ , OH , SH , N H ₂ , d-Ce-alkyl, d-Ce-haloalkyl, Ci-C6-alkoxy, Ci-C6-haloalkoxy, Ci-C6-alkylthio, Ci-C6-haloalkylthio or C3-C8- cycloalkyl;

R ^b is independently selected from hydrogen, halogen, cyano, NO2, OH , SH , N H ₂ , Ci-C6-alkyl, Ci-C6-haloalkyl, Ci-C6-alkoxy, Ci-C6-haloalkoxy, Ci-C6-alkylthio, Ci-C6-haloalkylthio and Cs-Cs-cycloalkyl;

R ¹ is hydrogen, Ci-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl or Cs-Cs-cycloalkyl;

R ² is C(=0)-(Ci-C ₆ -alkyl) or C(=0)-(Ci-C ₆ -alkoxy);

R ³ and R ⁴ together with the carbon atom to which they are bound form a saturated 3- or 4- membered carbocylic ring; and wherein the carbocylic ring is unsubstituted;

or the N-oxides, or the agriculturally acceptable salts thereof.

In a further embodiment the invention relates to compounds (1.3), wherein A is (A.2). In a further embodiment the invention relates to compounds (1.3), wherein A is (A.2), and wherein A is substituted by 1 group R ^A as defined or preferably defined herein. In yet another embodiment the invention relates to compounds (1.3), wherein A is (A.2), and wherein A is unsubstituted. In another embodiment the invention relates to compounds (1.3), wherein A is (A.8). In a further embodiment the invention relates to compounds (1.3), wherein A is (A.8), and wherein A is substituted by 1 group R ^A as defined or preferably defined herein. In yet another embodiment the invention relates to compounds (1.3), wherein A is (A.8), and wherein A is unsubstituted. In another embodiment the invention relates to compounds (1.3), wherein A is (A.4). In another embodiment the invention relates to compounds (1.3), wherein A is (A.4), and wherein R ⁴ is hydrogen or CH3. In a further embodiment the invention relates to compounds (1.3), wherein A is (A.4), and wherein A is substituted by 1 group R ^A as defined or preferably defined herein. In a further embodiment the invention relates to compounds (1.3), wherein A is (A.4), and wherein A is substituted by 1 group R ^A as defined or preferably defined herein, and wherein R ⁴ is hydrogen or CH ₃ . In yet another embodiment the invention relates to compounds (1.3), wherein A is (A.4), and wherein A is unsubstituted. In yet another embodiment the invention relates to compounds (1.3), wherein A is (A.4), and wherein A is unsubstituted, and wherein R ⁴ is hydrogen or CH3.

In one embodiment the present invention relates to compounds (1.4) of the formula I

wherein:

A is phenyl or a 5- or 6-membered aromatic heterocycle, wherein the ring member atoms of the heterocyclic ring include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from N, O and S as ring member atoms; and wherein the cyclic groups A are unsubstituted or substituted by 1 , 2, 3 or 4 identical or different groups R ^A ; wherein

R ^A is chlorine, fluorine or methyl;

R ¹ is hydrogen, Ci-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl or Cs-Cs-cycloalkyl;

R ² is C(=0)-(Ci-C ₆ -alkyl) or C(=0)-(Ci-C ₆ -alkoxy);

R ³ and R ⁴ together with the carbon atom to which they are bound form a saturated 3- or 4- membered carbocylic ring; and wherein the carbocylic ring is unsubstituted; or the N-oxides, or the agriculturally acceptable salts thereof.

In a further embodiment the invention relates to compounds (1.4), wherein A is (A.2). In a further embodiment the invention relates to compounds (1.4), wherein A is (A.2), and wherein A is substituted by 1 group R ^A as defined or preferably defined herein. In yet another embodiment the invention relates to compounds (1.4), wherein A is (A.2), and wherein A is unsubstituted. In another embodiment the invention relates to compounds (I.4), wherein A is (A.8). In a further embodiment the invention relates to compounds (1.4), wherein A is (A.8), and wherein A is substituted by 1 group R ^A as defined or preferably defined herein. In yet another embodiment the invention relates to compounds (1.4), wherein A is (A.8), and wherein A is unsubstituted. In another embodiment the invention relates to compounds (I.4), wherein A is (A.4). In a further embodiment the invention relates to compounds (1.4), wherein A is (A.4), and wherein A is substituted by 1 group R ^A as defined or preferably defined herein. In yet another embodiment the invention relates to compounds (1.4), wherein A is (A.4), and wherein A is unsubstituted.

In one embodiment the present invention relates to compounds (1.5) of the formula I

wherein:

A is phenyl or a 5- or 6-membered aromatic heterocycle, wherein the ring member atoms of the heterocyclic ring include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from N, O and S as ring member atoms; and wherein the cyclic groups A are unsubstituted or substituted by 1 , 2, 3 or 4 identical or different groups R ^A ; wherein

R ^A is halogen, cyano, N0 ₂ , OH, NH ₂ , SH, S(=0) ₂ N(R ^b ) ₂ , Ci-C ₆ -alkyl, C C ₆ -alkoxy,

Ci-C6-alkylthio, Ci-C6-alkylsulfinyl, Ci-C6-alkylsulfonyl, C ₂ -C6-alkenyl, C ₂ -C6-alkynyl, C3-C8-cycloalkyl or Cs-Cs-cycloalkoxy; and wherein any of the aliphatic or cyclic moieties are unsubstituted or substituted by 1 , 2, 3 or 4 identical or different groups R ^a ; wherein

R ^a is halogen, cyano, N0 ₂ , OH, SH, NH ₂ , Ci-C ₆ -alkyl, Ci-C ₆ -haloalkyl,

Ci-C6-alkoxy, Ci-C6-haloalkoxy, Ci-C6-alkylthio, Ci-C6-haloalkylthio or C3-C8- cycloalkyl;

R ^b is independently selected from hydrogen, halogen, cyano, N0 ₂ , OH, SH, NH ₂ , Ci-C6-alkyl, Ci-C6-haloalkyl, Ci-C6-alkoxy, Ci-C6-haloalkoxy, Ci-C6-alkylthio, Ci-C6-haloalkylthio and Cs-Cs-cycloalkyl;

R ¹ and R ² together with the nitrogen atom to which they are bound form a saturated or partially unsaturated monocyclic 5- to 7-membered heterocycle, wherein the heterocycle includes beside one nitrogen atom and one or more carbon atoms no further heteroatom or 1 or 2 further heteroatoms independently selected from N, O and S as ring member atoms; and wherein one or two CH ₂ groups of the heterocycle are replaced by one or two groups independently selected from the group of C(=0) and C(=S); and wherein the heterocycle is unsubstituted or carries 1 , 2, 3, 4 or up to the maximum possible number of identical or different groups R ^1a as defined or preferably defined herein; particularly R ^1a is halogen or d-Ce-alkyl;

R ³ and R ⁴ together with the carbon atom to which they are bound form a saturated monocyclic 3- to 5-membered heterocycle or carbocycle; wherein the heterocycle includes beside one or more carbon atoms 1 or 2 heteroatoms independently selected from N, O and S as ring member atoms; and wherein the heterocycle or the carbocycle is unsubstituted or carries 1 , 2, 3, 4 or up to the maximum possible number of identical or different groups R ^3a ;

wherein R ^3a is halogen, cyano or Ci-C2-alkyl;

or the N-oxides, or the agriculturally acceptable salts thereof.

In a further embodiment the invention relates to compounds (1.5), wherein A is (A.2). In a further embodiment the invention relates to compounds (1.5), wherein A is (A.2), and wherein A is substituted by 1 group R ^A as defined or preferably defined herein. In yet another embodiment the invention relates to compounds (1.5), wherein A is (A.2), and wherein A is unsubstituted. In another embodiment the invention relates to compounds (1.5), wherein A is (A.8). In a further embodiment the invention relates to compounds (1.5), wherein A is (A.8), and wherein A is substituted by 1 group R ^A as defined or preferably defined herein. In yet another embodiment the invention relates to compounds (1.5), wherein A is (A.8), and wherein A is unsubstituted. In another embodiment the invention relates to compounds (1.5), wherein A is (A.4). In another embodiment the invention relates to compounds (1.5), wherein A is (A.4), and wherein R ⁴ is hydrogen or CH ₃ . In a further embodiment the invention relates to compounds (1.5), wherein A is (A.4), and wherein A is substituted by 1 group R ^A as defined or preferably defined herein. In a further embodiment the invention relates to compounds (1.5), wherein A is (A.4), and wherein A is substituted by 1 group R ^A as defined or preferably defined herein, and wherein R ³ is hydrogen and R ⁴ is hydrogen or CH3. In yet another embodiment the invention relates to compounds (1.5), wherein A is (A.4), and wherein A is unsubstituted. In yet another embodiment the invention relates to compounds (1.5), wherein A is (A.4), and wherein A is unsubstituted, and wherein R ³ is hydrogen and wherein R ⁴ is hydrogen or CH ₃ .

In one embodiment the present invention relates to compounds (1.6) of the formula I

wherein:

A is phenyl or a 5- or 6-membered aromatic heterocycle, wherein the ring member atoms of the heterocyclic ring include besides carbon atoms 1 , 2, 3 or 4 heteroatoms selected from N, O and S as ring member atoms; and wherein the cyclic groups A are unsubstituted or substituted by 1 , 2, 3 or 4 identical or different groups R ^A ; wherein

R ^A is halogen, cyano, N0 ₂ , OH, NH ₂ , SH, S(=0) ₂ N(R ^b ) ₂ , Ci-C ₆ -alkyl, Ci-C ₆ -alkoxy,

Ci-C6-alkylthio, Ci-C6-alkylsulfinyl, Ci-C6-alkylsulfonyl, C2-C6-alkenyl, C2-C6-alkynyl, C3-C8-cycloalkyl or Cs-Cs-cycloalkoxy; and wherein any of the aliphatic or cyclic moieties are unsubstituted or substituted by 1 , 2, 3 or 4 identical or different groups R ^a ; wherein

R ^a is halogen, cyano, N0 ₂ , OH, SH, NH ₂ , Ci-C ₆ -alkyl, Ci-C ₆ -haloalkyl,

Ci-C6-alkoxy, Ci-C6-haloalkoxy, Ci-C6-alkylthio, Ci-C6-haloalkylthio or C3-C8- cycloalkyl;

R ^b is independently selected from hydrogen, halogen, cyano, NO2, OH, SH, NH2, Ci-C6-alkyl, Ci-C6-haloalkyl, Ci-C6-alkoxy, Ci-C6-haloalkoxy, Ci-C6-alkylthio, Ci-C6-haloalkylthio and Cs-Cs-cycloalkyl;

R ¹ and R ² together with the nitrogen atom to which they are bound form a saturated or partially unsaturated monocyclic 5- or 6-membered heterocycle, wherein the heterocycle includes beside one nitrogen atom and one or more carbon atoms no further heteroatom or 1 further heteroatom independently selected from N, O and S as ring member atoms; and wherein one or two Chb groups of the heterocycle are replaced by one or two groups independently selected from the group of C(=0) and C(=S); and wherein the heterocycle is unsubstituted or carries 1 , 2, 3, 4 or up to the maximum possible number of identical or different groups R ^1a as defined or preferably defined herein; particularly R ^1a is halogen or d-Ce-alkyl;

R ³ and R ⁴ together with the carbon atom to which they are bound form a saturated 3- or 4- membered carbocylic ring; and wherein the carbocylic ring is unsubstituted

or the N-oxides, or the agriculturally acceptable salts thereof.

In a further embodiment the invention relates to compounds (1.6), wherein A is (A.2). In a further embodiment the invention relates to compounds (1.6), wherein A is (A.2), and wherein A is substituted by 1 group R ^A as defined or preferably defined herein. In yet another embodiment the invention relates to compounds (1.6), wherein A is (A.2), and wherein A is unsubstituted. In another embodiment the invention relates to compounds (1.6), wherein A is (A.8). In a further embodiment the invention relates to compounds (1.6), wherein A is (A.8), and wherein A is substituted by 1 group R ^A as defined or preferably defined herein. In yet another embodiment the invention relates to compounds (1.6), wherein A is (A.8), and wherein A is unsubstituted. In another embodiment the invention relates to compounds (1.6), wherein A is (A.4). In another embodiment the invention relates to compounds (1.6), wherein A is (A.4), and wherein R ⁴ is hydrogen or CH3. In a further embodiment the invention relates to compounds (1.6), wherein A is (A.4), and wherein A is substituted by 1 group R ^A as defined or preferably defined herein. In a further embodiment the invention relates to compounds (1.6), wherein A is (A.4), and wherein A is substituted by 1 group R ^A as defined or preferably defined herein, and wherein R ⁴ is hydrogen or CH3. In yet another embodiment the invention relates to compounds (1.6), wherein A is (A.4), and wherein A is unsubstituted. In yet another embodiment the invention relates to compounds (1.6), wherein A is (A.4), and wherein A is unsubstituted, and wherein R ⁴ is hydrogen or CH3.

According to one embodiment, th mpounds of the formula I.A

I.A

or to the use of the compounds of the formula I.A for controlling phytopathogenic fungi. Here, the variables are as defined elsewhere herein for formula I, or as defined as being preferred for formula I.

According to one embodiment, the present invention relates to compounds of the formula I.B

or to the use of the compounds of the formula I.B for controlling phytopathogenic fungi. Here, the variables are as defined elsewhere herein for formula I, or as defined as being preferred for formula I.

According to one embodiment, th mpounds of the formula I.C

I.C

or to the use of the compounds of the formula I.C for controlling phytopathogenic fungi. Here, the variables are as defined elsewhere herein for formula I, or as defined as being preferred for formula I.

According to one embodiment, th mpounds of the formula I.D

I.D

or to the use of the compounds of the formula I.D for controlling phytopathogenic fungi. Here, the variables are as defined elsewhere herein for formula I, or as defined as being preferred for formula I.

According to one embodiment, th mpounds of the formula I.E

or to the use of the compounds of the formula I.E for controlling phytopathogenic fungi. Here, the variables are as defined elsewhere herein for formula I, or as defined as being preferred for formula I.

According to one embodiment, the present invention relates to compounds of the formula I.F

I .F

or to the use of the compounds of the formula I.F for controlling phytopathogenic fungi. Here, the variables are as defined elsewhere herein for formula I, or as defined as being preferred for formula I.

According to one embodiment, th mpounds of the formula I.G

I.G

or to the use of the compounds of the formula I.G for controlling phytopathogenic fungi. Here, the variables are as defined elsewhere herein for formula I, or as defined as being preferred for formula I.

According to one embodiment, the present invention relates to compounds of the formula I.H

I.H

or to the use of the compounds of the formula I.H for controlling phytopathogenic fungi. Here, the variables are as defined elsewhere herein for formula I, or as defined as being preferred for formula I.

Preference is given to the compounds I used according to the invention and to the compounds according to the invention compiled in Tables 1 to 8 below. With regard to the compounds according to the invention the exception as defined above will be considered. The groups mentioned for a substituent in the tables are furthermore per se, independently of the combination in which they are mentioned, a particularly preferred aspect of the substituent in question.

Table 1

Compounds of the formula I .A, in which R ¹ and R ² for each individual compound corresponds in each case to one line of Table A (I.A.A-1 to I.A.A-973).

Table 2

Compounds of the formula I.B, in which R ¹ and R ² for each individual compound corresponds in each case to one line of Table A (I.B.A-1 to I.B.A-973).

Table 3

Compounds of the formula I.C, in which R ¹ and R ² for each individual compound corresponds in each case to one line of Table A (I.C.A-1 to I.C.A-973)

Table 4 Compounds of the formula I.D, in which R ¹ and R ² for each individual compound corresponds in each case to one line of Table A (I.D.A-1 to I.D.A-973).

Table 5

Compounds of the formula I.E, in which R ¹ and R ² for each individual compound corresponds in each case to one line of Table A (I.E.A-1 to I.E.A-973).

Table 6

Compounds of the formula I.F, in which R ¹ and R ² for each individual compound corresponds in each case to one line of Table A (I.F.A-1 to I.F.A-973).

Table 7

Compounds of the formula I.G, in which R ¹ and R ² for each individual compound corresponds in each case to one line of Table A (I.G.A-1 to I.G.A-973).

Table 8

Compounds of the formula I.H, in which R ¹ and R ² for each individual compound corresponds in each case to one line of Table A (I.H.A-1 to I.H.A-973).

Table A:

o R1 R2 No R1 R2

A-63 H 2-trifluoromethyl-phenyl A-108 H 3-methyl-4-F-phenyl

A-64 H 3-trifluoromethyl-phenyl A-109 H 2-F-3-CF ₃ -phenyl

A-65 H 4-trifluoromethyl-phenyl A-1 10 H 2-F-4-CF ₃ -phenyl

A-66 H 2-methoxy-phenyl A-1 1 1 H 2-F-5-CF ₃ -phenyl

A-67 H 3-methoxy-phenyl A-1 12 H 2-F-6-CF ₃ -phenyl

A-68 H 4-methoxy-phenyl A-1 13 H 3-F-4-CF ₃ -phenyl

A-69 H 2-trifluoromethoxy-phenyl A-1 14 H 3-F-5-CF ₃ -phenyl

A-70 H 3-trifluoromethoxy-phenyl A-1 15 H 2-CF ₃ -3-F-phenyl

A-71 H 4-trifluoromethoxy-phenyl A-1 16 H 2-CF ₃ -4-F-phenyl

A-72 H 2-difluoromethoxy-phenyl A-1 17 H 2-CF ₃ -5-F-phenyl

A-73 H 3-difluoromethoxy-phenyl A-1 18 H 3-CF ₃ -4-F-phenyl

A-74 H 4-difluoromethoxy-phenyl A-1 19 H 2-F-3-OMe-phenyl

A-75 H 2-(2,2,2-trifluoroethoxy)-phenyl A-120 H 2-F-4-OMe-phenyl

A-76 H 3-(2,2,2-trifluoroethoxy)-phenyl A-121 H 2-F-5-OMe-phenyl

A-77 H 4-(2,2,2-trifluoroethoxy)-phenyl A-122 H 2-F-6-OMe-phenyl

A-78 H 2-cyano-phenyl A-123 H 3-F-4-OMe-phenyl

A-79 H 3-cyano-phenyl A-124 H 3-F-5-OMe-phenyl

A-80 H 4-cyano-phenyl A-125 H 2-OMe-3-F-phenyl

A-81 H 2,3-difluoro-phenyl A-126 H 2-OMe-4-F-phenyl

A-82 H 2,4-difluoro-phenyl A-127 H 2-OMe-5-F-phenyl

A-83 H 2,5-difluoro-phenyl A-128 H 3-OMe-4-F-phenyl

A-84 H 2,6-difluoro-phenyl A-129 H 2-F-3-OCHF ₂ -phenyl

A-85 H 2,3-dichloro-phenyl A-130 H 2-F-4-OCHF ₂ -phenyl

A-86 H 2,4-dichloro-phenyl A-131 H 2-F-5-OCHF ₂ -phenyl

A-87 H 2,5-dichloro-phenyl A-132 H 2-F-6-OCHF ₂ -phenyl

A-88 H 2,6-dichloro-phenyl A-133 H 3-F-4-OCHF ₂ -phenyl

A-89 H 2-F-3-CI-phenyl A-134 H 3-F-5-OCHF ₂ -phenyl

A-90 H 2-F-4-CI-phenyl A-135 H 2-OCHF ₂ -3-F-phenyl

A-91 H 2-F-5-CI-phenyl A-136 H 2-OCHF ₂ -4-F-phenyl

A-92 H 2-F-6-CI-phenyl A-137 H 2-OCHF ₂ -5-F-phenyl

A-93 H 3-F-4-CI-phenyl A-138 H 3-OCHF ₂ -4-F-phenyl

A-94 H 3-F-5-CI-phenyl A-139 H 2-F-3-CN-phenyl

A-95 H 2-CI-3-F-phenyl A-140 H 2-F-4-CN-phenyl

A-96 H 2-CI-4-F-phenyl A-141 H 2-F-5-CN-phenyl

A-97 H 2-CI-5-F-phenyl A-142 H 2-F-6-CN-phenyl

A-98 H 3-CI-4-F-phenyl A-143 H 3-F-4-CN-phenyl

A-99 H 2-F-3-methyl-phenyl A-144 H 3-F-5-CN-phenyl

A-100 H 2-F-4-methyl-phenyl A-145 H 2-CN-3-F-phenyl

A-101 H 2-F-5-methyl-phenyl A-146 H 2-CN-4-F-phenyl

A- 102 H 2-F-6-methyl-phenyl A-147 H 2-CN-5-F-phenyl

A-103 H 3-F-4-methyl-phenyl A-148 H 3-CN-4-F-phenyl

A- 104 H 3-F-5-methyl-phenyl A-149 H 2-CI-3-methyl-phenyl

A-105 H 2-methyl-3-F-phenyl A-150 H 2-CI-4-methyl-phenyl

A-106 H 2-methyl-4-F-phenyl A-151 H 2-CI-5-methyl-phenyl

A-107 H 2-methyl-5-F-phenyl A-152 H 2-CI-6-methyl-phenyl

o R1 R2 No R1 R2

A-243 H (2,4-dichloro-phenyl)methyl A-280 CH ₃ C(=0)-OCH ₂ CH(CH ₃ )CH ₃

A-244 H (2,5-dichloro-phenyl)methyl A-281 CH ₃ C(=0)-OC(CH ₃ ) ₃

A-245 H (2,6-dichloro-phenyl)methyl A-282 CH ₃ C(=0)-OCH2CH ₂ CH2CH ₂ CH ₃

A-246 R and R ² together with the nitrogen to which A-283 CH ₃ C(=0)-OCH(CH ₃ )CH ₂ CH ₂ CH ₃ thev are hniind fnrm a a7iridinvl A-284 CH ₃ C(=0)-OCH ₂ CH(CH ₃ )CH ₂ CH ₃

A-247 R and R ² together with the nitrogen to which A-285 CH ₃ C(=0)-OCH ₂ CH ₂ CH(CH ₃ )CH ₃ thev are bound form a azetidinvl A-286 CH ₃ C(=0)-OCH(CH ₂ CH ₃ )CH ₂ CH ₃

A-248 R and R ² together with the nitrogen to which A-287 CH ₃ allyl

they are bound form a 1-pyrrolidinyl A-288 CH ₃ propargyl

A-249 R and R ² together with the nitrogen to which A-289 CH ₃ cyclopropyl

thev are bound form a 1-DiDeridinvl A-290 CH ₃ cylopentyl

A-250 R and R ² together with the nitrogen to which A-291 CH ₃ cyclohexyl

they are bound form a 1-piperazinyl A-292 CH ₃ phenyl

A-293 CH ₃ 2-pyridyl

A-251 R and R ² together with the nitrogen to which

A-294 CH ₃ 3-pyridyl

they are bound form a 1 -methyl-4-piperazinyl

A-295 CH ₃ 4-pyridyl

A-252 R and R ² together with the nitrogen to which A-296 CH ₃ 2-F-phenyl

they are bound form a 4-morpholinyl A-297 CH ₃ 3-F-phenyl

A-253 CH ₃ CH ₃ A-298 CH ₃ 4-F-phenyl

A-254 CH ₃ CH ₂ CH ₃ A-299 CH ₃ 2-CI-phenyl

A-255 CH ₃ CH2CH2CH ₃ A-300 CH ₃ 3-CI-phenyl

A-256 CH ₃ CH(CH ₃ ) ₂ A-301 CH ₃ 4-CI-phenyl

A-257 CH ₃ CH2CH2CH2CH ₃ A-302 CH ₃ 2-methyl-phenyl

A-258 CH ₃ CH(CH ₃ )CH ₂ CH ₃ A-303 CH ₃ 3-methyl-phenyl

A-259 CH ₃ CH ₂ CH(CH ₃ )CH ₃ A-304 CH ₃ 4-methyl-phenyl

A-260 CH ₃ C(CH ₃ ) ₃ A-305 CH ₃ 2-ethyl-phenyl

A-261 CH ₃ C(=0)-CH ₃ A-306 CH ₃ 3-ethyl-phenyl

A-262 CH ₃ C(=0)-CH ₂ CH ₃ A-307 CH ₃ 4-ethyl-phenyl

A-263 CH ₃ C(=0)-CH ₂ CH ₂ CH ₃ A-308 CH ₃ 2-isopropyl-phenyl

A-264 CH ₃ C(=0)-CH(CH ₃ ) ₂ A-309 CH ₃ 3-isopropyl-phenyl

A-265 CH ₃ C(=0)-CH2CH ₂ CH ₂ CH ₃ A-310 CH ₃ 4-isopropyl-phenyl

A-266 CH ₃ C(=0)-CH(CH ₃ )CH ₂ CH ₃ A-31 1 CH ₃ 2-(2,2,2-trifluoroethyl)-phenyl

A-267 CH ₃ C(=0)-CH ₂ CH(CH ₃ )CH ₃ A-312 CH ₃ 3-(2,2,2-trifluoroethyl)-phenyl

A-268 CH ₃ C(=0)-C(CH ₃ ) ₃ A-313 CH ₃ 4-(2,2,2-trifluoroethyl)-phenyl

A-269 CH ₃ C(=0)-CH2CH ₂ CH2CH ₂ CH ₃ A-314 CH ₃ 2-trifluoromethyl-phenyl

A-270 CH ₃ C(=0)-CH(CH ₃ )CH ₂ CH ₂ CH ₃ A-315 CH ₃ 3-trifluoromethyl-phenyl

A-271 CH ₃ C(=0)-CH ₂ CH(CH ₃ )CH ₂ CH ₃ A-316 CH ₃ 4-trifluoromethyl-phenyl

A-272 CH ₃ C(=0)-CH ₂ CH ₂ CH(CH ₃ )CH ₃ A-317 CH ₃ 2-methoxy-phenyl

A-273 CH ₃ C(=0)-CH(CH ₂ CH ₃ )CH ₂ CH ₃ A-318 CH ₃ 3-methoxy-phenyl

A-274 CH ₃ C(=0)-OCH ₃ A-319 CH ₃ 4-methoxy-phenyl

A-275 CH ₃ C(=0)-OCH ₂ CH ₃ A-320 CH ₃ 2-trifluoromethoxy-phenyl

A-276 CH ₃ C(=0)-OCH ₂ CH ₂ CH ₃ A-321 CH ₃ 3-trifluoromethoxy-phenyl

A-277 CH ₃ C(=0)-OCH(CH ₃ ) ₂ A-322 CH ₃ 4-trifluoromethoxy-phenyl

A-278 CH ₃ C(=0)-OCH2CH ₂ CH ₂ CH ₃ A-323 CH ₃ 2-difluoromethoxy-phenyl

A-279 CH ₃ C(=0)-OCH(CH ₃ )CH ₂ CH ₃ A-324 CH ₃ 3-difluoromethoxy-phenyl

SUBSTITUTE SH (RULE 26) o R1 R2 No R1 R2

A-325 CH ₃ 4-difluoromethoxy-phenyl A-370 CH ₃ 2-F-3-OMe-phenyl

A-326 CH ₃ 2-(2,2,2-trifluoroethoxy)-phenyl A-371 CH ₃ 2-F-4-OMe-phenyl

A-327 CH ₃ 3-(2,2,2-trifluoroethoxy)-phenyl A-372 CH ₃ 2-F-5-OMe-phenyl

A-328 CH ₃ 4-(2,2,2-trifluoroethoxy)-phenyl A-373 CH ₃ 2-F-6-OMe-phenyl

A-329 CH ₃ 2-cyano-phenyl A-374 CH ₃ 3-F-4-OMe-phenyl

A-330 CH ₃ 3-cyano-phenyl A-375 CH ₃ 3-F-5-OMe-phenyl

A-331 CH ₃ 4-cyano-phenyl A-376 CH ₃ 2-OMe-3-F-phenyl

A-332 CH ₃ 2,3-difluoro-phenyl A-377 CH ₃ 2-OMe-4-F-phenyl

A-333 CH ₃ 2,4-difluoro-phenyl A-378 CH ₃ 2-OMe-5-F-phenyl

A-334 CH ₃ 2,5-difluoro-phenyl A-379 CH ₃ 3-OMe-4-F-phenyl

A-335 CH ₃ 2,6-difluoro-phenyl A-380 CH ₃ 2-F-3-OCHF ₂ -phenyl

A-336 CH ₃ 2,3-dichloro-phenyl A-381 CH ₃ 2-F-4-OCHF ₂ -phenyl

A-337 CH ₃ 2,4-dichloro-phenyl A-382 CH ₃ 2-F-5-OCHF ₂ -phenyl

A-338 CH ₃ 2,5-dichloro-phenyl A-383 CH ₃ 2-F-6-OCHF ₂ -phenyl

A-339 CH ₃ 2,6-dichloro-phenyl A-384 CH ₃ 3-F-4-OCHF ₂ -phenyl

A-340 CH ₃ 2-F-3-CI-phenyl A-385 CH ₃ 3-F-5-OCHF ₂ -phenyl

A-341 CH ₃ 2-F-4-CI-phenyl A-386 CH ₃ 2-OCHF ₂ -3-F-phenyl

A-342 CH ₃ 2-F-5-CI-phenyl A-387 CH ₃ 2-OCHF ₂ -4-F-phenyl

A-343 CH ₃ 2-F-6-CI-phenyl A-388 CH ₃ 2-OCHF ₂ -5-F-phenyl

A-344 CH ₃ 3-F-4-CI-phenyl A-389 CH ₃ 3-OCHF ₂ -4-F-phenyl

A-345 CH ₃ 3-F-5-CI-phenyl A-390 CH ₃ 2-F-3-CN-phenyl

A-346 CH ₃ 2-CI-3-F-phenyl A-391 CH ₃ 2-F-4-CN-phenyl

A-347 CH ₃ 2-CI-4-F-phenyl A-392 CH ₃ 2-F-5-CN-phenyl

A-348 CH ₃ 2-CI-5-F-phenyl A-393 CH ₃ 2-F-6-CN-phenyl

A-349 CH ₃ 3-CI-4-F-phenyl A-394 CH ₃ 3-F-4-CN-phenyl

A-350 CH ₃ 2-F-3-methyl-phenyl A-395 CH ₃ 3-F-5-CN-phenyl

A-351 CH ₃ 2-F-4-methyl-phenyl A-396 CH ₃ 2-CN-3-F-phenyl

A-352 CH ₃ 2-F-5-methyl-phenyl A-397 CH ₃ 2-CN-4-F-phenyl

A-353 CH ₃ 2-F-6-methyl-phenyl A-398 CH ₃ 2-CN-5-F-phenyl

A-354 CH ₃ 3-F-4-methyl-phenyl A-399 CH ₃ 3-CN-4-F-phenyl

A-355 CH ₃ 3-F-5-methyl-phenyl A-400 CH ₃ 2-CI-3-methyl-phenyl

A-356 CH ₃ 2-methyl-3-F-phenyl A-401 CH ₃ 2-CI-4-methyl-phenyl

A-357 CH ₃ 2-methyl-4-F-phenyl A-402 CH ₃ 2-CI-5-methyl-phenyl

A-358 CH ₃ 2-methyl-5-F-phenyl A-403 CH ₃ 2-CI-6-methyl-phenyl

A-359 CH ₃ 3-methyl-4-F-phenyl A-404 CH ₃ 3-CI-4-methyl-phenyl

A-360 CH ₃ 2-F-3-CF ₃ -phenyl A-405 CH ₃ 3-CI-5-methyl-phenyl

A-361 CH ₃ 2-F-4-CF ₃ -phenyl A-406 CH ₃ 2-methyl-3-CI-phenyl

A-362 CH ₃ 2-F-5-CF ₃ -phenyl A-407 CH ₃ 2-methyl-4-CI-phenyl

A-363 CH ₃ 2-F-6-CF ₃ -phenyl A-408 CH ₃ 2-methyl-5-CI-phenyl

A-364 CH ₃ 3-F-4-CF ₃ -phenyl A-409 CH ₃ 3-methyl-4-CI-phenyl

A-365 CH ₃ 3-F-5-CF ₃ -phenyl A-410 CH ₃ 2-CI-3-CF ₃ -phenyl

A-366 CH ₃ 2-CF ₃ -3-F-phenyl A-41 1 CH ₃ 2-CI-4-CF ₃ -phenyl

A-367 CH ₃ 2-CF ₃ -4-F-phenyl A-412 CH ₃ 2-CI-5-CF ₃ -phenyl

A-368 CH ₃ 2-CF ₃ -5-F-phenyl A-413 CH ₃ 2-CI-6-CF ₃ -phenyl

A-369 CH ₃ 3-CF ₃ -4-F-phenyl A-414 CH ₃ 3-CI-4-CF ₃ -phenyl

o R1 R2 No R1 R2

A-685 allvl C(=0)-OC(CH ₃ ) ₃ A-730 fe/7-butvl C(=0)-CH(CH ₂ CH ₃ )CH ₂ CH ₃

A-686 allvl C(=0)-OCH ₂ CH2CH2CH ₂ CH3 A-731 fe/7-butyl C(=0)-OCH ₃

A-687 allvl C(=0)-OCH(CH3)CH ₂ CH ₂ CH3 A-732 fe/7-butvl C(=0)-OCH ₂ CH ₃

A-688 allvl C(=0)-OCH ₂ CH(CH ₃ )CH ₂ CH ₃ A-733 fe/7-butyl C(=0)-OCH ₂ CH ₂ CH ₃

A-689 allvl C(=0)-OCH ₂ CH ₂ CH(CH ₃ )CH ₃ A-734 fe/7-butvl C(=0)-OCH(CH ₃ ) ₂

A-690 allvl C(=0)-OCH(CH ₂ CH ₃ )CH ₂ CH ₃ A-735 fe/7-butyl C(=0)-OCH ₂ CH ₂ CH ₂ CH ₃

A-691 allvl allyl A-736 fe/7-butyl C(=0)-OCH(CH ₃ )CH ₂ CH ₃

A-692 allvl propargyl A-737 fe/7-butyl C(=0)-OCH ₂ CH(CH ₃ )CH ₃

A-693 allvl cyclopropyl A-738 fe/7-butvl C(=0)-OC(CH ₃ ) ₃

A-694 allvl cylopentyl A-739 fe/7-butyl C(=0)-OCH ₂ CH ₂ CH ₂ CH ₂ CH ₃

A-695 allvl cyclohexyl A-740 fe/7-butvl C(=0)-OCH(CH ₃ )CH ₂ CH ₂ CH ₃

A-696 allvl phenyl A-741 fe/7-butyl C(=0)-OCH ₂ CH(CH ₃ )CH ₂ CH ₃

A-697 allvl 2-pyridyl A-742 fe/7-butvl C(=0)-OCH ₂ CH ₂ CH(CH ₃ )CH ₃

A-698 allvl 3-pyridyl A-743 fe/7-butyl C(=0)-OCH(CH ₂ CH ₃ )CH ₂ CH ₃

A-699 allvl 4-pyridyl A-744 fe/7-butvl allyl

A-700 allvl 2-F-phenyl A-745 fe/7-butyl propargyl

A-701 allvl 3-F-phenyl A-746 fe/7-butyl cyclopropyl

A-702 allvl 4-F-phenyl A-747 fe/7-butyl cylopentyl

A-703 allvl 2-CI-phenyl A-748 fe/7-butvl cyclohexyl

A-704 allvl 3-CI-phenyl A-749 fe/7-butyl phenyl

A-705 allvl 4-CI-phenyl A-750 fe/7-butvl 2-pyridyl

A-706 allvl 2-methyl-phenyl A-751 fe/7-butyl 3-pyridyl

A-707 allvl 3-methyl-phenyl A-752 fe/7-butvl 4-pyridyl

A-708 allvl 4-methyl-phenyl A-753 fe/7-butyl 2-F-phenyl

A-709 feri-butyl H A-754 fe/7-butvl 3-F-phenyl

A-710 feri-butyl CH ₃ A-755 fe/t-butyl 4-F-phenyl

A-71 1 feri-butyl CH ₂ CH ₃ A-756 fe/7-butyl 2-CI-phenyl

A-712 ter buly\ CH ₂ CH ₂ CH ₃ A-757 fe/7-butyl 3-CI-phenyl

A-713 feri-butyl CH(CH ₃ ) ₂ A-758 fe/7-butvl 4-CI-phenyl

A-714 ter buly\ CH ₂ CH ₂ CH ₂ CH ₃ A-759 fe/7-butyl 2-methyl-phenyl

A-715 feri-butyl CH(CH ₃ )CH ₂ CH ₃ A-760 fe/7-butvl 3-methyl-phenyl

A-716 ter buly\ CH ₂ CH(CH ₃ )CH ₃ A-761 fe/7-butyl 4-methyl-phenyl

A-717 feri-butyl C(CH ₃ ) ₃ A-762 phenyl H

A-718 ter buly\ C(=0)-CH ₃ A-763 phenyl CH ₃

A-719 feri-butyl C(=0)-CH ₂ CH ₃ A-764 phenyl CH ₂ CH ₃

A-720 ter buly\ C(=0)-CH ₂ CH ₂ CH ₃ A-765 phenyl CH ₂ CH ₂ CH ₃

A-721 feri-butyl C(=0)-CH(CH ₃ ) ₂ A-766 phenyl CH(CH ₃ ) ₂

A-722 ter buly\ C(=0)-CH ₂ CH ₂ CH ₂ CH ₃ A-767 phenyl CH ₂ CH ₂ CH ₂ CH ₃

A-723 feri-butyl C(=0)-CH(CH ₃ )CH ₂ CH ₃ A-768 phenyl CH(CH ₃ )CH ₂ CH ₃

A-724 ter buly\ C(=0)-CH ₂ CH(CH ₃ )CH ₃ A-769 phenyl CH ₂ CH(CH ₃ )CH ₃

A-725 feri-butyl C(=0)-C(CH ₃ ) ₃ A-770 phenyl C(CH ₃ ) ₃

A-726 teri-butvl C(=0)-CH ₂ CH ₂ CH ₂ CH ₂ CH ₃ A-771 phenyl C(=0)-CH ₃

A-727 feri-butyl C(=0)-CH(CH ₃ )CH ₂ CH ₂ CH ₃ A-772 phenyl C(=0)-CH ₂ CH ₃

A-728 teri-butvl C(=0)-CH ₂ CH(CH ₃ )CH ₂ CH ₃ A-773 phenyl C(=0)-CH ₂ CH ₂ CH ₃

A-729 feri-butyl C(=0)-CH ₂ CH ₂ CH(CH ₃ )CH ₃ A-774 phenyl C(=0)-CH(CH ₃ ) ₂

SUBSTITUTE SH (RULE 26)

The compounds of the formula I can be prepared according to methods or in analogy to methods that are described in the prior art. The synthesis takes advantage of starting materials that are commercially available or may be prepared according to conventional procedures starting from readily available compounds. For example, compounds of the formula I can be prepared by reactingamidines of type II with trifluoroacetic anhydride in an organic solvent, preferably an ethereal solvent at temperatures between 0 °C and 100 °C, preferably at room temperature, as previously described for example in WO2013/008162.

Compounds of type II can be accessed from the respective nitrile by reacting compounds of type III with hydroxylamine (or its HCI salt) in an organic solvent and in the presence of a base (see for example WO2009/074950, WO2006/013104, EP1932843). Preferably, an alcoholic solvent and an inorganic base are used, most preferably ethanol and potassium carbonate. If appropriate, water may be added to enhance solubility of the reactants. The reaction is best performed at elevated temperatures, most preferably in the range between 60 and 80 °C.

Compounds III can be prepared from compounds IV, if appropriate via compounds of type Ilia. As exemplified in WO2009/068682, compounds of type IV can be metallated by treatment with an appropriate organometallic reagent in an ethereal solvent at low temperatures. Preferably, an organolithium or organomagnesium compound is used and the reaction is best performed in THF and between -78 °C and 0 °C. The intermediary organometallic species can be trapped with imines of type IVa to furnish compounds of type Ilia (R ² = H) after aqueous workup. In case R ² is not H, compounds of type Ilia can be reacted further with electrophiles R ² -LG in an organic solvent and in the presence of a base at temperatures between -20 and 100 °C, most preferably between 0 and 40 °C. LG represents a suitable leaving group, preferably a halogen or a sulfonate.

(Hal p

(IVa)

Alternatively, compounds of type III, where R ³ and R ⁴ form a cyclopropyl ring, can be accessed from 1 ,4-dicyano compounds of type V in a Kulinkovich-type reaction. As showcased for example in WO2006/074940 or WO2008/101665, compounds V can be reacted with an organoethyl species, preferably an ethyl magnesium halide, in the presence of a Lewis acid, for example, but not limited to titanium isopropoxide or boron trifluoride diethyl etherate complex, to afford compounds of type 1Mb. The reaction is preferably performed in an ethereal solvent at temperatures between -78 °C and 70 °C, more preferred in diethyl ether and between ambient temperature and 40 °C.

Compounds of type 1Mb can be reacted further in a stepwise manner with electrophiles R ¹ -LG and, if appropriate, R ² -LG to yield compounds of type III. The reactions are best performed in an organic solvent and in the presence of a base at temperatures between -20 and 100 °C, most preferably between 0 and 40 °C.

base, solvent

Compounds of type IV, IVa, and/or V are either commercially available, or can be accessed from suitable starting materials by methods that are obvious to a person skilled in the art.

The compounds of the formula I or compositions comprising said compounds according to the invention and the mixtures comprising said compounds and compositions, respectively, are suitable as fungicides. They are distinguished by an outstanding effectiveness against a broad spectrum of phytopathogenic fungi, including soil-borne fungi, which derive especially from the following classes or are closely related to any of them: Ascomycota (Ascomycetes), for example, but not limited to the genus Cocholiobolus, Colletotrichum, Fusarium, Microdochium, Penicillium, Phoma, Magnaporte, Zymoseptoria, and Pseudocercosporella; Basdiomycota (Basidiomycetes), for example, but not limited to the genus Phakospora, Puccinia, Rhizoctonia, Sphacelotheca, Tilletia, Typhula, and Ustilago; Chytridiomycota (Chytridiomycetes), for example, but not limited to the genus Chytridiales, and Synchytrium; Deuteromycetes (syn. Fungi imperfect!), for example, but not limited to the genus Ascochyta, Diplodia, Erysiphe, Fusarium, Phomopsis, and Pyrenophora; Peronosporomycetes (syn. Oomycetes), for example but not limited to the genus Peronospora, Pythium, Phytophthora; Plasmodiophoromycetes, for example but not limited to the genus Plasmodiophora; Zygomycetes, for example, but not limited to the genus Rhizopus.

Some of the compounds of the formula I and the compositions according to the invention are systemically effective and they can be used in crop protection as foliar fungicides, fungicides for seed dressing and soil fungicides. Moreover, they are suitable for controlling harmful fungi, which inter alia occur in wood or roots of plants.

The compounds I and the compositions according to the invention are particularly important in the control of a multitude of phytopathogenic fungi on various cultivated plants, such as cereals, e. g. wheat, rye, barley, triticale, oats or rice; beet, e. g. sugar beet or fodder beet; fruits, such as pomes, stone fruits or soft fruits, e. g. apples, pears, plums, peaches, almonds, cherries, strawberries, raspberries, blackberries or gooseberries; leguminous plants, such as lentils, peas, alfalfa or soybeans; oil plants, such as rape, mustard, olives, sunflowers, coconut, cocoa beans, castor oil plants, oil palms, ground nuts or soybeans; cucurbits, such as squashes, cucumber or melons; fiber plants, such as cotton, flax, hemp or jute; citrus fruit, such as oranges, lemons, grapefruits or mandarins; vegetables, such as spinach, lettuce, asparagus, cabbages, carrots, onions, tomatoes, potatoes, cucurbits or paprika; lauraceous plants, such as avocados, cinnamon or camphor; energy and raw material plants, such as corn, soybean, rape, sugar cane or oil palm; corn; tobacco; nuts; coffee; tea; bananas; vines (table grapes and grape juice grape vines); hop; turf; sweet leaf (also called Stevia); natural rubber plants or ornamental and forestry plants, such as flowers, shrubs, broad-leaved trees or evergreens, e. g. conifers; and on the plant propagation material, such as seeds, and the crop material of these plants. Preferably, compounds I and compositions thereof, respectively are used for controlling a multitude of fungi on field crops, such as potatoes sugar beets, tobacco, wheat, rye, barley, oats, rice, corn, cotton, soybeans, rape, legumes, sunflowers, coffee or sugar cane; fruits; vines; ornamentals; or vegetables, such as cucumbers, tomatoes, beans or squashes.

The term "plant propagation material" is to be understood to denote all the generative parts of the plant such as seeds and vegetative plant material such as cuttings and tubers (e. g.

potatoes), which can be used for the multiplication of the plant. This includes seeds, roots, fruits, tubers, bulbs, rhizomes, shoots, sprouts and other parts of plants, including seedlings and young plants, which are to be transplanted after germination or after emergence from soil.

These young plants may also be protected before transplantation by a total or partial treatment by immersion or pouring.

Preferably, treatment of plant propagation materials with compounds I and compositions thereof, respectively, is used for controlling a multitude of fungi on cereals, such as wheat, rye, barley and oats; rice, corn, cotton and soybeans.

The term "cultivated plants" is to be understood as including plants which have been modified by breeding, mutagenesis or genetic engineering including but not limiting to agricultural biotech products on the market or in development (cf. http://cera-gmc.org/, see GM crop database therein). Genetically modified plants are plants, which genetic material has been so modified by the use of recombinant DNA techniques that under natural circumstances cannot readily be obtained by cross breeding, mutations or natural recombination. Typically, one or more genes have been integrated into the genetic material of a genetically modified plant in order to improve certain properties of the plant. Such genetic modifications also include but are not limited to targeted post-translational modification of protein(s), oligo- or polypeptides e. g. by glycosylation or polymer additions such as prenylated, acetylated or farnesylated moieties or PEG moieties. Plants that have been modified by breeding, mutagenesis or genetic engineering, e. g. have been rendered tolerant to applications of specific classes of herbicides, such as auxin herbicides such as dicamba or 2,4-D; bleacher herbicides such as hydroxylphenylpyruvate dioxygenase (HPPD) inhibitors or phytoene desaturase (PDS) inhibitors; acetolactate synthase (ALS) inhibitors such as sulfonyl ureas or imidazolinones; enolpyruvylshikimate-3-phosphate synthase (EPSPS) inhibitors, such as glyphosate; glutamine synthetase (GS) inhibitors such as glufosinate; protoporphyrinogen-IX oxidase inhibitors; lipid biosynthesis inhibitors such as acetyl CoA carboxylase (ACCase) inhibitors; or oxynil (i. e. bromoxynil or ioxynil) herbicides as a result of conventional methods of breeding or genetic engineering. Furthermore, plants have been made resistant to multiple classes of herbicides through multiple genetic modifications, such as resistance to both glyphosate and glufosinate or to both glyphosate and a herbicide from another class such as ALS inhibitors, HPPD inhibitors, auxin herbicides, or ACCase inhibitors. These herbicide resistance technologies are e. g. described in Pest Managem. Sci. 61 , 2005, 246; 61 , 2005, 258; 61 , 2005, 277; 61 , 2005, 269; 61 , 2005, 286; 64, 2008, 326; 64, 2008, 332; Weed Sci. 57, 2009, 108; Austral. J. Agricult. Res. 58, 2007, 708; Science 316, 2007, 1 185; and references quoted therein. Several cultivated plants have been rendered tolerant to herbicides by conventional methods of breeding (mutagenesis), e. g. Clearfield ^® summer rape (Canola, BASF SE, Germany) being tolerant to imidazolinones, e. g. imazamox, or ExpressSun ^® sunflowers (DuPont, USA) being tolerant to sulfonyl ureas, e. g. tribenuron. Genetic engineering methods have been used to render cultivated plants such as soybean, cotton, corn, beets and rape, tolerant to herbicides such as glyphosate and glufosinate, some of which are

commercially available under the trade names RoundupReady ^® (glyphosate-tolerant, Monsanto, U.S.A.), Cultivance ^® (imidazolinone tolerant, BASF SE, Germany) and LibertyLink ^® (glufosinate- tolerant, Bayer CropScience, Germany).

Furthermore, plants are also covered that are by the use of recombinant DNA techniques capable to synthesize one or more insecticidal proteins, especially those known from the bacterial genus Bacillus, particularly from Bacillus thuringiensis, such as δ-endotoxins, e. g. CrylA(b), CrylA(c), CrylF, CrylF(a2), CryllA(b), CrylllA, CrylllB(bl ) or Cry9c; vegetative insecticidal proteins (VIP), e. g. VIP1 , VIP2, VIP3 or VIP3A; insecticidal proteins of bacteria colonizing nematodes, e. g. Photorhabdus spp. or Xenorhabdus spp.; toxins produced by animals, such as scorpion toxins, arachnid toxins, wasp toxins, or other insect-specific neurotoxins; toxins produced by fungi, such Streptomycetes toxins, plant lectins, such as pea or barley lectins; agglutinins; proteinase inhibitors, such as trypsin inhibitors, serine protease inhibitors, patatin, cystatin or papain inhibitors; ribosome-inactivating proteins (RIP), such as ricin, maize-RIP, abrin, luffin, saporin or bryodin; steroid metabolism enzymes, such as 3- hydroxysteroid oxidase, ecdysteroid-IDP-glycosyl-transferase, cholesterol oxidases, ecdysone inhibitors or HMG-CoA-reductase; ion channel blockers, such as blockers of sodium or calcium channels; juvenile hormone esterase; diuretic hormone receptors (helicokinin receptors);

stilbene synthase, bibenzyl synthase, chitinases or glucanases. In the context of the present invention these insecticidal proteins or toxins are to be understood expressly also as pre-toxins, hybrid proteins, truncated or otherwise modified proteins. Hybrid proteins are characterized by a new combination of protein domains, (see, e. g. WO 02/015701 ). Further examples of such toxins or genetically modified plants capable of synthesizing such toxins are disclosed, e. g., in EP-A 374 753, WO 93/007278, WO 95/34656, EP-A 427 529, EP-A 451 878, WO 03/18810 und WO 03/52073. The methods for producing such genetically modified plants are generally known to the person skilled in the art and are described, e. g. in the publications mentioned above. These insecticidal proteins contained in the genetically modified plants impart to the plants producing these proteins tolerance to harmful pests from all taxonomic groups of arthropods, especially to beetles (Coeloptera), two-winged insects (Diptera), and moths (Lepidoptera) and to nematodes (Nematoda). Genetically modified plants capable to synthesize one or more insecticidal proteins are, e. g., described in the publications mentioned above, and some of which are commercially available such as YieldGard ^® (corn cultivars producing the CrylAb toxin), YieldGard ^® Plus (corn cultivars producing CrylAb and Cry3Bb1 toxins), Starlink ^® (corn cultivars producing the Cry9c toxin), Herculex ^® RW (corn cultivars producing Cry34Ab1 ,

Cry35Ab1 and the enzyme phosphinothricin-N-acetyltransferase [PAT]); NuCOTN ^® 33B (cotton cultivars producing the CrylAc toxin), Bollgard ^® I (cotton cultivars producing the Cry1 Ac toxin), Bollgard ^® II (cotton cultivars producing CrylAc and Cry2Ab2 toxins); VIPCOT ^® (cotton cultivars producing a VIP-toxin); NewLeaf ^® (potato cultivars producing the Cry3A toxin); Bt-Xtra ^® , NatureGard ^® , KnockOut ^® , BiteGard ^® , Protecta ^® , Bt1 1 (e. g. Agrisure ^® CB) and Bt176 from Syngenta Seeds SAS, France, (corn cultivars producing the CrylAb toxin and PAT enyzme), MIR604 from Syngenta Seeds SAS, France (corn cultivars producing a modified version of the Cry3A toxin, c.f. WO 03/018810), MON 863 from Monsanto Europe S.A., Belgium (corn cultivars producing the Cry3Bb1 toxin), IPC 531 from Monsanto Europe S.A., Belgium (cotton cultivars producing a modified version of the CrylAc toxin) and 1507 from Pioneer Overseas

Corporation, Belgium (corn cultivars producing the Cry1 F toxin and PAT enzyme).

Furthermore, plants are also covered that are by the use of recombinant DNA techniques capable to synthesize one or more proteins to increase the resistance or tolerance of those plants to bacterial, viral or fungal pathogens. Examples of such proteins are the so-called "pathogenesis-related proteins" (PR proteins, see, e. g. EP-A 392 225), plant disease resistance genes (e. g. potato cultivars, which express resistance genes acting against Phytophthora infestans derived from the Mexican wild potato Solanum bulbocastanum) or T4-lysozym (e. g. potato cultivars capable of synthesizing these proteins with increased resistance against bacteria such as Erwinia amyivora). The methods for producing such genetically modified plants are generally known to the person skilled in the art and are described, e. g. in the publications mentioned above.

Furthermore, plants are also covered that are by the use of recombinant DNA techniques capable to synthesize one or more proteins to increase the productivity (e. g. bio mass production, grain yield, starch content, oil content or protein content), tolerance to drought, salinity or other growth-limiting environmental factors or tolerance to pests and fungal, bacterial or viral pathogens of those plants.

Furthermore, plants are also covered that contain by the use of recombinant DNA techniques a modified amount of substances of content or new substances of content, specifically to improve human or animal nutrition, e. g. oil crops that produce health-promoting long-chain omega-3 fatty acids or unsaturated omega-9 fatty acids (e. g. Nexera ^® rape, DOW Agro Sciences, Canada).

Furthermore, plants are also covered that contain by the use of recombinant DNA techniques a modified amount of substances of content or new substances of content, specifically to improve raw material production, e. g. potatoes that produce increased amounts of amylopectin (e. g. Amflora ^® potato, BASF SE, Germany).

The compounds I and compositions thereof, respectively, are particularly suitable for controlling the following plant diseases:

Albugo spp. (white rust) on ornamentals, vegetables (e. g. A. Candida) and sunflowers (e. g. A. tragopogonis); Alternaria spp. (Alternaria leaf spot) on vegetables, rape (A. brass/cola or brassicae), sugar beets (A. tenuis), fruits, rice, soybeans, potatoes (e. g. A. solan/ or A.

alternata), tomatoes (e. g. A. solani or A. alternata) and wheat; Aphanomyces spp. on sugar beets and vegetables; Ascochyta spp. on cereals and vegetables, e. g. A. (anthracnose) on wheat and A. horde/ on barley; Bipolar/s and Drechslera spp. (teleomorph: Cochliobolus spp.), e. g. Southern leaf blight (D. maydis) or Northern leaf blight (B. zeicoia) on corn, e. g. spot blotch (B. sorokiniana) on cereals and e. g. B. oryzae on rice and turfs; Blumeria (formerly Erysiphe) graminis (powdery mildew) on cereals (e. g. on wheat or barley); Botrytis cinerea (teleomorph: Botryotinia fuckeliana. grey mold) on fruits and berries (e. g. strawberries), vegetables (e. g. lettuce, carrots, celery and cabbages), rape, flowers, vines, forestry plants and wheat; Bremia lactucae (downy mildew) on lettuce; Ceratocystis (syn. Ophiostoma) spp. (rot or wilt) on broad-leaved trees and evergreens, e. g. C. ulmi (Dutch elm disease) on elms;

Cercospora spp. (Cercospora leaf spots) on corn (e. g. Gray leaf spot: C. zeae-maydis), rice, sugar beets (e. g. C. bet/cola), sugar cane, vegetables, coffee, soybeans (e. g. C. sojina or C. k/kuch/ή and rice; Cladosporium spp. on tomatoes (e. g. C. fulvum. leaf mold) and cereals, e. g. C. herbarum (black ear) on wheat; Claviceps purpurea (ergot) on cereals; Cochliobolus

(anamorph: Helminthosporium of Bipolaris) spp. (leaf spots) on corn (C. carbonum), cereals (e. g. C. sativus, anamorph: B. sorokiniana) and rice (e. g. C. miyabeanus, anamorph: H.

oryzae); Colletotrichum (teleomorph: Glomerella) spp. (anthracnose) on cotton (e. g. C.

gossyp/ή, corn (e. g. C. graminico/a: Anthracnose stalk rot), soft fruits, potatoes (e. g. C.

coccodes: black dot), beans (e. g. C. lindemuthianum) and soybeans (e. g. C. truncatum or C. g/oeosporioides); Corticium spp., e. g. C. sasakii (sheath blight) on rice; Corynespora cassiicoia (leaf spots) on soybeans and ornamentals; Cycloconium spp., e. g. C. oleaginum on olive trees; Cylindrocarpon spp. (e. g. fruit tree canker or young vine decline, teleomorph: Nectria or Neonectria spp.) on fruit trees, vines (e. g. C liriodendri, teleomorph: Neonectria liriodendri. Black Foot Disease) and ornamentals; Dematophora (teleomorph: Rosellinia) necatrix (root and stem rot) on soybeans; Diaporthe spp., e. g. D. phaseolorum (damping off) on soybeans;

Drechslera (syn. Helminthosporium, teleomorph: Pyrenophora) spp. on corn, cereals, such as barley (e. g. D. teres, net blotch) and wheat (e. g. D. tritici-repentis: tan spot), rice and turf; Esca (dieback, apoplexy) on vines, caused by Formitiporia (syn. Phellinus) punctata, F. mediterranea, Phaeomoniella chlamydospora (earlier Phaeoacremonium chlamydosporum),

Phaeoacremonium aleophilum and/or Botryosphaeria obtusa; Elsinoe spp. on pome fruits (E. pyri), soft fruits (E. veneta: anthracnose) and vines (E. ampe/ina: anthracnose); Enty/oma oryzae (leaf smut) on rice; Ep/coccum spp. (black mold) on wheat; Erysiphe spp. (powdery mildew) on sugar beets {E. betae), vegetables (e. g. E. pis/), such as cucurbits (e. g. E.

c/choracearum), cabbages, rape (e. g. E. cruciferarum); Eutypa lata (Eutypa canker or dieback, anamorph: Cytosporina lata, syn. Libertella blepharis) on fruit trees, vines and ornamental woods; Exserohilum (syn. Helminthosporium) spp. on corn (e. g. E. turcicum); Fusarium

(teleomorph: Gibberella) spp. (wilt, root or stem rot) on various plants, such as F. graminearum or F. culmorum (root rot, scab or head blight) on cereals (e. g. wheat or barley), F. oxysporum on tomatoes, F. so/an/ (f. sp. glycines now syn. F. virguliforme ) and F. tucumaniae and .

brasiliense each causing sudden death syndrome on soybeans, and . verticillioides on corn; Gaeumannomyces graminis (take-all) on cereals (e. g. wheat or barley) and corn; Gibberella spp. on cereals (e. g. G zeae) and rice (e. g. G fujikuror ^' . Bakanae disease); Glomerella cingulata on vines, pome fruits and other plants and G. gossypiion cotton; Grainstaining complex on rice; Guignardia bidwellii ^' (black rot) on vines; Gymnosporangium spp. on rosaceous plants and junipers, e. g. G sabinae (rust) on pears; Helminthosporium spp. (syn. Drechslera, teleomorph: Cochiioboius) on corn, cereals and rice; Hemileia spp., e. g. A/, vastatrix (coffee leaf rust) on coffee; Isariopsis clavispora (syn. Cladosporium vitis) on vines; Macrophomina phaseolina (syn. phaseoli) (root and stem rot) on soybeans and cotton; Microdochium (syn. Fusarium) nivale (pink snow mold) on cereals (e. g. wheat or barley); Microsphaera diffusa (powdery mildew) on soybeans; Monilinia spp., e. g. fructicola and fructigena (bloom and twig blight, brown rot) on stone fruits and other rosaceous plants; Mycosphaerella spp. on cereals, bananas, soft fruits and ground nuts, such as e. g. M. graminicola (anamorph: Septoria tritici, Septoria blotch) on wheat or M. fijiensis (black Sigatoka disease) on bananas; Peronospora spp. (downy mildew) on cabbage (e. g. P. brassicae), rape (e. g. P. parasitica), onions (e. g. P. destructor), tobacco {P. tabacina) and soybeans (e. g. P. manshurica);

Phakopsora pachyrhizi and P. meibomiae (soybean rust) on soybeans; Phialophora spp. e. g. on vines (e. g. P. tracheiphila and P. tetraspora) and soybeans (e. g. P. gregata: stem rot); Phoma lingam (root and stem rot) on rape and cabbage and P. betae (root rot, leaf spot and damping-off) on sugar beets; Phomopsis spp. on sunflowers, vines (e. g. P. viticola: can and leaf spot) and soybeans (e. g. stem rot: P. phaseoli, teleomorph: Diaporthe phaseolorum);

Physoderma maydis (brown spots) on corn; Phytophthora spp. (wilt, root, leaf, fruit and stem root) on various plants, such as paprika and cucurbits (e. g. P. capsicl), soybeans (e. g. P.

megasperma, syn. P. sojae), potatoes and tomatoes (e. g. P. infestans: late blight) and broad- leaved trees (e. g. P. ramorurrr. sudden oak death); Plasmodiophora brassicae (club root) on cabbage, rape, radish and other plants; Plasmopara spp., e. g. P. viticola (grapevine downy mildew) on vines and P. ha/stediion sunflowers; Podosphaera spp. (powdery mildew) on rosaceous plants, hop, pome and soft fruits, e. g. P. leucotricha on apples; Po/ymyxa spp., e. g. on cereals, such as barley and wheat (P. graminis) and sugar beets (P. betae) and thereby transmitted viral diseases; Pseudocercosporella herpotrichoides (eyespot, teleomorph: Tapes/a yallundae) on cereals, e. g. wheat or barley; Pseudoperonospora (downy mildew) on various plants, e. g. P. cubensis on cucurbits or P. hum/lion hop; Pseudopezicu/a tracheiphila (red fire disease or .rotbrenner', anamorph: Phialophora) on vines; Puccinia spp. (rusts) on various plants, e. g. P. triticina (brown or leaf rust), P. striiformis (stripe or yellow rust), P. horde/ (dwarf rust), P. graminis (stem or black rust) or P. recondita (brown or leaf rust) on cereals, such as e. g. wheat, barley or rye, P. kuehnii (orange rust) on sugar cane and P. asparagio asparagus; Pyrenophora (anamorph: Drechslera) tritici-repentis (tan spot) on wheat or P. teres (net blotch) on barley; Pyricularia spp., e. g. P. oryzae (teleomorph: Magnaporthe grisea, rice blast) on rice and P. grisea on turf and cereals; Pythium spp. (damping-off) on turf, rice, corn, wheat, cotton, rape, sunflowers, soybeans, sugar beets, vegetables and various other plants (e. g. P. ultimum or P. aphanidermatum); Ramularia spp., e. g. R. collo-cygni (Ramularia leaf spots, Physiological leaf spots) on barley and R. bet/cola on sugar beets; Rhizoctonia spp. on cotton, rice, potatoes, turf, corn, rape, potatoes, sugar beets, vegetables and various other plants, e. g. R. solani (root and stem rot) on soybeans, R. so/an/ (sheath blight) on rice or R. cerealis (Rhizoctonia spring blight) on wheat or barley; Rhizopus stolonifer (black mold, soft rot) on strawberries, carrots, cabbage, vines and tomatoes; Rhynchosporium secalis (scald) on barley, rye and triticale;

Sarocladium oryzae and S. attenuatum (sheath rot) on rice; Sclerotinia spp. (stem rot or white mold) on vegetables and field crops, such as rape, sunflowers (e. g. S. sclerotiorum) and soybeans (e. g. S. ro/fsiior S. sclerotiorum); Septoria spp. on various plants, e. g. S. glycines (brown spot) on soybeans, S. tritici (Septoria blotch) on wheat and S. (syn. Stagonospora) nodorum (Stagonospora blotch) on cereals; Uncinula (syn. Erysiphe) necator (powdery mildew, anamorph: Oidium tucker!) on vines; Setospaeria spp. (leaf blight) on corn (e. g. S. turcicum, syn. Helminthosporium turcicum) and turf; Sphacelotheca spp. (smut) on corn, (e. g. S. reiliana: head smut), sorghum und sugar cane; Sphaerotheca fuliginea (powdery mildew) on cucurbits; Spongospora subterranea (powdery scab) on potatoes and thereby transmitted viral diseases; Stagonospora pp. on cereals, e. g. S. nodorum (Stagonospora blotch, teleomorph:

Leptosphaeria [syn. Phaeosphaeria] nodorum) on wheat; Synchytrium endobioticum on potatoes (potato wart disease); Taphrina pp., e. g. T. deformans (leaf curl disease) on peaches and T. pruni (p\um pocket) on plums; Thielaviopsis spp. (black root rot) on tobacco, pome fruits, vegetables, soybeans and cotton, e. g. T. basicola (syn. Chalara elegans); Tilletia spp.

(common bunt or stinking smut) on cereals, such as e. g. T. tritici {s n. T. caries, wheat bunt) and T. controversa (dwarf bunt) on wheat; Typhula incarnata (grey snow mold) on barley or wheat; Urocystis spp., e. g. U. occulta (stem smut) on rye; Uromyces spp. (rust) on vegetables, such as beans (e. g. U. appendiculatus, syn. U. phaseoli) and sugar beets (e. g. U. betae); Ustilago spp. (loose smut) on cereals (e. g. U. nuda and U. avaenae), corn (e. g. U. maydis. corn smut) and sugar cane; Venturia spp. (scab) on apples (e. g. V. inaequalis) and pears; and Verticillium spp. (wilt) on various plants, such as fruits and ornamentals, vines, soft fruits, vegetables and field crops, e. g. V. dahliae o strawberries, rape, potatoes and tomatoes.

In a preferred embodiment the compounds I and compositions thereof, respectively, are particularly suitable for controlling the following plant diseases: Puccinia spp. (rusts) on various plants, for example, but not limited to P. triticina (brown or leaf rust), P. striiformis (stripe or yellow rust), P. hordei (dwarf rust), P. graminis (stem or black rust) or P. recondita (brown or leaf rust) on cereals, such as e. g. wheat, barley or rye and Phakopsoraceae spp. on various plants, in particular Phakopsora pachyrhizi and P. meibomiae (soybean rust) on soybeans.

The compounds I and compositions thereof, respectively, are also suitable for controlling harmful fungi in the protection of stored products or harvest and in the protection of materials. The term "protection of materials" is to be understood to denote the protection of technical and non-living materials, such as adhesives, glues, wood, paper and paperboard, textiles, leather, paint dispersions, plastics, cooling lubricants, fiber or fabrics, against the infestation and destruction by harmful microorganisms, such as fungi and bacteria. As to the protection of wood and other materials, the particular attention is paid to the following harmful fungi: Ascomycetes such as Ophiostoma spp., Ceratocystis spp., Aureobasidium pullulans, Sclerophoma spp., Chaetomium spp., Hum/cola spp., Petriella spp., Trichurus spp.; Basidiomycetes such as

Coniophora spp., Coriolus spp., Gloeophyllum spp., Lentinus spp., Pleurotus spp., Poria spp., Serpula spp. and Tyromyces spp., Deuteromycetes such as Aspergillus spp., Cladosporium spp., Penicillium spp., Trichoderma spp., Alternaria spp., Paecilomyces spp. and Zygomycetes such as Mucorspp., and in addition in the protection of stored products and harvest the following yeast fungi are worthy of note: Candida spp. and Saccharomyces cerevisae.

The method of treatment according to the invention can also be used in the field of protecting stored products or harvest against attack of fungi and microorganisms. According to the present invention, the term "stored products" is understood to denote natural substances of plant or animal origin and their processed forms, which have been taken from the natural life cycle and for which long-term protection is desired. Stored products of crop plant origin, such as plants or parts thereof, for example stalks, leafs, tubers, seeds, fruits or grains, can be protected in the freshly harvested state or in processed form, such as pre-dried, moistened, comminuted, ground, pressed or roasted, which process is also known as post-harvest treatment. Also falling under the definition of stored products is timber, whether in the form of crude timber, such as construction timber, electricity pylons and barriers, or in the form of finished articles, such as furniture or objects made from wood. Stored products of animal origin are hides, leather, furs, hairs and the like. The combinations according the present invention can prevent

disadvantageous effects such as decay, discoloration or mold. Preferably "stored products" is understood to denote natural substances of plant origin and their processed forms, more preferably fruits and their processed forms, such as pomes, stone fruits, soft fruits and citrus fruits and their processed forms.

The compounds of formula I can be present in different crystal modifications whose biological activity may differ. They are likewise subject matter of the present invention.

The compounds I are employed as such or in form of compositions by treating the fungi or the plants, plant propagation materials, such as seeds, soil, surfaces, materials or rooms to be protected from fungal attack with a fungicidally effective amount of the active substances. The application can be carried out both before and after the infection of the plants, plant propagation materials, such as seeds, soil, surfaces, materials or rooms by the fungi.

Plant propagation materials may be treated with compounds I as such or a composition comprising at least one compound I prophylactically either at or before planting or transplanting. The invention also relates to agrochemical compositions comprising an auxiliary and at least one compound I according to the invention.

An agrochemical composition comprises a fungicidally effective amount of a compound I. The term "effective amount" denotes an amount of the composition or of the compounds I, which is sufficient for controlling harmful fungi on cultivated plants or in the protection of materials and which does not result in a substantial damage to the treated plants. Such an amount can vary in a broad range and is dependent on various factors, such as the fungal species to be controlled, the treated cultivated plant or material, the climatic conditions and the specific compound I used.

The compounds I, their N-oxides and salts can be converted into customary types of agrochemical compositions, e. g. solutions, emulsions, suspensions, dusts, powders, pastes, granules, pressings, capsules, and mixtures thereof. Examples for composition types are suspensions (e. g. SC, OD, FS), emulsifiable concentrates (e. g. EC), emulsions (e. g. EW, EO, ES, ME), capsules (e. g. CS, ZC), pastes, pastilles, wettable powders or dusts (e. g. WP, SP, WS, DP, DS), pressings (e. g. BR, TB, DT), granules (e. g. WG, SG, GR, FG, GG, MG), insecticidal articles (e. g. LN), as well as gel formulations for the treatment of plant propagation materials such as seeds (e. g. GF). These and further compositions types are defined in the "Catalogue of pesticide formulation types and international coding system", Technical

Monograph No. 2, 6 ^th Ed. May 2008, CropLife International.

The compositions are prepared in a known manner, such as described by Mollet and

Grubemann, Formulation technology, Wiley VCH, Weinheim, 2001 ; or Knowles, New

developments in crop protection product formulation, Agrow Reports DS243, T&F Informa, London, 2005.

Suitable auxiliaries are solvents, liquid carriers, solid carriers or fillers, surfactants, dispersants, emulsifiers, wetters, adjuvants, solubilizers, penetration enhancers, protective colloids, adhesion agents, thickeners, humectants, repellents, attractants, feeding stimulants, compatibilizers, bactericides, anti-freezing agents, anti-foaming agents, colorants, tackifiers and binders.

Suitable solvents and liquid carriers are water and organic solvents, such as mineral oil fractions of medium to high boiling point, e. g. kerosene, diesel oil; oils of vegetable or animal origin; aliphatic, cyclic and aromatic hydrocarbons, e. g. toluene, paraffin,

tetrahydronaphthalene, alkylated naphthalenes; alcohols, e. g. ethanol, propanol, butanol, benzyl alcohol, cyclohexanol; glycols; DMSO; ketones, e. g. cyclohexanone; esters, e. g.

lactates, carbonates, fatty acid esters, gamma-butyrolactone; fatty acids; phosphonates;

amines; amides, e. g. N-methyl pyrrolidone, fatty acid dimethyl amides; and mixtures thereof. Suitable solid carriers or fillers are mineral earths, e. g. silicates, silica gels, talc, kaolins, limestone, lime, chalk, clays, dolomite, diatomaceous earth, bentonite, calcium sulfate, magnesium sulfate, magnesium oxide; polysaccharides, e. g. cellulose, starch; fertilizers, e. g. ammonium sulfate, ammonium phosphate, ammonium nitrate, ureas; products of vegetable origin, e. g. cereal meal, tree bark meal, wood meal, nutshell meal, and mixtures thereof.

Suitable surfactants are surface-active compounds, such as anionic, cationic, nonionic and amphoteric surfactants, block polymers, polyelectrolytes, and mixtures thereof. Such surfactants can be used as emulsifier, dispersant, solubilizer, wetter, penetration enhancer, protective colloid, or adjuvant. Examples of surfactants are listed in McCutcheon's, Vol.1 : Emulsifiers & Detergents, McCutcheon's Directories, Glen Rock, USA, 2008 (International Ed. or North American Ed.).

Suitable anionic surfactants are alkali, alkaline earth or ammonium salts of sulfonates, sulfates, phosphates, carboxylates, and mixtures thereof. Examples of sulfonates are alkylaryl sulfonates, diphenyl sulfonates, alpha-olefin sulfonates, lignin sulfonates, sulfonates of fatty acids and oils, sulfonates of ethoxylated alkylphenols, sulfonates of alkoxylated arylphenols, sulfonates of condensed naphthalenes, sulfonates of dodecyl- and tridecylbenzenes, sulfonates of naphthalenes and alkyl naphthalenes, sulfosuccinates or sulfosuccinamates. Examples of sulfates are sulfates of fatty acids and oils, of ethoxylated alkylphenols, of alcohols, of ethoxylated alcohols, or of fatty acid esters. Examples of phosphates are phosphate esters. Examples of carboxylates are alkyl carboxylates, and carboxylated alcohol or alkylphenol ethoxylates.

Suitable nonionic surfactants are alkoxylates, N-substituted fatty acid amides, amine oxides, esters, sugar-based surfactants, polymeric surfactants, and mixtures thereof. Examples of alkoxylates are compounds such as alcohols, alkylphenols, amines, amides, arylphenols, fatty acids or fatty acid esters which have been alkoxylated with 1 to 50 equivalents. Ethylene oxide and/or propylene oxide may be employed for the alkoxylation, preferably ethylene oxide. Examples of N-substituted fatty acid amides are fatty acid glucamides or fatty acid alkanolamides. Examples of esters are fatty acid esters, glycerol esters or monoglycerides. Examples of sugar-based surfactants are sorbitans, ethoxylated sorbitans, sucrose and glucose esters or alkylpolyglucosides. Examples of polymeric surfactants are home- or copolymers of vinyl pyrrolidone, vinyl alcohols, or vinyl acetate.

Suitable cationic surfactants are quaternary surfactants, for example quaternary ammonium compounds with one or two hydrophobic groups, or salts of long-chain primary amines. Suitable amphoteric surfactants are alkylbetains and imidazolines. Suitable block polymers are block polymers of the A-B or A-B-A type comprising blocks of polyethylene oxide and polypropylene oxide, or of the A-B-C type comprising alkanol, polyethylene oxide and polypropylene oxide. Suitable polyelectrolytes are polyacids or polybases. Examples of polyacids are alkali salts of polyacrylic acid or polyacid comb polymers. Examples of polybases are polyvinyl amines or polyethylene amines.

Suitable adjuvants are compounds, which have a negligible or even no pesticidal activity themselves, and which improve the biological performance of the compound I on the target.

Examples are surfactants, mineral or vegetable oils, and other auxiliaries. Further examples are listed by Knowles, Adjuvants and additives, Agrow Reports DS256, T&F Informa UK, 2006, chapter 5.

Suitable thickeners are polysaccharides (e. g. xanthan gum, carboxymethyl cellulose), inorganic clays (organically modified or unmodified), polycarboxylates, and silicates.

Suitable bactericides are bronopol and isothiazolinone derivatives such as alkylisothiazolinones and benzisothiazolinones.

Suitable anti-freezing agents are ethylene glycol, propylene glycol, urea and glycerin.

Suitable anti-foaming agents are silicones, long chain alcohols, and salts of fatty acids.

Suitable colorants (e. g. in red, blue, or green) are pigments of low water solubility and water- soluble dyes. Examples are inorganic colorants (e. g. iron oxide, titan oxide, iron

hexacyanoferrate) and organic colorants (e. g. alizarin-, azo- and phthalocyanine colorants). Suitable tackifiers or binders are polyvinyl pyrrolidones, polyvinyl acetates, polyvinyl alcohols, polyacrylates, biological or synthetic waxes, and cellulose ethers.

Examples for composition types and their preparation are:

i) Water-soluble concentrates (SL, LS)

10-60 wt% of a compound I and 5-15 wt% wetting agent (e. g. alcohol alkoxylates) are dissolved in water and/or in a water-soluble solvent (e. g. alcohols) ad 100 wt%. The active substance dissolves upon dilution with water.

ii) Dispersible concentrates (DC)

5-25 wt% of a compound I and 1-10 wt% dispersant (e. g. polyvinyl pyrrolidone) are dissolved in organic solvent (e. g. cyclohexanone) ad 100 wt%. Dilution with water gives a dispersion.

iii) Emulsifiable concentrates (EC)

15-70 wt% of a compound I and 5-10 wt% emulsifiers (e. g. calcium dodecylbenzenesulfonate and castor oil ethoxylate) are dissolved in water-insoluble organic solvent (e. g. aromatic hydrocarbon) ad 100 wt%. Dilution with water gives an emulsion.

iv) Emulsions (EW, EO, ES)

5-40 wt% of a compound I and 1-10 wt% emulsifiers (e. g. calcium dodecylbenzenesulfonate and castor oil ethoxylate) are dissolved in 20-40 wt% water-insoluble organic solvent (e. g. aromatic hydrocarbon). This mixture is introduced into water ad 100 wt% by means of an emulsifying machine and made into a homogeneous emulsion. Dilution with water gives an emulsion.

v) Suspensions (SC, OD, FS)

In an agitated ball mill, 20-60 wt% of a compound I are comminuted with addition of 2-10 wt% dispersants and wetting agents (e. g. sodium lignosulfonate and alcohol ethoxylate), 0.1 -2 wt% thickener (e. g. xanthan gum) and water ad 100 wt% to give a fine active substance suspension. Dilution with water gives a stable suspension of the active substance. For FS type composition up to 40 wt% binder (e. g. polyvinyl alcohol) is added.

vi) Water-dispersible granules and water-soluble granules (WG, SG)

50-80 wt% of a compound I are ground finely with addition of dispersants and wetting agents (e. g. sodium lignosulfonate and alcohol ethoxylate) ad 100 wt% and prepared as water-dispersible or water-soluble granules by means of technical appliances (e. g. extrusion, spray tower, fluidized bed). Dilution with water gives a stable dispersion or solution of the active substance. vii) Water-dispersible powders and water-soluble powders (WP, SP, WS)

50-80 wt% of a compound I are ground in a rotor-stator mill with addition of 1-5 wt% dispersants (e. g. sodium lignosulfonate), 1 -3 wt% wetting agents (e. g. alcohol ethoxylate) and solid carrier (e. g. silica gel) ad 100 wt%. Dilution with water gives a stable dispersion or solution of the active substance.

viii) Gel (GW, GF)

In an agitated ball mill, 5-25 wt% of a compound I are comminuted with addition of 3-10 wt% dispersants (e. g. sodium lignosulfonate), 1 -5 wt% thickener (e. g. carboxymethyl cellulose) and water ad 100 wt% to give a fine suspension of the active substance. Dilution with water gives a stable suspension of the active substance.

ix) Microemulsion (ME)

5-20 wt% of a compound I are added to 5-30 wt% organic solvent blend (e. g. fatty acid dimethyl amide and cyclohexanone), 10-25 wt% surfactant blend (e. g. alcohol ethoxylate and arylphenol ethoxylate), and water ad 100 %. This mixture is stirred for 1 h to produce

spontaneously a thermodynamically stable microemulsion.

x) Microcapsules (CS)

An oil phase comprising 5-50 wt% of a compound I, 0-40 wt% water insoluble organic solvent (e. g. aromatic hydrocarbon), 2-15 wt% acrylic monomers (e. g. methylmethacrylate, methacrylic acid and a di- or triacrylate) are dispersed into an aqueous solution of a protective colloid (e. g. polyvinyl alcohol). Radical polymerization results in the formation of poly(meth)acrylate microcapsules. Alternatively, an oil phase comprising 5-50 wt% of a compound I according to the invention, 0-40 wt% water insoluble organic solvent (e. g. aromatic hydrocarbon), and an isocyanate monomer (e. g. diphenylmethene-4,4'-diisocyanatae) are dispersed into an aqueous solution of a protective colloid (e. g. polyvinyl alcohol). The addition of a polyamine (e. g.

hexamethylenediamine) results in the formation of polyurea microcapsules. The monomers amount to 1 -10 wt%. The wt% relate to the total CS composition.

xi) Dustable powders (DP, DS)

1-10 wt% of a compound I are ground finely and mixed intimately with solid carrier (e. g. finely divided kaolin) ad 100 wt%. xii) Granules (GR, FG)

0.5-30 wt% of a compound I is ground finely and associated with solid carrier (e. g. silicate) ad 100 wt%. Granulation is achieved by extrusion, spray-drying or fluidized bed.

xiii) Ultra-low volume liquids (UL)

1-50 wt% of a compound I are dissolved in organic solvent (e. g. aromatic hydrocarbon) ad 100 wt%.

The compositions types i) to xiii) may optionally comprise further auxiliaries, such as 0.1-1 wt% bactericides, 5-15 wt% anti-freezing agents, 0.1 -1 wt% anti-foaming agents, and 0.1 -1 wt% colorants.

The agrochemical compositions generally comprise between 0.01 and 95%, preferably between 0.1 and 90%, more preferably between 1 and 70%, and in particular between 10 and 60%, by weight of active substance. The active substances are employed in a purity of from 90% to 100%, preferably from 95% to 100% (according to NMR spectrum).

For the purposes of treatment of plant propagation materials, particularly seeds, solutions for seed treatment (LS), Suspoemulsions (SE), flowable concentrates (FS), powders for dry treatment (DS), water-dispersible powders for slurry treatment (WS), water-soluble powders (SS), emulsions (ES), emulsifiable concentrates (EC), and gels (GF) are usually employed. The compositions in question give, after two-to-tenfold dilution, active substance concentrations of from 0.01 to 60% by weight, preferably from 0.1 to 40%, in the ready-to-use preparations.

Application can be carried out before or during sowing. Methods for applying compound I and compositions thereof, respectively, onto plant propagation material, especially seeds, include dressing, coating, pelleting, dusting, and soaking as well as in-furrow application methods. Preferably, compound I or the compositions thereof, respectively, are applied on to the plant propagation material by a method such that germination is not induced, e. g. by seed dressing, pelleting, coating and dusting.

When employed in plant protection, the amounts of active substances applied are, depending on the kind of effect desired, from 0.001 to 2 kg per ha, preferably from 0.005 to 2 kg per ha, more preferably from 0.05 to 0.9 kg per ha, and in particular from 0.1 to 0.75 kg per ha.

In treatment of plant propagation materials such as seeds, e. g. by dusting, coating or drenching seed, amounts of active substance of from 0.1 to 1000 g, preferably from 1 to 1000 g, more preferably from 1 to 100 g and most preferably from 5 to 100 g, per 100 kilogram of plant propagation material (preferably seeds) are generally required.

When used in the protection of materials or stored products, the amount of active substance applied depends on the kind of application area and on the desired effect. Amounts customarily applied in the protection of materials are 0.001 g to 2 kg, preferably 0.005 g to 1 kg, of active substance per cubic meter of treated material.

Various types of oils, wetters, adjuvants, fertilizer, or micronutrients, and further pesticides (e. g. herbicides, insecticides, fungicides, growth regulators, safeners, biopesticides) may be added to the active substances or the compositions comprising them as premix or, if appropriate not until immediately prior to use (tank mix). These agents can be admixed with the compositions according to the invention in a weight ratio of 1 :100 to 100:1 , preferably 1 :10 to 10:1.

A pesticide is generally a chemical or biological agent (such as pestidal active ingredient, compound, composition, virus, bacterium, antimicrobial or disinfectant) that through its effect deters, incapacitates, kills or otherwise discourages pests. Target pests can include insects, plant pathogens, weeds, mollusks, birds, mammals, fish, nematodes (roundworms), and microbes that destroy property, cause nuisance, spread disease or are vectors for disease. The term "pesticide" includes also plant growth regulators that alter the expected growth, flowering, or reproduction rate of plants; defoliants that cause leaves or other foliage to drop from a plant, usually to facilitate harvest; desiccants that promote drying of living tissues, such as unwanted plant tops; plant activators that activate plant physiology for defense of against certain pests; safeners that reduce unwanted herbicidal action of pesticides on crop plants; and plant growth promoters that affect plant physiology e.g. to increase plant growth, biomass, yield or any other quality parameter of the harvestable goods of a crop plant.

The user applies the composition according to the invention usually from a predosage device, a knapsack sprayer, a spray tank, a spray plane, or an irrigation system. Usually, the

agrochemical composition is made up with water, buffer, and/or further auxiliaries to the desired application concentration and the ready-to-use spray liquor or the agrochemical composition according to the invention is thus obtained. Usually, 20 to 2000 liters, preferably 50 to 400 liters, of the ready-to-use spray liquor are applied per hectare of agricultural useful area.

According to one embodiment, individual components of the composition according to the invention such as parts of a kit or parts of a binary or ternary mixture may be mixed by the user himself in a spray tank or any other kind of vessel used for applications (e. g. seed treater drums, seed pelleting machinery, knapsack sprayer) and further auxiliaries may be added, if appropriate.

Consequently, one embodiment of the invention is a kit for preparing a usable pesticidal composition, the kit comprising a) a composition comprising component 1 ) as defined herein and at least one auxiliary; and b) a composition comprising component 2) as defined herein and at least one auxiliary; and optionally c) a composition comprising at least one auxiliary and optionally a further active component 3) as defined herein.

Mixing the compounds I or the compositions comprising them in the use form as fungicides with other fungicides results in many cases in an expansion of the fungicidal spectrum of activity being obtained or in a prevention of fungicide resistance development. Furthermore, in many cases, synergistic effects are obtained.

The following list of pesticides II (e. g. pesticidally-active substances and biopesticides), in conjunction with which the compounds I can be used, is intended to illustrate the possible combinations but does not limit them:

A) Respiration inhibitors: Inhibitors of complex III at Q ₀ site: azoxystrobin (A.1.1 ), coumeth- oxystrobin (A.1.2), coumoxystrobin (A.1 .3), dimoxystrobin (A.1.4), enestroburin (A.1.5), fenaminstrobin (A.1 .6), fenoxystrobin/flufenoxystrobin (A.1.7), fluoxastrobin (A.1.8), kresoxim- methyl (A.1.9), mandestrobin (A.1 .10), metominostrobin (A.1.1 1 ), orysastrobin (A.1 .12), picoxy- strobin (A.1 .13), pyraclostrobin (A.1.14), pyrametostrobin (A.1 .15), pyraoxystrobin (A.1 .16), trifloxystrobin (A.1.17), 2-(2-(3-(2,6-dichlorophenyl)-1-methyl-allylideneaminooxymeth yl)- phenyl)-2-methoxyimino-N-methyl-acetamide (A.1.18), pyribencarb (A.1.19),

triclopyricarb/chlorodincarb (A.1 .20), famoxadone (A.1.21 ), fenamidone (A.1.21 ), methyl-/V-[2- [(1 ,4-dimethyl-5-phenyl-pyrazol-3-yl)oxylmethyl]phenyl]-N-metho xy-carbamate (A.1 .22), 1 -[3- chloro-2-[[1-(4-chlorophenyl)-1 H-pyrazol-3-yl]oxymethyl]phenyl]-4-methyl-tetrazol-5-one (A.1 .23), 1-[3-bromo-2-[[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl]phen yl]-4-methyl-tetrazol-5- one (A.1 .24), 1 -[2-[[1 -(4-chlorophenyl)pyrazol-3-yl]oxyrnethyl]-3-methyl-phenyl]-4 -methyl-tetra- zol-5-one (A.1.25), 1-[2-[[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl]-3-fluoro-ph enyl]-4-methyl- tetrazol-5-one (A.1 .26), 1 -[2-[[1 -(2,4-dichlorophenyl)pyrazol-3-yl]oxymethyl]-3-fluoro-phenyl ]-4- methyl-tetrazol-5-one (A.1.27), 1-[2-[[4-(4-chlorophenyl)thiazol-2-yl]oxymethyl]-3-methyl-ph enyl]-

4- methyl-tetrazol-5-one (A.1 .28), 1 -[3-chloro-2-[[4-(p-tolyl)thiazol-2-yl]oxymethyl]phenyl]-4- methyl-tetrazol-5-one (A.1.29), 1-[3-cyclopropyl-2-[[2-methyl-4-(1 -methylpyrazol-3-yl)phenoxy]- methyl]phenyl]-4-methyl-tetrazol-5-one (A.1.30), 1-[3-(difluoromethoxy)-2-[[2-methyl-4- (1-methylpyrazol-3-yl)phenoxy]methyl]phenyl]-4-methyl-tetraz ol-5-one (A.1.31 ), 1-methyl-4-[3- methyl-2-[[2-methyl-4-(1 -methylpyrazol-3-yl)phenoxy]methyl]phenyl]tetrazol-5-one (A.1.32), 1- methyl-4-[3-methyl-2-[[1 -[3-(trifluoromethyl)phenyl]-ethylideneamino]oxymethyl]pheny l]tet^^

5- 0 ne (A.1.33), (Z,2.r)-5-[1 -(2,4-dichlorophenyl)pyrazol-3-yl]-oxy-2-m6)thoxyimino-/V,3- dimethyl- pent-3-enamide (A.1.34), (Zi2-r)-5-[1 -(4-chlorophenyl)pyrazol-3-yl]oxy-2-methoxyimino-/V,3- dimethyl-pent-3-enamide (A.1.35), pyriminostrobin (A.1.36), bifujunzhi (A.1 .37), 2-(ortho-((2,5- dimethylphenyl-oxymethylen)phenyl)-3-methoxy-acrylic acid methylester (A.1 .38).

Inhibitors of complex III at Q, site: cyazofamid (A.2.1 ), amisulbrom (A.2.2),

[(6S,7R,8R)-8-benzyl-3-[(3-hydroxy-4-methoxy-pyridine-2-c arbonyl)amino]-6-methyl-4,9-dioxo- 1 ,5-dioxonan-7-yl] 2-methylpropanoate (A.2.3), [2-[[(7R,8R,9S)-7-benzyl-9-methyl-8- (2-methylpropanoyloxy)-2,6-dioxo-1 ,5-dioxonan-3-yl]carbamoyl]-4-methoxy-3-pyridyl]oxymethyl 2-methylpropanoate (A.2.4), [(6S,7R,8R)-8-benzyl-3-[[4-methoxy-3-(propanoyloxy- methoxy)pyridine-2-carbonyl]amino]-6-methyl-4,9-dioxo-1 ,5-dioxonan-7-yl] 2-methylpropanoate (A.2.5).

Inhibitors of complex II: benodanil (A.3.1 ), benzovindiflupyr (A.3.2), bixafen (A.3.3), boscalid (A.3.4), carboxin (A.3.5), fenfuram (A.3.6), fluopyram (A.3.7), flutolanil (A.3.8), fluxapyroxad (A.3.9), furametpyr (A.3.10), isofetamid (A.3.1 1 ), isopyrazam (A.3.12), mepronil (A.3.13), oxycarboxin (A.3.14), penflufen (A.3.15), penthiopyrad (A.3.16), 3-(difluoromethyl)-N-methoxy- 1-methyl-N-[1-methyl-2-(2,4,6-trichlorophenyl)ethyl]pyrazole -4-carboxamide (A.3.17), N-[2-(3,4- difluorophenyl)phenyl]-3-(trifluoromethyl)pyrazine-2-carboxa mide (A.3.18), sedaxane (A.3.19), tecloftalam (A.3.20), thifluzamide (A.3.21 ), 3-(difluoromethyl)-1-methyl-N-(1 ,1 ,3-trimethylindan- 4-yl)pyrazole-4-carboxamide (A.3.22), 3-(trifluoromethyl)-1-methyl-N-(1 ,1 ,3-trimethylindan-4- yl)pyrazole-4-carboxamide (A.3.23), 1 ,3-dimethyl-N-(1 ,1 ,3-trimethylindan-4-yl)pyrazole-4- carboxamide (A.3.24), 3-(trifluoromethyl)-1 ,5-dimethyl-N-(1 ,1 ,3-trimethylindan-4-yl)pyrazole-4- carboxamide (A.3.25), 1 ,3,5-trimethyl-N-(1 ,1 ,3-trimethylindan-4-yl)pyrazole-4-carboxamide (A.3.26), 3-(difluoromethyl)-1 ,5-dimethyl-N-(1 ,1 ,3-trimethylindan-4-yl)pyrazole-4-carboxamide (A.3.27), 3-(difluoromethyl)-N-(7-fluoro-1 ,1 ,3-trimethyl-indan-4-yl)-1-methyl-pyrazole-4- carboxamide (A.3.28), methyl (E)-2-[2-[(5-cyano-2-methyl-phenoxy)methyl]phenyl]-3-methoxy - prop-2-enoate (A.3.30), N-[(5-chloro-2-isopropyl-phenyl)methyl]-N-cyclopropyl-3- (difluoromethyl)-5 fluoro-1-methyl-pyrazole-4-carboxamide (A.3.31 ), 2-(difluoromethyl)-N-(1 ,1 ,3- trimethyl-indan-4-yl)pyridine-3-carboxamide (A.3.32), 2-(difluoromethyl)-N-[(3R)-1 ,1 ,3- trimethylindan-4-yl]pyridine-3-carboxamide (A.3.33), 2-(difluoromethyl)-N-(3-ethyl-1 ,1-dimethyl- indan-4-yl)-"pyridine-3-carboxamide (A.3.34), 2-(difluoromethyl)-N-[(3R)-3-ethyl-1 ,1 -dimethyl- indan^-y -'pyridine-S-carboxamide (A.3.35), 2-(difluoromethyl)-N-(1 ,1 -dimethyl-3-propyl-indan- 4-yl)- ^, py- ^, ridine-3-carboxamide (A.3.36), 2-(difluoromethyl)-N-[(3R)-1 ,1-dimethyl-3-propyl-indan- 4-yl] ^" "pyridine-3-carboxamide (A.3.37), 2-(difluoromethyl)-N-(3-isobutyl-1 ,1 -dimethyl-indan-4- yl^pyridine-S-carboxamide (A.3.38), 2-(difluoromethyl)-N-[(3R)-3-isobutyl-1 ,1-dimethyl-indan-4 yl]pyridine-3-carboxamide (A.3.39).

Other respiration inhibitors: diflumetorim (A.4.1 ); nitrophenyl derivates: binapacryl (A.4.2), dinobuton (A.4.3), dinocap (A.4.4), fluazinam (A.4.5), meptyldinocap (A.4.6), ferimzone (A.4.7); organometal compounds: fentin salts, e. g. fentin-acetate (A.4.8), fentin chloride (A.4.9) or fentin hydroxide (A.4.10); ametoctradin (A.4.1 1 ); silthiofam (A.4.12).

B) Sterol biosynthesis inhibitors (SBI fungicides)

C14 demethylase inhibitors: triazoles: azaconazole (B.1.1 ), bitertanol (B.1.2), bromuconazole (B.1 .3), cyproconazole (B.1 .4), difenoconazole (B.1 .5), diniconazole (B.1.6), diniconazole-M (B.1 .7), epoxiconazole (B.1.8), fenbuconazole (B.1 .9), fluquinconazole (B.1 .10), flusilazole (B.1 .1 1 ), flutriafol (B.1.12), hexaconazole (B.1.13), imibenconazole (B.1.14), ipconazole

(B.1 .15), metconazole (B.1 .17), myclobutanil (B.1.18), oxpoconazole (B.1.19), paclobutrazole (B.1 .20), penconazole (B.1.21 ), propiconazole (B.1 .22), prothioconazole (B.1.23), simeconazole (B.1 .24), tebuconazole (B.1.25), tetraconazole (B.1.26), triadimefon (B.1.27), triadimenol (B.1 .28), triticonazole (B.1.29), uniconazole (B.1 .30), 1 -[ A(2S;3 )-3-(2-chlorophenyl)-2-(2,4- difluorophenyl)-oxiranylmethyl]-5-thiocyanato-1 H-[1 ,2,4]triazole (B.1 .31 ), 2-[reA(2^3 )-3-(2- chlorophenyl)-2-(2,4-difluorophenyl)-oxiranylmethyl]-2H-[1 ,2,4]triazole-3-thiol (B.1.32), 2-[2- chloro-4-(4-chlorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1-yl)pentan-2-ol (B.1.33), 1-[4-(4- chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-cyclopropyl-2-(1 ,2,4-triazol-1 -yl)ethanol (B.1.34), 2- [4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1 ,2,4-triazol-1-yl)butan-2-ol (B.1 .35),

2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1-(1 ,2,4-triazol-1 -yl)butan-2-ol (B.1 .36), 2-[4-(4-chloro- phenoxy)-2-(trifluoromethyl)phenyl]-3-methyl-1-(1 ,2,4-triazol-1 -yl)butan-2-ol (B.1.37), 2-[4-(4- chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1 ,2,4-triazol-1-yl)propan-2-ol (B.1.38), 2-[2-chloro- 4-(4-chlorophenoxy)phenyl]-3-methyl-1 -(1 ,2,4-triazol-1 -yl)butan-2-ol (B.1 .39), 2-[4-(4- chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1 ,2,4-triazol-1-yl)pentan-2-ol (B.1 .40), 2-[4-(4- fluorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1 ,2,4-triazol-1 -yl)propan-2-ol (B.1 .41 ), 2-[2-chloro- 4-(4-chlorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 -yl)pent-3-yn-2-ol (B.1 .42), 2-(chloromethyl)-2- methyl-5-(p-tolylmethyl)-1 -(1 ,2,4-triazol-1 -ylmethyl)cyclopentanol (B.1.43); imidazoles: imazalil (B.1 .44), pefurazoate (B.1 .45), prochloraz (B.1.46), triflumizol (B.1.47); pyrimidines, pyridines and piperazines: fenarimol (B.1.49), pyrifenox (B.1.50), triforine (B.1.51 ), [3-(4-chloro-2-fluoro- phenyl)-5-(2,4-difluorophenyl)isoxazol-4-yl]-(3-pyridyl)meth anol (B.1 .52).

Delta 14-reductase inhibitors: aldimorph (B.2.1 ), dodemorph (B.2.2), dodemorph-acetate (B.2.3), fenpropimorph (B.2.4), tridemorph (B.2.5), fenpropidin (B.2.6), piperalin (B.2.7), spiroxamine (B.2.8).

Inhibitors of 3-keto reductase: fenhexamid (B.3.1 ).

Other Sterol biosynthesis inhibitors: chlorphenomizole (B.4.1 ).

C) Nucleic acid synthesis inhibitors

Phenylamides or acyl amino acid fungicides: benalaxyl (C.1 .1 ), benalaxyl-M (C.1.2), kiralaxyl (C.1.3), metalaxyl (C.1.4), metalaxyl-M (C.1 .5), ofurace (C.1.6), oxadixyl (C.1.7).

Other nucleic acid synthesis inhibitors: hymexazole (C.2.1 ), octhilinone (C.2.2), oxolinic acid (C.2.3), bupirimate (C.2.4), 5-fluorocytosine (C.2.5), 5-fluoro-2-(p-tolylmethoxy)pyrimidin- 4-amine (C.2.6), 5-fluoro-2-(4-fluorophenylmethoxy)pyrimidin-4-amine (C.2.7), 5-fluoro- 2-(4-chlorophenylmethoxy)pyrimidin-4 amine (C.2.8).

D) Inhibitors of cell division and cytoskeleton Tubulin inhibitors: benomyl (D.1 .1 ), carbendazim (D.1.2), fuberidazole (D1 .3), thiabendazole (D.1.4), thiophanate-methyl (D.1.5), 3-chloro-4-(2,6-difluorophenyl)-6-methyl-5-phenyl-pyrida- zine (D.1 .6), 3-chloro-6-methyl-5-phenyl-4-(2,4,6-trifluorophenyl)pyridazi ne (D.1 .7), N-ethyl-2- [(3-ethynyl-8-methyl-6-quinolyl)oxy]butanamide (D.1.8), N-ethyl-2-[(3-ethynyl-8-methyl- 6-quinolyl)oxy]-2-methylsulfanyl-acetamide (D.1 .9), 2-[(3-ethynyl-8-methyl-6-quinolyl)oxy]-N-(2- fluoroethyl)butanamide (D.1 .10), 2-[(3-ethynyl-8-methyl-6-quinolyl)oxy]-N-(2-fluoroethyl)-2- methoxy-acetamide (D.1.1 1 ), 2-[(3-ethynyl-8-methyl-6-quinolyl)oxy]-N-propyl-butanamide (D.1.12), 2-[(3-ethynyl-8-methyl-6-quinolyl)oxy]-2-methoxy-N-propyl-ac etamide (D.1 .13), 2-[(3- ethynyl-8-methyl-6-quinolyl)oxy]-2-methylsulfanyl-N-propyl-a cetamide (D.1.14), 2-[(3-ethynyl-8- methyl-6-quinolyl)oxy]-N-(2-fluoroethyl)-2-methylsulfanyl-ac etamide (D.1.15), 4-(2-bromo-4- fluoro-phenyl)-N-(2-chloro-6-fluoro-phenyl)-2,5-dimethyl-pyr azol-3-amine (D.1 .16).

Other cell division inhibitors: diethofencarb (D.2.1 ), ethaboxam (D.2.2), pencycuron (D.2.3), fluopicolide (D.2.4), zoxamide (D.2.5), metrafenone (D.2.6), pyriofenone (D.2.7).

E) Inhibitors of amino acid and protein synthesis

Methionine synthesis inhibitors: cyprodinil (E.1.1 ), mepanipyrim (E.1 .2), pyrimethanil (E.1.3). Protein synthesis inhibitors: blasticidin-S (E.2.1 ), kasugamycin (E.2.2), kasugamycin

hydrochloride-hydrate (E.2.3), mildiomycin (E.2.4), streptomycin (E.2.5), oxytetracyclin (E.2.6).

F) Signal transduction inhibitors

MAP / histidine kinase inhibitors: fluoroimid (F.1.1 ), iprodione (F.1.2), procymidone (F.1.3), vinclozolin (F.1 .4), fludioxonil (F.1.5).

G protein inhibitors: quinoxyfen (F.2.1 ).

G) Lipid and membrane synthesis inhibitors

Phospholipid biosynthesis inhibitors: edifenphos (G.1 .1 ), iprobenfos (G.1 .2), pyrazophos (G.1 .3), isoprothiolane (G.1 .4).

Lipid peroxidation: dicloran (G.2.1 ), quintozene (G.2.2), tecnazene (G.2.3), tolclofos-methyl (G.2.4), biphenyl (G.2.5), chloroneb (G.2.6), etridiazole (G.2.7).

Phospholipid biosynthesis and cell wall deposition: dimethomorph (G.3.1 ), flumorph (G.3.2), mandipropamid (G.3.3), pyrimorph (G.3.4), benthiavalicarb (G.3.5), iprovalicarb (G.3.6), valifenalate (G.3.7).

Compounds affecting cell membrane permeability and fatty acides: propamocarb (G.4.1 ).

Inhibitors of oxysterol binding protein: oxathiapiprolin (G.5.1 ), 2-{3-[2-(1-{[3,5-bis(difluoromethyl- 1 H-pyrazol-1 -yl]acetyl}piperidin-4-yl)-1 ,3-thiazol-4-yl]-4,5-dihydro-1 ,2-oxazol-5-yl}phenyl methanesulfonate (G.5.2), 2-{3-[2-(1 -{[3,5-bis(difluoromethyl)-1 H-pyrazol-1 -yl]acetyl}piperidin-4- yl) 1 ,3-thiazol-4-yl]-4,5-dihydro-1 ,2-oxazol-5-yl}-3-chlorophenyl methanesulfonate (G.5.3), 4-[1 - [2-[3-(difluoromethyl)-5-methyl-pyrazol-1-yl]acetyl]-4-piper idyl]-N-tetralin-1-yl-pyridine-2- carboxamide (G.5.4), 4-[1 -[2-[3,5-bis(difluoromethyl)pyrazol-1 -yl]acetyl]-4-piperidyl]-N-tetralin-1 - yl-pyridine-2-carboxamide (G.5.5), 4-[1-[2-[3-(difluoromethyl)-5-(trifluoromethyl)pyrazol-1- yl]acetyl]-4-piperidyl]-N-tetralin-1 -yl-pyridine-2-carboxamide (G.5.6), 4-[1 -[2-[5-cyclopropyl-3- (difluoromethyl)pyrazol-l -yl]acetyl]-4-piperidyl]-N-tetralin-1 -yl-pyridine-2-carboxamide (G.5.7), 4- [1 -[2-[5-methyl-3-(trifluoromethyl)pyrazol-1 -yl]acetyl]-4-piperidyl]-N-tetralin-1 -yl-pyridine-2- carboxamide (G.5.8), 4-[1 -[2-[5-(difluoromethyl)-3-(trifluoromethyl)pyrazol-1 -yl]acetyl]-4- piperidyl]-N-tetralin-1 -yl-pyridine-2-carboxamide (G.5.9), 4-[1 -[2-[3,5-bis(trifluoromethyl)pyrazol- 1-yl]acetyl]-4-piperidyl]-N-tetralin-1 -yl-pyridine-2-carboxamide (G.5.10), (4-[1-[2-[5-cyclopropyl- 3-(trifluoromethyl)pyrazol-1-yl]acetyl]-4-piperidyl]-N-tetra lin-1-yl-pyridine-2-carboxamide (G.5.1 1 ).

H) Inhibitors with Multi Site Action

Inorganic active substances: Bordeaux mixture (H.1.1 ), copper (H.1 .2), copper acetate (H.1 .3), copper hydroxide (H.1.4), copper oxychloride (H.1.5), basic copper sulfate (H.1.6), sulfur (H.1.7).

Thio- and dithiocarbamates: ferbam (H.2.1 ), mancozeb (H.2.2), maneb (H.2.3), metam (H.2.4), metiram (H.2.5), propineb (H.2.6), thiram (H.2.7), zineb (H.2.8), ziram (H.2.9).

Organochlorine compounds: anilazine (H.3.1 ), chlorothalonil (H.3.2), captafol (H.3.3), captan (H.3.4), folpet (H.3.5), dichlofluanid (H.3.6), dichlorophen (H.3.7), hexachlorobenzene (H.3.8), pentachlorphenole (H.3.9) and its salts, phthalide (H.3.10), tolylfluanid (H.3.1 1 ).

Guanidines and others: guanidine (H.4.1 ), dodine (H.4.2), dodine free base (H.4.3), guazatine (H.4.4), guazatine-acetate (H.4.5), iminoctadine (H.4.6), iminoctadine-triacetate (H.4.7), iminoctadine-tris(albesilate) (H.4.8), dithianon (H.4.9), 2,6-dimethyl-1 H,5H-[1 ,4]dithiino[2,3- c:5,6-c']dipyrrole-1 ,3,5,7(2H,6H)-tetraone (H.4.10).

I) Cell wall synthesis inhibitors

Inhibitors of glucan synthesis: validamycin (1.1 .1 ), polyoxin B (1.1.2).

Melanin synthesis inhibitors: pyroquilon (1.2.1 ), tricyclazole (I.2.2), carpropamid (I.2.3), dicyclomet (I.2.4), fenoxanil (I.2.5).

J) Plant defence inducers

Acibenzolar-S-methyl (J.1 .1 ), probenazole (J.1.2), isotianil (J.1 .3), tiadinil (J.1 .4), prohexadione- calcium (J.1.5); phosphonates: fosetyl (J.1 .6), fosetyl-aluminum (J.1 .7), phosphorous acid and its salts (J.1 .8), potassium or sodium bicarbonate (J.1.9), 4-cyclopropyl-N-(2,4- dimethoxyphenyl)thiadiazole-5-carboxamide (J.1.10).

K) Unknown mode of action

Bronopol (K.1 .1 ), chinomethionat (K.1.2), cyflufenamid (K.1.3), cymoxanil (K.1 .4), dazomet (K.1 .5), debacarb (K.1.6), diclocymet (K.1.7), diclomezine (K.1 .8), difenzoquat (K.1.9), di- fenzoquat-methylsulfate (K.1.10), diphenylamin (K.1 .1 1 ), fenitropan (K.1 .12), fenpyrazamine (K.1 .13), flumetover (K.1 .14), flusulfamide (K.1.15), flutianil (K.1.16), harpin (K.1 .17), metha- sulfocarb (K.1.18), nitrapyrin (K.1 .19), nitrothal-isopropyl (K.1 .20), tolprocarb (K.1 .21 ), oxin- copper (K.1.22), proquinazid (K.1.23), tebufloquin (K.1 .24), tecloftalam (K.1.25), triazoxide (K.1 .26), N'-(4-(4-chloro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-phen yl)-N-ethyl-N-methyl formamidine (K.1.27), N'-(4-(4-fluoro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-phen yl)-N-ethyl-N- methyl formamidine (K.1.28), N'-[4-[[3-[(4-chlorophenyl)methyl]-1 ,2,4-thiadiazol-5-yl]oxy]-2,5- dimethyl-phenyl]-N-ethyl-N-methyl-formamidine (K.1.29), N'-(5-bromo-6-indan-2-yloxy-2-methyl- 3-pyridyl)-N-ethyl-N-methyl-formamidine (K.1 .30), N'-[5-bromo-6-[1-(3,5-difluorophenyl)ethoxy]- 2-methyl-3-pyridyl]-N-ethyl-N-methyl-formamidine (K.1.31 ), N'-[5-bromo-6-(4- isopropylcyclohexoxy)-2-methyl-3-pyridyl]-N-ethyl-N-methyl-f ormamidine (K.1.32), N'-[5-bromo- 2-methyl-6-(1 -phenylethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine (K.1 .33), N'-(2-methyl-5- trifluoromethyl-4-(3-trimethylsilanyl-propoxy)-phenyl)-N-eth yl-N-methyl formamidine (K.1 .34), N'- (5-difluoromethyl-2-methyl-4-(3-trimethylsilanyl-propoxy)-ph enyl)-N-ethyl-N-methyl formamidine (K.1 .35), 2-(4-chloro-phenyl)-N-[4-(3,4-dimethoxy-phenyl)-isoxazol-5-y l]-2-prop-2-ynyloxy- acetamide (K.1 .36), 3-[5-(4-chloro-phenyl)-2,3-dimethyl-isoxazolidin-3-yl]-pyrid ine (pyrisoxazole) (K.1 .37), 3-[5-(4-methylphenyl)-2,3-dimethyl-isoxazolidin-3 yl]-pyridine (K.1.38), 5-chloro-1-(4,6- dimethoxy-pyrimidin-2-yl)-2-methyl-1 H-benzoimidazole (K.1 .39), ethyl (Z)-3-amino-2-cyano-3- phenyl-prop-2-enoate (K.1.40), picarbutrazox (K.1.41 ), pentyl N-[6-[[(Z)-[(1 -methyltetrazol-5-yl)- phenyl-methylene]amino]oxymethyl]-2-pyridyl]carbamate (K.1 .42), but-3-ynyl N-[6-[[(Z)-[(1- methyltetrazol-5-yl)-phenyl-methylene]amino]oxymethyl]-2-pyr idyl]carbamate (K.1 .43), 2-[2- [(7,8-difluoro-2-methyl-3-quinolyl)oxy]-6-fluoro-phenyl]prop an-2-ol (K.1.44), 2-[2-fluoro-6-[(8- fluoro-2-methyl-3-quinolyl)oxy]phen-yl]propan-2-ol (K.1 .45), 3-(5-fluoro-3,3,4,4-tetramethyl-3,4- dihydroisoquinolin-1 -yl)quinoline (K.1 .46), quinofumelin (K.1 .47), 3-(4,4,5-trifluoro-3,3-dimethyl- 3,4-dihydroisoquinolin-1-yl)quinoline (K.1 .48), 9-fluoro-2,2-dimethyl-5-(3-quinolyl)- 3H-1 ,4-benzoxazepine (K.1.49), 2-(6-benzyl-2-pyridyl)quinazoline (K.1 .50), 2-[6-(3-fluoro- 4-methoxy-phenyl)-5-methyl-2-pyridyl]quinazoline (K.1.51 ), 3-[(3,4-dichloroisothiazol- 5-yl)methoxy]-1 ,2-benzothiazole 1 ,1 -dioxide (K.1.52), N'-(2,5-dimethyl-4-phenoxy-phenyl)-N- ethyl-N-methyl-formamidine (K.1 .53).

M) Growth regulators

abscisic acid (M.1 .1 ), amidochlor, ancymidol, 6-benzylaminopurine, brassinolide, butralin, chlormequat, chlormequat chloride, choline chloride, cyclanilide, daminozide, dikegulac, dimethipin, 2,6-dimethylpuridine, ethephon, flumetralin, flurprimidol, fluthiacet, forchlorfenuron, gibberellic acid, inabenfide, indole-3-acetic acid , maleic hydrazide, mefluidide, mepiquat, mepiquat chloride, naphthaleneacetic acid, N-6-benzyladenine, paclobutrazol, prohexadione, prohexadione-calcium, prohydrojasmon, thidiazuron, triapenthenol, tributyl phosphorotrithioate, 2,3,5-tri-iodobenzoic acid , trinexapac-ethyl and uniconazole;

N) Herbicides from classes N.1 to N.15

N.1 Lipid biosynthesis inhibitors: alloxydim (N.1 .1 ), alloxydim-sodium (N.1.2), butroxydim (N.1.3), clethodim (N.1.4), clodinafop (N.1 .5), clodinafop-propargyl (N.1.6), cycloxydim (N.1.7), cyhalofop (N.1 .8), cyhalofop-butyl (N.1.9), diclofop(N.1 .10), diclofop-methyl (N.1.1 1 ), fenoxaprop (N.1 .12), fenoxaprop-ethyl (N.1 .13), fenoxaprop-P (N.1 .14), fenoxaprop-P-ethyl (N.1.15), fluazifop (N.1 .16), fluazifop-butyl (N.1 .17), fluazifop-P (N.1.18), fluazifop-P-butyl (N.1.19), haloxyfop (N.1.20), haloxyfop-methyl (N.1.21 ), haloxyfop-P (N.1.22), haloxyfop-P- methyl (N.1 .23), metamifop (N.1 .24), pinoxaden (N.1 .25), profoxydim (N.1 .26), propaquizafop (N.1.27), quizalofop (N.1 .28), quizalofop-ethyl (N.1.29), quizalofop-tefuryl (N.1.30), quizalofop-P (N.1.31 ), quizalofop-P-ethyl (N.1 .32), quizalofop-P-tefuryl (N.1.33), sethoxydim (N.1 .34), tepraloxydim (N.1 .35), tralkoxydim (N.1.36), 4-(4'-chloro-4-cyclo-"propyl-2'-fluoro[1 ,1 '-biphenyl]- 3-yl)-5-hydroxy-2,2,6,6-tetramethyl-2H-pyran-3(6H)-one ((N.1 .37) CAS 1312337-72-6); 4-(2',4'- dichloro-4-cyclopropyl[1 ,1 '-biphenyl]-3-yl)-5-hydroxy-2,2,6,6-tetramethyl-2H-pyran-3(6 H)-one ((N.1.38) CAS 1312337-45-3); 4-(4'-chloro-4-ethyl-2'-fluoro[1 ,1 '-biphenyl]-3-yl)-5-hydroxy- 2,2,6,6-tetramethyl-2H-pyran-3(6H)-one ((N.1.39) CAS 1033757-93-5); 4-(2',4'-Dichloro-4- ethyl[1 ,1 '-biphenyl]-3-yl)-2,2,6,6-tetramethyl-2H-pyran-3,5(4H,6H)-di one ((N.1.40) CAS

1312340-84-3); 5-(acetyloxy)-4-(4'-chloro-4-cyclopropyl-2'-fluoro[1 ,1 '-biphenyl]-3-yl)-3,6-dihydro- 2,2,6,6-tetramethyl-2H-pyran-3-one ((N.1.41 ) CAS 1312337-48-6); 5-(acetyloxy)-4-(2 ^' ,4'- dichloro-4-cyclopropyl- [1 ,1 '-biphenyl]-3-yl)-3,6-dihydro-2,2,6,6-tetramethyl-2H-pyran-3 -one (N.1.42); 5-(acetyloxy)-4-(4'-chloro-4-ethyl-2'-fluoro[1 ,1 '-biphenyl]-3-yl)-3,6-dihydro-2,2,6,6- tetramethyl-2H-pyran-3-one ((N.1 .43) CAS 1312340-82-1 ); 5-(acetyloxy)-4-(2',4'-dichloro-4- ethyl[1 ,1 '-biphenyl]-3-yl)-3,6-dihydro-2,2,6,6-tetramethyl-2H-pyran-3 -one ((N.1.44) CAS

1033760-55-2); 4-(4'-chloro-4-cyclopropyl-2'-fluoro[1 ,1 '-biphenyl]-3-yl)-5,6-dihydro-2,2,6,6- tetramethyl-5-oxo-2H-pyran-3-yl carbonic acid methyl ester ((N.1.45) CAS 1312337-51 -1 ); 4- (2 ^' ,4'-dichloro -4-cyclopropyl- [1 ,1 '-biphenyl]-3-yl)-5,6-dihydro-2,2,6,6-tetramethyl-5-oxo-2H- pyran-3-yl carbonic acid methyl ester (N.1.46); 4-(4'-chloro-4-ethyl-2'-fluoro[1 ,1 '-biphenyl]-3-yl)- 5,6-dihydro-2,2,6,6-tetramethyl-5-oxo-2H-pyran-3-yl carbonic acid methyl ester ((N.1 .47) CAS 1312340-83-2); 4-(2',4'-dichloro-4-ethyh[1 ,1 '-biphenyl]-3-yl)-5,6-dihydro-2,2,6,6-tetramethyl-5- oxo-2H-pyran-3-yl carbonic acid methyl ester ((N.1.48) CAS 1033760-58-5); benfuresate (N.1.49), butylate (N.1 .50), cycloate (N.1 .51 ), dalapon (N.1.52), dimepiperate (N.1.53), EPTC (N.1.54), esprocarb (N.1 .55), ethofumesate (N.1 .56), flupropanate (N.1 .57), molinate (N.1.58), orbencarb (N.1 .59), pebulate (N.1.60), prosulfocarb (N.1.61 ), TCA (N.1.62), thiobencarb (N.1.63), tiocarbazil (N.1.64), triallate (N.1.65) and vernolate (N.1 .66);

N.2 ALS inhibitors: amidosulfuron (N.2.1 ), azimsulfuron (N.2.2), bensulfuron (N.2.3), bensul- furon-methyl (N.2.4), chlorimuron (N.2.5), chlorimuron-ethyl (N.2.6), chlorsulfuron (N.2.7), cinosulfuron (N.2.8), cyclosulfamuron (N.2.9), ethametsulfuron (N.2.10), ethametsulfuron- methyl (N.2.1 1 ), ethoxysulfuron (N.2.12), flazasulfuron (N.2.13), flucetosulfuron (N.2.14), flupyrsulfuron (N.2.15), flupyrsulfuron-methyl-sodium (N.2.16), foramsulfuron (N.2.17), halosulfuron (N.2.18), halosulfuron-methyl (N.2.19), imazosulfuron (N.2.20), iodosulfuron (N.2.21 ), iodosulfuron-methyl-sodium (N.2.22), iofensulfuron (N.2.23), iofensulfuron-sodium (N.2.24), mesosulfuron (N.2.25), metazosulfuron (N.2.26), metsulfuron (N.2.27), metsulfuron- methyl (N.2.28), nicosulfuron (N.2.29), orthosulfamuron (N.2.30), oxasulfuron (N.2.31 ), primisulfuron (N.2.32), primisulfuron-methyl (N.2.33), propyrisulfuron (N.2.34), prosulfuron (N.2.35), pyrazosulfuron (N.2.36), pyrazosulfuron-ethyl (N.2.37), rimsulfuron (N.2.38), sulfometuron (N.2.39), sulfometuron-methyl (N.2.40), sulfosulfuron (N.2.41 ), thifensulfuron (N.2.42), thifensulfuron-methyl (N.2.43), triasulfuron (N.2.44), tribenuron (N.2.45), tribenuron- methyl (N.2.46), trifloxysulfuron (N.2.47), triflusulfuron (N.2.48), triflusulfuron-methyl (N.2.49), tritosulfuron (N.2.50), imazamethabenz (N.2.51 ), imazamethabenz-methyl (N.2.52), imazamox (N.2.53), imazapic (N.2.54), imazapyr (N.2.55), imazaquin (N.2.56), imazethapyr (N.2.57); cloransulam (N.2.58), cloransulam-methyl (N.2.59), diclosulam (N.2.60), flumetsulam (N.2.61 ), florasulam (N.2.62), metosulam (N.2.63), penoxsulam (N.2.64), pyrimisulfan (N.2.65) and pyroxsulam (N.2.66); bispyribac (N.2.67), bispyribac-sodium (N.2.68), pyribenzoxim (N.2.69), pyriftalid (N.2.70), pyriminobac (N.2.71 ), pyriminobac-methyl (N.2.72), pyrithiobac (N.2.73), pyrithiobac-sodium (N.2.74), 4-[[[2-[(4,6-dimethoxy-2-pyrimidinyl)oxy]phenyl]methyl]amino ]- benzoic acid-1 -methyhethyl ester ((N.2.75) CAS 420138-41-6), 4-[[[2-[(4,6-dimethoxy-2- pyrimidinyl)oxy]phenyl]-"methyl]amino]-benzoic acid propyl ester ((N.2.76) CAS 420138-40-5), N-(4-bromophenyl)-2-[(4,6-dimethoxy-2-pyrimidinyl)oxy]benzen emethanamine ((N.2.77) CAS 420138-01 -8); flucarbazone (N.2.78), flucarbazone-sodium (N.2.79), propoxycarbazone (N.2.80), propoxycarbazone-sodium (N.2.81 ), thiencarbazone (N.2.82), thiencarbazone-methyl (N.2.83), triafamone (N.2.84);

N.3 Photosynthesis inhibitors: amicarbazone (N.3.1 ); chlorotriazine (N.3.2); ametryn (N.3.3), atrazine (N.3.4), chloridazone (N.3.5), cyanazine (N.3.6), desmetryn (N.3.7), dimethametryn (N.3.8),hexazinone (N.3.9), metribuzin (N.3.10), prometon (N.3.1 1 ), prometryn (N.3.12), pro- pazine (N.3.13), simazine (N.3.14), simetryn (N.3.15), terbumeton (N.3.16), terbuthylazin (N.3.17), terbutryn (N.3.18), trietazin (N.3.19); chlorobromuron (N.3.20), chlorotoluran (N.3.21 ), chloroxuron (N.3.22), dimefuron (N.3.23), diuron (N.3.24), fluometuron (N.3.25), isoproturon (N.3.26), isouron (N.3.27), linuron (N.3.28), metamitron (N.3.29), methabenzthiazuran (N.3.30), metobenzuron (N.3.31 ), metoxuron (N.3.32), monolinuron (N.3.33), neburon (N.3.34), siduron (N.3.35), tebuthiuron (N.3.36), thiadiazuron (N.3.37), desmedipham (N.3.38), karbutilat (N.3.39), phenmedipham (N.3.40), phenmedipham-ethyl (N.3.41 ), bromofenoxim (N.3.42), bromoxynil (N.3.43) and its salts and esters, ioxynil (N.3.44) and its salts and esters, bromacil (N.3.45), lenacil (N.3.46), terbacil (N.3.47), bentazon (N.3.48), bentazon-sodium (N.3.49), pyridate (N.3.50), pyridafol (N.3.51 ), pentanochlor (N.3.52), propanil (N.3.53); diquat (N.3.54), diquat- dibromide (N.3.55), paraquat (N.3.56), paraquat-dichloride (N.3.57), paraquat-dimetilsulfate (N.3.58);

N.4 protoporphyrinogen-IX oxidase inhibitors: acifluorfen (N.4.1 ), acifluorfen-sodium (N.4.2), azafenidin (N.4.3), bencarbazone (N.4.4), benzfendizone (N.4.5), bifenox (N.4.6), butafenacil (N.4.7), carfentrazone (N.4.8), carfentrazone-ethyl (N.4.9), chlormethoxyfen (N.4.10), cinidon- ethyl (N.4.1 1 ), fluazolate (N.4.12), flufenpyr (N.4.13), flufenpyr-ethyl (N.4.14), flumiclorac (N.4.15), flumiclorac-pentyl (N.4.16), flumioxazin (N.4.17), fluoroglycofen (N.4.18),

fluoroglycofen-ethyl (N.4.19), fluthiacet (N.4.20), fluthiacet-methyl (N.4.21 ), fomesafen (N.4.22), halosafen (N.4.23), lactofen (N.4.24), oxadiargyl (N.4.25), oxadiazon (N.4.26), oxyfluorfen (N.4.27), pentoxazone (N.4.28), profluazol (N.4.29), pyraclonil (N.4.30), pyraflufen (N.4.31 ), pyraflufen-ethyl (N.4.32), saflufenacil (N.4.33), sulfentrazone (N.4.34), thidiazimin (N.4.35), tiafenacil (N.4.36), trifludimoxazin (N.4.37), ethyl [3-[2-chloro-4-fluoro-5-(1 -methyl-6- trifluoromethyl-2,4-dioxo-1 ,2,3,4-tetrahydropyrimidin-3-yl)phenoxy]-2-pyridyloxy]acetat e

((N.4.38) CAS 353292-31-6), N-ethyl-3-(2,6-dichloro-4-trifluoro-methylphenoxy)-5-methyl- 1 H- pyrazole-1-carboxamide ((N.4.39) CAS 452098-92-9), N tetrahydrofurfuryl-3-(2,6-dichloro-4- trifluoromethylphenoxy)-5-methyl-1 H-pyrazole-1 -carboxamide ((N.4.40) CAS 915396-43-9), N- ethyl-3-(2-chloro-6-fluoro-4-trifluoromethyhphenoxy)-5-methy l-1 H-pyrazole-1 -carboxamide ((N.4.41 ) CAS 452099-05-7), N tetrahydro->furfuryl-3-(2-chloro-6-fluoro-4- trifluoro-"methylphenoxy)-5-methyl-1 H-pyrazole-1-carboxamide ((N.4.42) CAS 452100-03-7), 3- [7-fluoro-3-oxo-4-(prop-2-ynyl)-3,4-dihydro-2H-benzo[1 ,4]oxazin-6-yl]-1 ,5-dimethyl-6-thioxo- [1 ,3,5]triazinan-2,4-dione ((N.4.43) CAS 451484-50-7), 2-(2,2,7-trifluoro-3-oxo-4-prop-2-ynyl- 3,4-dihydro-2H-benzo[1 ,4]oxazin-6-yl)-4,5,6,7-tetrahydro-isoindole-1 ,3-dione ((N.4.44) CAS 13001 18-96-0), 1-methyl-6-trifluoro->methyl-3-(2,2,7-tri-fluoro-3-oxo-4- prop-2-ynyl-3,4-dihydro- 2H-benzo[1 ,4]oxazin-6-yl)-1 H-pyrimidine-2,4-dione ((N.4.45) CAS 13041 13-05-0), methyl (E)-4- [2-chloro-5-[4-chloro-5-(difluoromethoxy)-1 H-methyl-pyrazol-3-yl]-4-fluoro-phenoxy]-3-methoxy- but-2-enoate ((N.4.46) CAS 948893-00-3), 3-[7-chloro-5-fluoro-2-(trifluoromethyl)-1 H- benzimidazol-4-yl]-1 -methyl-6-(trifluoromethyl)-1 H-pyrimidine-2,4-dione ((N.4.47) CAS 212754- 02-4);

N.5 Bleacher herbicides: beflubutamid (N.5.1 ), diflufenican (N.5.2), fluridone (N.5.3),

flurochloridone (N.5.4), flurtamone (N.5.5), norflurazon (N.5.6), picolinafen (N.5.7), 4-(3- trifluoromethyhphenoxy)-2-(4-trifluoromethylphenyl)->pyri midine ((N.5.8) CAS 180608-33-7); benzobicyclon (N.5.9), benzofenap (N.5.10), bicyclopyrone (N.5.1 1 ), clomazone (N.5.12), fenquintrione (N.5.13), isoxaflutole (N.5.14), mesotrione (N.5.15), pyrasulfotole (N.5.16), pyrazolynate (N.5.17), pyrazoxyfen (N.5.18), sulcotrione (N.5.19), tefuryltrione (N.5.20), tembotrione (N.5.21 ), tolpyralate (N.5.22), topramezone (N.5.23); aclonifen (N.5.24), amitrole (N.5.25), flumeturon (N.5.26);

N.6 EPSP synthase inhibitors: glyphosate (N.6.1 ), glyphosate-isopropylammonium (N.6.2), glyposate-potassium (N.6.3), glyphosate-trimesium (sulfosate) (N.6.4); N.7 Glutamine synthase inhibitors: bilanaphos (bialaphos) (N.7.1 ), bilanaphos-sodium (N.7.2), glufosinate (N.7.3), glufosinate-P (N.7.4), glufosinate-ammonium (N.7.5);

N.8 DHP synthase inhibitors: asulam (N.8.1 );

N.9 Mitosis inhibitors: benfluralin (N.9.1 ), butralin (N.9.2), dinitramine (N.9.3), ethalfluralin (N.9.4), fluchloralin (N.9.5), oryzalin (N.9.6), pendimethalin (N.9.7), prodiamine (N.9.8), trifluralin (N.9.9); amiprophos (N.9.10), amiprophos-methyl (N.9.1 1 ), butamiphos (N.9.12); chlorthal (N.9.13), chlorthal-dimethyl (N.9.14), dithiopyr (N.9.15), thiazopyr (N.9.16), propyzamide (N.9.17), tebutam (N.9.18); carbetamide (N.9.19), chlorpropham (N.9.20), flamprop (N.9.21 ), flamprop-isopropyl (N.9.22), flamprop-methyl (N.9.23), flamprop-M-isopropyl (N.9.24), flamprop- M-methyl (N.9.25), propham (N.9.26);

N.10 VLCFA inhibitors: acetochlor (N.10.1 ), alachlor (N.10.2), butachlor (N.10.3), dimethachlor (N.10.4), dimethenamid (N.10.5), dimethenamid-P (N.10.6), metazachlor (N.10.7), metolachlor (N.10.8), metolachlor-S (N.10.9), pethoxamid (N.10.10), pretilachlor (N.10.1 1 ), propachlor (N.10.12), propisochlor (N.10.13), thenylchlor (N.10.14), flufenacet (N.10.15), mefenacet (N.10.16), diphenamid (N.10.17), naproanilide (N.10.18), napropamide (N.10.19), napropamide- M (N.10.20), fentrazamide (N.10.21 ), anilofos (N.10.22), cafenstrole (N.10.23), fenoxasulfone (N.10.24), ipfencarbazone (N.10.25), piperophos (N.10.26), pyroxasulfone (N.10.27), isoxazoline compounds of the formulae 11.1 , II.2, II.3, II.4, I I.5, II.6, II.7, II.8 and II.9

1.1

II.2

II.6 II.7

II.9

II.8

N.1 1 Cellulose biosynthesis inhibitors: chlorthiamid (N.1 1.1 ), dichlobenil (N.1 1 .2), flupoxam (N.1 1 .3), indaziflam (N.1 1 .4), isoxaben (N.1 1 .5), triaziflam (N.1 1.6), 1 -cyclohexyl-5- pentafluorphenyloxy-14-[1 ,2,4,6]thiatriazin-3-ylamine ((N.11 .7) CAS 175899-01-1 );

N.12 Decoupler herbicides: dinoseb (N.12.1 ), dinoterb (N.12.2), DNOC (N.12.3) and its salts; N.13 Auxinic herbicides: 2,4-D (N.13.1 ) and its salts and esters, clacyfos (N.13.2), 2,4-DB (N.13.3) and its salts and esters, aminocyclopyrachlor (N.13.4) and its salts and esters, aminopyralid (N.13.5) and its salts such as aminopyralid-dimethylammonium (N.13.6), aminopyralid-tris(2-hydroxypropyl)ammonium (N.13.7) and its esters, benazolin (N.13.8), benazolin-ethyl (N.13.9), chloramben (N.13.10) and its salts and esters, clomeprop (N.13.1 1 ), clopyralid (N.13.12) and its salts and esters, dicamba (N.13.13) and its salts and esters, dichlorprop (N.13.14) and its salts and esters, dichlorprop-P (N.13.15) and its salts and esters, fluroxypyr (N.13.16), fluroxypyr-butometyl (N.13.17), fluroxypyr-meptyl (N.13.18), halauxifen (N.13.) and its salts and esters (CAS 943832-60-8); MCPA (N.13.) and its salts and esters, MCPA-thioethyl (N.13.19), MCPB (N.13.20) and its salts and esters, mecoprop (N.13.21 ) and its salts and esters, mecoprop-P (N.13.22) and its salts and esters, picloram (N.13.23) and its salts and esters, quinclorac (N.13.24), quinmerac (N.13.25), TBA (2,3,6) (N.13.26) and its salts and esters, triclopyr (N.13.27) and its salts and esters, 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-meth- oxyphenyl)-5-fluoropyridine-2-carboxylic acid (N.13.28), benzyl 4-amino-3-chloro-6-(4-chloro-2- fluoro-3-methoxyphenyl)-5-fluoropyridine-2-carboxylate ((N.13.29) CAS 1390661-72-9);

N.14 Auxin transport inhibitors: diflufenzopyr (N.14.1 ), diflufenzopyr-sodium (N.14.2), naptalam (N.14.3) and naptalam-sodium (N.14.4);

N.15 Other herbicides: bromobutide (N.15.1 ), chlorflurenol (N.15.2), chlorflurenol-methyl (N.15.3), cinmethylin (N.15.4), cumyluron (N.15.5), cyclopyrimorate ((N.15.6) CAS 499223-49-3) and its salts and esters, dalapon (N.15.7), dazomet (N.15.8), difenzoquat (N.15.9), difenzoquat- metilsulfate (N.15.10), dimethipin (N.15.1 1 ), DSMA (N.15.12), dymron (N.15.13), endothal (N.15.14) and its salts, etobenzanid (N.15.15), flurenol (N.15.16), flurenol-butyl (N.15.17), flurprimidol (N.15.18), fosamine (N.15.19), fosamine-ammonium (N.15.20), indanofan (N.15.21 ), maleic hydrazide (N.15.22), mefluidide (N.15.23), metam (N.15.24), methiozolin ((N.15.25) CAS 403640-27-7), methyl azide (N.15.26), methyl bromide (N.15.27), methyl-dymron (N.15.28), methyl iodide (N.15.29), MSMA (N.15.30), oleic acid (N.15.31 ), oxaziclomefone (N.15.32), pelargonic acid (N.15.33), pyributicarb (N.15.34), quinoclamine (N.15.35), tridiphane (N.15.36); O) Insecticides from classes 0.1 to 0.29

0.1 Acetylcholine esterase (AChE) inhibitors: aldicarb (0.1.1 ), alanycarb (0.1 .2), bendiocarb (0.1 .3), benfuracarb (0.1.4), butocarboxim (0.1.5), butoxycarboxim (0.1 .6), carbaryl (0.1.7), carbofuran (0.1.8), carbosulfan (0.1 .9), ethiofencarb (0.1 .10), fenobucarb (0.1 .1 1 ),

formetanate (0.1 .12), furathiocarb (0.1.13), isoprocarb (0.1.14), methiocarb (0.1.15), methomyl (0.1 .16), metolcarb (0.1 .17), oxamyl (0.1 .18), pirimicarb (0.1.19), propoxur (O.1.20), thiodicarb (0.1 .21 ), thiofanox (0.1.22), trimethacarb (0.1.23), XMC (0.1 .24), xylylcarb (0.1.25) and triazamate (0.1.26); acephate (0.1 .27), azamethiphos (0.1 .28), azinphos-ethyl (0.1 .29), azinphosmethyl (0.1 .30), cadusafos (0.1 .31 ), chlorethoxyfos (0.1.32), chlorfenvinphos

(0.1 .33), chlormephos (0.1.34), chlorpyrifos (0.1 .35), chlorpyrifos-methyl (0.1 .36), coumaphos (0.1 .37), cyanophos (0.1 .38), demeton-S-methyl (0.1.39), diazinon (0.1 .40), dichlorvos/ DDVP (0.1 .41 ), dicrotophos (0.1 .42), dimethoate (0.1 .43), dimethylvinphos (0.1 .44), disulfoton (0.1 .45), EPN (0.1.46), ethion (0.1.47), ethoprophos (0.1.48), famphur (0.1.49), fenamiphos (0.1 .50), fenitrothion (0.1 .51 ), fenthion (0.1.52), fosthiazate (0.1.53), heptenophos (0.1.54), imicyafos (0.1.55), isofenphos (0.1.56), isopropyl O-(methoxyaminothio-phosphoryl) salicylate (0.1 .57), isoxathion (0.1.58), malathion (0.1.59), mecarbam (0.1.60), methamidophos

(0.1 .61 ), methidathion (0.1 .62), mevinphos (0.1 .63), monocrotophos (0.1.64), naled (0.1 .65), omethoate (0.1 .66), oxydemeton-methyl (0.1.67), parathion (0.1.68), parathion-methyl (0.1 .69), phenthoate (0.1.70), phorate (0.1.71 ), phosalone (0.1 .72), phosmet (0.1 .73), phosphamidon (0.1 .74), phoxim (0.1 .75), pirimiphos- methyl (0.1 .76), profenofos (0.1.77), propetamphos (0.1.78), prothiofos (0.1 .79), pyraclofos (0.1 .80), pyridaphenthion (0.1.81 ), quinalphos (0.1 .82), sulfotep (0.1 .83), tebupirimfos (0.1 .84), temephos (0.1 .85), terbufos (0.1 .86), tetrachlorvinphos (0.1 .87), thiometon (0.1.88), triazophos (0.1.89), trichlorfon (0.1 .90), vamidothion (0.1 .91 );

0.2 GABA-gated chloride channel antagonists: endosulfan (0.2.1 ), chlordane (0.2.2); ethiprole (0.2.3), fipronil (0.2.4), flufiprole (0.2.5), pyrafluprole (0.2.6), pyriprole (0.2.7);

0.3 Sodium channel modulators: acrinathrin (0.3.1 ), allethrin (0.3.2), d-cis-trans allethrin (0.3.3), d-trans allethrin (0.3.4), bifenthrin (0.3.5), bioallethrin (0.3.6), bioallethrin S- cylclopentenyl (0.3.7), bioresmethrin (0.3.8), cycloprothrin (0.3.9), cyfluthrin (0.3.10), beta- cyfluthrin (0.3.1 1 ), cyhalothrin (0.3.12), lambda-cyhalothrin (0.3.13), gamma-cyhalothrin (0.3.14), cypermethrin (0.3.15), alpha-cypermethrin (0.3.16), beta-cypermethrin (0.3.17), theta-cypermethrin (0.3.18), zeta-cypermethrin (0.3.19), cyphenothrin (0.3.20), deltamethrin (0.3.21 ), empenthrin (0.3.22), esfenvalerate (0.3.23), etofenprox (0.3.24), fenpropathrin (0.3.25), fenvalerate (0.3.26), flucythrinate (0.3.27), flumethrin (0.3.28), tau-fluvalinate (0.3.29), halfenprox (0.3.30), heptafluthrin (0.3.31 ), imiprothrin (0.3.32), meperfluthrin

(0.3.33), metofluthrin (0.3.34), momfluorothrin (0.3.35), permethrin (0.3.36), phenothrin (0.3.37), prallethrin (0.3.38), profluthrin (0.3.39), pyrethrin (pyrethrum) (O.3.40), resmethrin (0.3.41 ), silafluofen (0.3.42), tefluthrin (0.3.43), tetramethylfluthrin (0.3.44), tetramethrin (0.3.45), tralomethrin (0.3.46) and transfluthrin (0.3.47); DDT (0.3.48), methoxychlor (0.3.49); 0.4 Nicotinic acetylcholine receptor agonists (nAChR): acetamiprid (0.4.1 ), clothianidin (0.4.2), cycloxaprid (0.4.3), dinotefuran (0.4.4), imidacloprid (0.4.5), nitenpyram (0.4.6), thiacloprid (0.4.7), thiamethoxam (0.4.8); (2E)-1 -[(6-chloropyridin-3-yl)methyl]-N'-nitro-2-pentylidene- hydrazinecarboximidamide (0.4.9); 1-[(6-chloropyridin-3-yl)methyl]-7-methyl-8-nitro-5-propoxy- 1 ,2,3,5,6,7-hexahydroimidazo[1 ,2-a]pyridine (0.4.10); nicotine (0.4.1 1 );

0.5 Nicotinic acetylcholine receptor allosteric activators: spinosad (0.5.1 ), spinetoram (0.5.2); 0.6 Chloride channel activators: abamectin (0.6.1 ), emamectin benzoate (0.6.2), ivermectin (0.6.3), lepimectin (0.6.4), milbemectin (0.6.5);

0.7 Juvenile hormone mimics: hydroprene (0.7.1 ), kinoprene (0.7.2), methoprene (0.7.3); fenoxycarb (0.7.4), pyriproxyfen (0.7.5);

0.8 miscellaneous non-specific (multi-site) inhibitors: methyl bromide (0.8.1 ) and other alkyl halides; chloropicrin (0.8.2), sulfuryl fluoride (0.8.3), borax (0.8.4), tartar emetic (0.8.5);

0.9 Selective homopteran feeding blockers: pymetrozine (0.9.1 ), flonicamid (0.9.2);

O.10 Mite growth inhibitors: clofentezine (O.10.1 ), hexythiazox (O.10.2), diflovidazin (O.10.3); etoxazole (0.10.4);

0.1 1 Microbial disruptors of insect midgut membranes: the Bt crop proteins: Cry1 Ab, Cry1 Ac,

Cryl Fa, Cry2Ab, mCry3A, Cry3Ab, Cry3Bb, Cry34/35Ab1 ;

0.12 Inhibitors of mitochondrial ATP synthase: diafenthiuron (0.12.1 ); azocyclotin (0.12.2), cyhexatin (0.12.3), fenbutatin oxide (0.12.4), propargite (0.12.5), tetradifon (0.12.6); 0.13 Uncouplers of oxidative phosphorylation via disruption of the proton gradient: chlorfenapyr (0.13.1 ), DNOC (0.13.2), sulfluramid (0.13.3);

0.14 Nicotinic acetylcholine receptor (nAChR) channel blockers: bensultap (0.14.1 ), cartap hydrochloride (0.14.2), thiocyclam (0.14.3), thiosultap sodium (0.14.4);

0.15 Inhibitors of the chitin biosynthesis type 0: bistrifluron (0.15.1 ), chlorfluazuron (0.15.2), diflubenzuron (0.15.3), flucycloxuron (0.15.4), flufenoxuron (0.15.5), hexaflumuron (0.15.6), lufenuron (0.15.7), novaluron (0.15.8), noviflumuron (0.15.9), teflubenzuron (0.15.10), triflumuron (0.15.1 1 );

0.16 Inhibitors of the chitin biosynthesis type 1 : buprofezin (0.16.1 );

0.17 Moulting disruptors: cyromazine (0.17.1 );

0.18 Ecdyson receptor agonists: methoxyfenozide (0.18.1 ), tebufenozide (0.18.2),

halofenozide (0.18.3), fufenozide (0.18.4), chromafenozide (0.18.5);

0.19 Octopamin receptor agonists: amitraz (0.19.1 );

O.20 Mitochondrial complex III electron transport inhibitors: hydramethylnon (O.20.1 ), acequinocyl (O.20.2), fluacrypyrim (O.20.3);

0.21 Mitochondrial complex I electron transport inhibitors: fenazaquin (0.21.1 ), fenpyroximate (0.21.2), pyrimidifen (0.21 .3), pyridaben (0.21.4), tebufenpyrad (0.21.5), tolfenpyrad (0.21.6); rotenone (0.21 .7);

0.22 Voltage-dependent sodium channel blockers: indoxacarb (0.22.1 ), metaflumizone

(0.22.2), 2-[2-(4-cyanophenyl)-1 -[3-(trifluoromethyl)phenyl]ethylidene]-N-[4-

(difluoromethoxy)phenyl]-hydrazinecarboxamide (0.22.3), N-(3-chloro-2-methylphenyl)-2-[(4- chlorophenyl)-[4-[methyl(methylsulfonyl)amino]phenyl]methyle ne]-hydrazinecarboxamide

(0.22.4);

0.23 Inhibitors of the of acetyl CoA carboxylase: spirodiclofen (0.23.1 ), spiromesifen (0.23.2), spirotetramat (0.23.3);

0.24 Mitochondrial complex IV electron transport inhibitors: aluminium phosphide (0.24.1 ), calcium phosphide (0.24.2), phosphine (0.24.3), zinc phosphide (0.24.4), cyanide (0.24.5); 0.25 Mitochondrial complex II electron transport inhibitors: cyenopyrafen (0.25.1 ), cyflumetofen (0.25.2);

0.26 Ryanodine receptor-modulators: flubendiamide (0.26.1 ), chlorantraniliprole (0.26.2), cyantraniliprole (0.26.3), cyclaniliprole (0.26.4), tetraniliprole (0.26.5); (R)-3-chloro-N1 -{2- methyl-4-[1 ,2,2,2 -tetrafluoro-1 -(trifluoromethyl)ethyl]phenyl}-N2-(1 -methyl-2- methylsulfonylethyl)phthalamide (0.26.6), (S)-3-chloro-N1 -{2-methyl-4-[1 ,2,2,2-tetrafluoro-1 - (trifluoromethyl)ethyl]phenyl}-N2-(1-methyl-2-methylsulfonyl ethyl)phthalamide (0.26.7), methyl- 2-[3,5-dibromo-2-({[3-bromo-1-(3-chloropyridin-2-yl)-1 H-pyrazol-5-yl]carbonyl}amino)benzoyl]- 1 ,2-dimethylhydrazinecarboxylate (0.26.8); N-[4,6-dichloro-2-[(diethyl-lambda-4-sulfanylidene)- carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl )pyrazole-3-carboxamide (0.26.9); N- [4-chloro-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-6-me thyl-phenyl]-2-(3-chloro-2-pyridyl)- 5-(trifluoromethyl)pyrazole-3-carboxamide (0.26.10); N-[4-chloro-2-[(di-2-propyl-lambda-4- sulfanylidene)carbamoyl]-6-methyl-phenyl]-2-(3-chloro-2-pyri dyl)-5-(trifluoromethyl)pyrazole-3- carboxamide (0.26.1 1 ); N-[4,6-dichloro-2-[(di-2-propyl-lambda-4-sulfanylidene)carba moyl]- phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3 -carboxamide (0.26.12); N-[4,6-di- bromo-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]- 2-(3-chloro-2-pyridyl)-5-(tri- fluoromethyl)pyrazole-3-carboxamide (0.26.13); N-[2-(5-amino-1 ,3,4-thiadiazol-2-yl)-4-chloro-6- methylphenyl]-3-bromo-1 -(3-chloro-2-pyridinyl)-1 H-pyrazole-5-carboxamide (0.26.14); 3-chloro- 1-(3-chloro-2-pyridinyl)-N-[2,4-dichloro-6-[[(1-cyano-1-meth ylethyl)amino]carbonyl]phenyl]-1 H- pyrazole-5-carboxamide (0.26.15); 3-bromo-N-[2,4-dichloro-6-(methylcarbamoyl)phenyl]-1-(3,5- dichloro-2-pyridyl)-1 H-pyrazole-5-carboxamide (0.26.16); N-[4-chloro-2-[[(1 ,1- dimethylethyl)amino]carbonyl]-6-methylphenyl]-1-(3-chloro-2- pyridinyl)-3-(fluoromethoxy)-1 H- pyrazole-5-carboxamide (0.26.17); cyhalodiamide (0.26.18);

0.27. insecticidal active compounds of unknown or uncertain mode of action: afidopyropen (0.27.1 ), afoxolaner (0.27.2), azadirachtin (0.27.3), amidoflumet (0.27.4), benzoximate (0.27.5), bifenazate (0.27.6), broflanilide (0.27.7), bromopropylate (0.27.8), chinomethionat (0.27.9), cryolite (0.27.10), dicloromezotiaz (0.27.1 1 ), dicofol (0.27.12), flufenerim (0.27.13), flometoquin (0.27.14), fluensulfone (0.27.15), fluhexafon (0.27.16), fluopyram (0.27.17), flu pyradifu rone (0.27.18), fluralaner (0.27.19), metoxadiazone (0.27.20), piperonyl butoxide (0.27.21 ), pyflubumide (0.27.22), pyridalyl (0.27.23), pyrifluquinazon (0.27.24), sulfoxaflor (0.27.25), tioxazafen (0.27.26), triflumezopyrim (0.27.27), 1 1 -(4-chloro-2,6-dimethylphenyl)- 12-hydroxy-1 ,4-dioxa-9-azadispiro[4.2.4.2]-tetradec-1 1-en-10-one (0.27.28), 3-(4'-fluoro-2,4- dimethylbiphenyl-3-yl)-4-hydroxy-8-oxa-1-azaspiro[4.5]dec-3- en-2-one (0.27.28), 1 -[2-fluoro-4- methyl-5-[(2,2,2-trifluoroethyl)sulfinyl]phenyl]-3-(trifluor omethyl)-1 H-1 ,2,4-triazole-5-amine (0.27.29), (E/Z)-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2, 2-trifluoro-acetamide (0.27.31 ); (E/Z)-N-[1-[(6-chloro-5-fluoro-3-pyridyl)methyl]-2-pyridylid ene]-2,2,2-trifluoro- acetamide (0.27.32); (E/Z)-2,2,2-trifluoro-N-[1 -[(6-fluoro-3-pyridyl)methyl]-2-pyridyli- dene]acetamide (0.27.33); (E/Z)-N-[1-[(6-bromo-3-pyridyl)methyl]-2-pyridylidene]-2,2,2 -trifluoro- acetamide (0.27.34); (E/Z)-N-[1 -[1-(6-chloro-3-pyridyl)ethyl]-2-pyridylidene]-2,2,2-trifluo ro- acetamide (0.27.35); (E/Z)-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2- difluoro- acetamide (0.27.36); (E/Z)-2-chloro-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylid ene]-2,2- difluoro-acetamide (0.27.37); (E/Z)-N-[1-[(2-chloropyrimidin-5-yl)methyl]-2-pyridylidene]- 2,2,2- trifluoro-acetamide (0.27.38); (E/Z)-N-[1 -[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2, 3,3,3- pentafluoro-propanamide (0.27.39); N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2- trifluoro-thioacetamide (O.27.40); N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trif luoro- N'-isopropyl-acetamidine (0.27.41 ); fluazaindolizine (0.27.42); 4-[5-(3,5-dichlorophenyl)-5- (trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-N-(1 -oxothietan-3-yl)benzamide (0.27.43); fluxamet- amide (0.27.44); 5-[3-[2,6-dichloro-4-(3,3-dichloroallyloxy)phenoxy]propoxy]- 1 H-pyrazole (0.27.45); 3-(benzoylmethylamino)-N-[2-bromo-4-[1 ,2,2,3,3,3-hexafluoro-1 - (trifluoromethyl)propyl]-6-(trifluoromethyl)phenyl]-2-fluoro -benzamide (0.27.46); 3- (benzoylmethylamino)-2-fluoro-N-[2-iodo-4-[1 ,2,2,2-tetrafluoro-1 -(trifluoromethyl)ethyl]-6- (trifluoromethyl)phenyl]-benzamide (0.27.47); N-[3-[[[2-iodo-4-[1 ,2,2,2-tetrafluoro-1 -

(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]amino]c arbonyl]phenyl]-N-methyl-benzamide (0.27.48); N-[3-[[[2-bromo-4-[1 ,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6- (trifluoromethyl)phenyl]amino]carbonyl]-2-fluorophenyl]-4-fl uoro-N-methyl-benzamide (0.27.49); 4-fluoro-N-[2-fluoro-3-[[[2-iodo-4-[1 ,2,2,2-tetrafluoro-1 -(trifluoromethyl)ethyl]-6-(trifluoro- methyl)phenyl]amino]carbonyl]phenyl]-N-methyl-benzamide (0.27.50); 3-fluoro-N-[2-fluoro-3- [[[2-iodo-4-[1 ,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6(trifluorometh yl)phenyl]amino]- carbonyl]phenyl]-N-methyl-benzamide (0.27.51 ); 2-chloro-N-[3-[[[2-iodo-4-[1 ,2,2,2-tetrafluoro-1 - (trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]amino]carb onyl]phenyl]-3-pyridinecarboxamide (0.27.52); 4-cyano-N-[2-cyano-5-[[2,6-dibromo-4-[1 ,2,2,3,3,3-hexafluoro-1-(trifluorometh- yl)propyl]phenyl]carbamoyl]phenyl]-2-methyl-benzamide (0.27.53); 4-cyano-3-[(4-cyano-2- methyl-benzoyl)amino]-N-[2,6-dichloro-4-[1 ,2,2,3,3,3-hexafluoro-1-(trifluoromethyl)- propyl]phenyl]-2-fluoro-benzamide (0.27.54); N-[5-[[2-chloro-6-cyano-4-[1 ,2,2,3,3,3-hexafluoiO- 1-(trifluoromethyl)propyl]phenyl]carbamoyl]-2-cyano-phenyl]- 4-cyano-2-methyl-benzamide (0.27.55); N-[5-[[2-bromo-6-chloro-4-[2,2,2-trifluoro-1 -hydroxy-1 -

(trifluoromethyl)ethyl]phenyl]carbamoyl]-2-cyano-phenyl]- 4-cyano-2-methyl-benzamide

(0.27.56); N-[5-[[2-bromo-6-chloro-4-[1 ,2,2,3, 3,3-hexafluoro-1-(trifluoromethyl)- propyl]phenyl]carbamoyl]-2-cyano-phenyl]-4-cyano-2-methyl-be nzamide (0.27.57); 4-cyano- N-[2-cyano-5-[[2,6-dichloro-4-[1 , 2,2,3, 3,3-hexafluoro-1 -(trifluoromethyl)propyl]phenyl]- carbamoyl]phenyl]-2-methyl-benzamide (0.27.58); 4-cyano-N-[2-cyano-5-[[2,6-dichloro-4- [1 ,2,2,2-tetrafluoro-1 -(trifluoromethyl)ethyl]phenyl]carbamoyl]phenyl]-2-methyl-be nzamide (0.27.59); N-[5-[[2-bromo-6-chloro-4-[1 ,2,2,2-tetrafluoro-1 -

(trifluoromethyl)ethyl]phenyl]carbamoyl]-2-cyano-phenyl]- 4-cyano-2-methyl-benzamide

(O.27.60); 2-(1 ,3-dioxan-2-yl)-6-[2-(3-pyridinyl)-5-thiazolyl]-pyridine; 2-[6-[2-(5-fluoro-3- pyridinyl)-5-thiazolyl]-2-pyridinyl]-pyrimidine (0.27.61 ); 2-[6-[2-(3-pyridinyl)-5-thiazolyl]-2- pyridinyl]-pyrimidine (0.27.62); N-methylsulfonyl-6-[2-(3-pyridyl)thiazol-5-yl]pyridine-2-car - boxamide (0.27.63); N-methylsulfonyl-6-[2-(3-pyridyl)thiazol-5-yl]pyridine-2-car boxamide (0.27.64); N-ethyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3-methylthio- propanamide (0.27.65); N- methyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3-methylthio-p ropanamide (0.27.66); N,2-dimethyl- N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3-methylthio-propanam ide (0.27.67); N-ethyl-2-methyl-N- [4-methyl-2-(3-pyridyl)thiazol-5-yl]-3-methylthio-propanamid e (0.27.68); N-[4-chloro-2-(3- pyridyl)thiazol-5-yl]-N-ethyl-2-methyl-3-methylthio-propanam ide (0.2769.); N-[4-chloro-2-(3- pyridyl)thiazol-5-yl]-N,2-dimethyl-3-methylthio-propanamide (0.27.70); N-[4-chloro-2-(3- pyridyl)thiazol-5-yl]-N-methyl-3-methylthio-propanamide (0.27.71 ); N-[4-chloro-2-(3- pyridyl)thiazol-5-yl]-N-ethyl-3-methylthio-propanamide (0.27.72); 1 -[(6-chloro-3-pyri- dinyl)methyl]-1 ,2,3,5,6,7-hexahydro-5-methoxy-7-methyl-8-nitro-imidazo[1 ,2-a]pyridine

(0.27.73); 1-[(6-chloropyridin-3-yl)methyl]-7-methyl-8-nitro-1 ,2,3,5, 6,7-hexahydroimidazo[1 ,2- a]pyridin-5-ol (0.27.74); 1 -isopropyl-N,5-dimethyl-N-pyridazin-4-yl-pyrazole-4-carboxam ide (0.27.75); 1-(1 ,2-dimethylpropyl)-N-ethyl-5-methyl-N-pyridazin-4-yl-pyrazol e-4-carboxamide (0.27.76); N,5-dimethyl-N-pyridazin-4-yl-1 -(2,2,2-trifluoro-1 -methyl-ethyl)pyrazole-4- carboxamide (0.27.77); 1-[1 -(1 -cyanocyclopropyl)ethyl]-N-ethyl-5-methyl-N-pyridazin-4-yl- pyrazole-4-carboxamide (0.27.78); N-ethyl-1 -(2-fluoro-1-methyl-propyl)-5-methyl-N-pyridazin-4- yl-pyrazole-4-carboxamide (0.27.79); 1-(1 ,2-dimethylpropyl)-N,5-dimethyl-N-pyridazin-4-yl- pyrazole-4-carboxamide (0.27.80); 1-[1-(1-cyanocyclopropyl)ethyl]-N,5-dimethyl-N-pyridazin-4- yl-pyrazole-4-carboxamide (0.27.81 ); N-methyl-1 -(2-fluoro-1-methyl-propyl]-5-methyl-N- pyridazin-4-yl-pyrazole-4-carboxamide (0.27.82); 1 -(4,4-difluorocyclohexyl)-N-ethyl-5-methyl-N- pyridazin-4-yl-pyrazole-4-carboxamide (0.27.83); 1 -(4,4-difluorocyclohexyl)-N,5-dimethyl-N- pyridazin-4-yl-pyrazole-4-carboxamide (0.27.84), N-(1-methylethyl)-2-(3-pyridinyl)-2H-indazole- 4-carboxamide (0.27.85); N-cyclopropyl-2-(3-pyridinyl)-2H-indazole-4-carboxamide (0.27.86); N-cyclohexyl-2-(3-pyridinyl)-2H-indazole-4-carboxamide (0.27.87); 2-(3-pyridinyl)-N-(2,2,2- trifluoroethyl)-2H-indazole-4-carboxamide (0.27.88); 2-(3-pyridinyl)-N-[(tetrahydro-2- furanyl)methyl]-2H-indazole-5-carboxamide (0.27.89); methyl 2-[[2-(3-pyridinyl)-2H-indazol-5- yl]carbonyl]hydrazinecarboxylate (0.27.90); N-[(2,2-difluorocyclopropyl)methyl]-2-(3-pyridinyl)- 2H-indazole-5-carboxamide (0.27.91 ); N-(2,2-difluoropropyl)-2-(3-pyridinyl)-2H-indazole-5- carboxamide (0.27.92); 2-(3-pyridinyl )-N-(2-pyrimidinylmethyl )-2H-indazole-5-carboxamide (0.27.93); N-[(5-methyl-2-pyrazinyl)methyl]-2-(3-pyridinyl)-2H-indazole -5-carboxamide

(0.27.94), N-[3-chloro-1-(3-pyridyl)pyrazol-4-yl]-N-ethyl-3-(3,3,3-trif luoropropylsulfanyl)- propanamide (0.27.95); N-[3-chloro-1-(3-pyridyl)pyrazol-4-yl]-N-ethyl-3-(3,3,3- trifluoropropylsulfinyl)propanamide (0.27.96); N-[3-chloro-1 -(3-pyridyl)pyrazol-4-yl]-3-[(2,2-di- fluorocyclopropyl)methylsulfanyl]-N-ethyl-propanamide (0.27.97); N-[3-chloro-1-(3- pyridyl)pyrazol-4-yl]-3-[(2,2-difluorocyclopropyl)methylsulf inyl]-N-ethyl-propanamide (0.27.98); sarolaner (0.27.99), lotilaner (0.27.100). The active substances referred to as component 2, their preparation and their activity e. g. against harmful fungi is known (cf.: http://www.alanwood.net/pesticides/); these substances are commercially available. The compounds described by lUPAC nomenclature, their preparation and their pesticidal activity are also known (cf. Can. J. Plant Sci. 48(6), 587-94, 1968;

EP-A 141 317; EP-A 152 031 ; EP-A 226 917; EP-A 243 970; EP-A 256 503; EP-A 428 941 ; EP-A 532 022; EP-A 1 028 125; EP-A 1 035 122; EP-A 1 201 648; EP-A 1 122 244,

JP 2002316902; DE 19650197; DE 10021412; DE 102005009458; US 3,296,272;

US 3,325,503; WO 98/46608; WO 99/14187; WO 99/24413; WO 99/27783; WO 00/29404; WO 00/46148; WO 00/65913; WO 01/54501 ; WO 01/56358; WO 02/22583; WO 02/40431 ; WO 03/10149; WO 03/1 1853; WO 03/14103; WO 03/16286; WO 03/53145; WO 03/61388; WO 03/66609; WO 03/74491 ; WO 04/49804; WO 04/83193; WO 05/120234; WO 05/123689; WO 05/123690; WO 05/63721 ; WO 05/87772; WO 05/87773; WO 06/15866; WO 06/87325; WO 06/87343; WO 07/82098; WO 07/90624, WO 10/139271 , WO 1 1/028657, WO 12/168188, WO 07/006670, WO 1 1/77514; WO 13/047749, WO 10/069882, WO 13/047441 , WO 03/16303, WO 09/90181 , WO 13/007767, WO 13/010862, WO 13/127704, WO 13/024009, WO 13/24010, WO 13/047441 , WO 13/162072, WO 13/092224, WO 1 1/135833, CN 1907024, CN 1456054, CN 103387541 , CN 1309897, WO 12/84812, CN 1907024, WO 09094442, WO 14/60177, WO 13/1 16251 , WO 08/013622, WO 15/65922, WO 94/01546, EP 2865265, WO 07/129454, WO 12/16551 1 , WO 1 1/081 174, WO 13/47441 ). The present invention furthermore relates to agrochemical compositions comprising a mixture of at least one compound I (component 1 ) and at least one further active substance useful for plant protection, e. g. selected from the groups A) to O) (component 2), in particular one further fungicide, e. g. one or more fungicide from the groups A) to K), as described above, and if desired one suitable solvent or solid carrier. Those mixtures are of particular interest, since many of them at the same application rate show higher efficiencies against harmful fungi.

Furthermore, combating harmful fungi with a mixture of compounds I and at least one fungicide from groups A) to K), as described above, is more efficient than combating those fungi with individual compounds I or individual fungicides from groups A) to K).

By applying compounds I together with at least one active substance from groups A) to O) a synergistic effect can be obtained, i.e. more then simple addition of the individual effects is obtained (synergistic mixtures).

This can be obtained by applying the compounds I and at least one further active substance simultaneously, either jointly (e. g. as tank-mix) or seperately, or in succession, wherein the time interval between the individual applications is selected to ensure that the active substance applied first still occurs at the site of action in a sufficient amount at the time of application of the further active substance(s). The order of application is not essential for working of the present invention.

When applying compound I and a pesticide II sequentially the time between both applications may vary e. g. between 2 hours to 7 days. Also a broader range is possible ranging from 0.25 hour to 30 days, preferably from 0.5 hour to 14 days, particularly from 1 hour to 7 days or from 1.5 hours to 5 days, even more preferred from 2 hours to 1 day.

In the binary mixtures and compositions according to the invention the weight ratio of the component 1 ) and the component 2) generally depends from the properties of the active components used, usually it is in the range of from 1 :10,000 to 10,000:1 , often it is in the range of from 1 :100 to 100:1 , regularly in the range of from 1 :50 to 50:1 , preferably in the range of from 1 :20 to 20:1 , more preferably in the range of from 1 :10 to 10:1 , even more preferably in the range of from 1 :4 to 4:1 and in particular in the range of from 1 :2 to 2:1 .

According to further embodiments of the binary mixtures and compositions, the weight ratio of the component 1 ) and the component 2) usually is in the range of from 1000:1 to 1 :1 , often in the range of from 100: 1 to 1 :1 , regularly in the range of from 50:1 to 1 :1 , preferably in the range of from 20:1 to 1 :1 , more preferably in the range of from 10:1 to 1 :1 , even more preferably in the range of from 4:1 to 1 :1 and in particular in the range of from 2:1 to 1 :1 .

According to a further embodiments of the binary mixtures and compositions, the weight ratio of the component 1 ) and the component 2) usually is in the range of from 1 :1 to 1 :1000, often in the range of from 1 :1 to 1 :100, regularly in the range of from 1 :1 to 1 :50, preferably in the range of from 1 :1 to 1 :20, more preferably in the range of from 1 :1 to 1 :10, even more preferably in the range of from 1 :1 to 1 :4 and in particular in the range of from 1 :1 to 1 :2.

In the ternary mixtures, i.e. compositions according to the invention comprising the component 1 ) and component 2) and a compound III (component 3), the weight ratio of component 1 ) and component 2) depends from the properties of the active substances used, usually it is in the range of from 1 :100 to 100:1 , regularly in the range of from 1 :50 to 50:1 , preferably in the range of from 1 :20 to 20:1 , more preferably in the range of from 1 :10 to 10:1 and in particular in the range of from 1 :4 to 4:1 , and the weight ratio of component 1 ) and component 3) usually it is in the range of from 1 :100 to 100:1 , regularly in the range of from 1 :50 to 50:1 , preferably in the range of from 1 :20 to 20:1 , more preferably in the range of from 1 :10 to 10:1 and in particular in the range of from 1 :4 to 4:1.

Any further active components are, if desired, added in a ratio of from 20:1 to 1 :20 to the component 1 ).

These ratios are also suitable for inventive mixtures applied by seed treatment.

Preference is also given to mixtures comprising as component 2) at least one active substance selected from inhibitors of complex III at Q ₀ site in group A), more preferably selected from compounds (A.1.1 ), (A.1.4), (A.1.8), (A.1.9), (A.1.10), (A.1 .12), (A.1.13), (A.1 .14), (A.1.17), (A.1 .21 ), (A.1.24), (A.1.25), (A.1 .26), (A.1.27), (A.1 .30), (A.1.31 ), (A.1.32), (A.1 .34) and

(A.1 .35); particularly selected from (A.1.1 ), (A.1.4), (A.1.8), (A.1.9), (A.1.13), (A.1 .14), (A.1.17), (A.1 .24), (A.1.25), (A.1.26), (A.1 .27), (A.1.30), (A.1 .31 ), (A.1.32), (A.1 .34) and (A.1 .35).

Preference is also given to mixtures comprising as component 2) at least one active substance selected from inhibitors of complex III at Q, site in group A), more preferably selected from compounds (A.2.1 ), (A.2.3) and (A.2.4); particularly selected from (A.2.3) and (A.2.4).

Preference is also given to mixtures comprising as component 2) at least one active substance selected from inhibitors of complex II in group A), more preferably selected from compounds (A.3.2), (A.3.3), (A.3.4), (A.3.7), (A.3.9), (A.3.1 1 ), (A.3.12), (A.3.15), (A.3.16), (A.3.17), (A.3.18), (A.3.19), (A.3.20), (A.3.21 ), (A.3.22), (A.3.23), (A.3.24), (A.3.25), (A.3.27), (A.3.28), (A.3.29), (A.3.31 ), (A.3.32), (A.3.33), (A.3.34), (A.3.35), (A.3.36), (A.3.37), (A.3.38) and (A.3.39);

particularly selected from (A.3.2), (A.3.3), (A.3.4), (A.3.7), (A.3.9), (A.3.12), (A.3.15), (A.3.17), (A.3.19), (A.3.22), (A.3.23), (A.3.24), (A.3.25), (A.3.27), (A.3.29), (A.3.31 ), (A.3.32), (A.3.33), (A.3.34), (A.3.35), (A.3.36), (A.3.37), (A.3.38) and (A.3.39).

Preference is also given to mixtures comprising as component 2) at least one active substance selected from other respiration nhibitors in group A), more preferably selected from compounds (A.4.5) and (A.4.1 1 ); in particular (A.4.1 1 ).

Preference is also given to mixtures comprising as component 2) at least one active substance selected from C14 demethylase inhibitors in group B), more preferably selected from

compounds (B.1.4), (B.1.5), (B.1.8), (B.1.10), (B.1 .1 1 ), (B.1.12), (B.1 .13), (B.1.17), (B.1 .18), (B.1 .21 ), (B.1.22), (B.1.23), (B.1 .25), (B.1.26), (B.1 .29), (B.1.34), (B.1 .37), (B.1.38), (B.1 .43) and (B.1 .46); particularly selected from (B.1.5), (B.1.8), (B.1 .10), (B.1.17), (B.1.22), (B.1.23), (B.1 .25), (B.1.33), (B.1 .34), (B.1.37), (B.138), (B.1.43) and (B.1.46).

Preference is also given to mixtures comprising as component 2) at least one active substance selected from Delta 14-reductase inhibitors in group B), more preferably selected from compounds (B.2.4), (B.2.5), (B.2.6) and (B.2.8); in particular (B.2.4).

Preference is also given to mixtures comprising as component 2) at least one active substance selected from phenylamides and acyl amino acid fungicides in group C), more preferably selected from compounds (C.1.1 ), (C.1 .2), (C.1.4) and (C.1.5); particularly selected from (C.1 .1 ) and (C.1.4).

Preference is also given to mixtures comprising as component 2) at least one active substance selected from other nucleic acid synthesis inhibitors in group C), more preferably selected from compounds (C.2.6),(C.2.7) and (C.2.8).

Preference is also given to mixtures comprising as component 2) at least one active substance selected from group D), more preferably selected from compounds (D.1.1 ), (D.1 .2), (D.1.5), (D.2.4) and (D.2.6); particularly selected from (D.1 .2), (D.1.5) and (D.2.6).

Preference is also given to mixtures comprising as component 2) at least one active substance selected from group E), more preferably selected from compounds (E.1.1 ), (E.1.3), (E.2.2) and (E.2.3); in particular (E.1.3).

Preference is also given to mixtures comprising as component 2) at least one active substance selected from group F), more preferably selected from compounds (F.1.2), (F.1.4) and (F.1.5). Preference is also given to mixtures comprising as component 2) at least one active substance selected from group G), more preferably selected from compounds (G.3.1 ), (G.3.3), (G.3.6), (G.5.1 ), (G.5.2), (G.5.3), (G.5.4), (G.5.5), G.5.6), G.5.7), (G.5.8), (G.5.9), (G.5.10) and (G.5.1 1 ); particularly selected from (G.3.1 ), (G.5.1 ), (G.5.2) and (G.5.3).

Preference is also given to mixtures comprising as component 2) at least one active substance selected from group H), more preferably selected from compounds (H.2.2), (H.2.3), (H.2.5), (H.2.7), (H.2.8), (H.3.2), (H.3.4), (H.3.5), (H.4.9) and (H.4.10); particularly selected from (H.2.2), (H.2.5), (H.3.2), (H.4.9) and (H.4.10). Preference is also given to mixtures comprising as component 2) at least one active substance selected from group I), more preferably selected from compounds (1.2.2) and (1.2.5).

Preference is also given to mixtures comprising as component 2) at least one active substance selected from group J), more preferably selected from compounds (J.1 .2), (J.1.5) and (J.1 .8); in particular (J.1.5).

Preference is also given to mixtures comprising as component 2) at least one active substance selected from group K), more preferably selected from compounds (K.1.41 ), (K.1 .42), (K.1.44), (K.1 .45), (K.1.47) and (K.1.49); particularly selected from (K.1 .41 ), (K.1.44), (K.1 .45), (K.1.47) and (K.1 .49).

Accordingly, the present invention furthermore relates to mixtures comprising one compound of the formula I (component 1 ) and one pesticide II (component 2), wherein pesticide II is selected from the column "Co. 2" of the lines B-1 to B-727 of Table B.

A further embodiment relates to the mixtures B-1 to B-727 listed in Table B, where a row of Table B corresponds in each case to a fungicidal mixture comprising as active components one of the in the present specification individualized compounds of formula I, i.e. compounds I.A.A-1 to I.A.A-973, I.B.A-1 to I.B.A-973, I.C.A-1 to I.C.A-973, I.D.A-1 to I.D.A-973, I.E.A-1 to I.E.A-973, I.F.A-1 to I.F.A-973, I.G.A-1 to I.G.A-973 and I.H.A-1 to I.H.A-973 as defined in tables 1 to 8 above (component 1 in column "Co.1 ") and the respective pesticide II from groups A) to O) (component 2) stated in the row in question.

Another embodiment relates to the mixtures B-1 to B-727 listed in Table B, where a row of Table B corresponds in each case to a fungicidal mixture comprising as active components one of the compounds Ex-1 to Ex-9 of formula I as defined below in table I (component 1 in column "Co.1 ") and the respective pesticide II from groups A) to O) (component 2) stated in the row in question.

Preferably, the compositions described in Table B comprise the active components in synergistically effective amounts.

Table B: Mixtures comprising as active components one indiviualized compound of the fomula I

(in column Co. 1 ), and as component 2) (in co umn Co. 2) one pesticide from groups A) to O) [which is coded e. g. as (A.1 .1 ) for azoxystrob n as defined above].

Mixt. Co.1 Co.2 Mixt. Co.1 Co.2 Mixt. Co.1 Co.2

B-37 (I) (A.2.8) B-79 (I) (A.4.3) B-121 (I) (B.1.38)

B-38 (I) (A.3.1) B-80 (I) (A.4.4) B-122 (I) (B.1.43)

B-39 (I) (A.3.2) B-81 (I) (A.4.5) B-123 (I) (B.1.44)

B-40 (I) (A.3.3) B-82 (I) (A.4.6) B-124 (I) (B.1.45)

B-41 (I) (A.3.4) B-83 (I) (A.4.7) B-125 (I) (B.1.46)

B-42 (I) (A.3.5) B-84 (I) (A.4.8) B-126 (I) (B.1.47)

B-43 (I) (A.3.6) B-85 (I) (A.4.9) B-127 (I) (B.1.48)

B-44 (I) (A.3.7) B-86 (I) (A.4.10) B-128 (I) (B.1.49)

B-45 (I) (A.3.8) B-87 (I) (A.4.11) B-129 (I) (B.1.50)

B-46 (I) (A.3.9) B-88 (I) (A.4.12) B-130 (I) (B.1.51)

B-47 (I) (A.3.10) B-89 (I) (B.1.1) B-131 (I) (B.2.1)

B-48 (I) (A.3.11) B-90 (I) (B.1.2) B-132 (I) (B.2.2)

B-49 (I) (A.3.12) B-91 (I) (B.1.3) B-133 (I) (B.2.3)

B-50 (I) (A.3.13) B-92 (I) (B.1.4) B-134 (I) (B.2.4)

B-51 (I) (A.3.14) B-93 (I) (B.1.5) B-135 (I) (B.2.5)

B-52 (I) (A.3.15) B-94 (I) (B.1.6) B-136 (I) (B.2.6)

B-53 (I) (A.3.16) B-95 (I) (B.1.7) B-137 (I) (B.2.7)

B-54 (I) (A.3.17) B-96 (I) (B.1.8) B-138 (I) (B.2.8)

B-55 (I) (A.3.18) B-97 (I) (B.1.9) B-139 (I) (B.3.1)

B-56 (I) (A.3.19) B-98 (I) (B.1.10) B-140 (I) (C.1.1)

B-57 (I) (A.3.20) B-99 (I) (B.1.11) B-141 (I) (C.1.2)

B-58 (I) (A.3.21) B-100 (I) (B.1.12) B-142 (I) (C.1.3)

B-59 (I) (A.3.22) B-101 (I) (B.1.13) B-143 (I) (C.1.4)

B-60 (I) (A.3.23) B-102 (I) (B.1.14) B-144 (I) (C.1.5)

B-61 (I) (A.3.24) B-103 (I) (B.1.15) B-145 (I) (C.1.6)

B-62 (I) (A.3.25) B-104 (I) (B.1.16) B-146 (I) (C.1.7)

B-63 (I) (A.3.26) B-105 (I) (B.1.17) B-147 (I) (C.2.1)

B-64 (I) (A.3.27) B-106 (I) (B.1.18) B-148 (I) (C.2.2)

B-65 (I) (A.3.28) B-107 (I) (B.1.19) B-149 (I) (C.2.3)

B-66 (I) (A.3.29) B-108 (I) (B.1.20) B-150 (I) (C.2.4)

B-67 (I) (A.3.30) B-109 (I) (B.1.21) B-151 (I) (C.2.5)

B-68 (I) (A.3.31) B-110 (I) (B.1.22) B-152 (I) (C.2.6)

B-69 (I) (A.3.32) B-111 (I) (B.1.23) B-153 (I) (C.2.7)

B-70 (I) (A.3.33) B-112 (I) (B.1.24) B-154 (I) (D.1.1)

B-71 (I) (A.3.34) B-113 (I) (B.1.25) B-155 (I) (D.1.2)

B-72 (I) (A.3.35) B-114 (I) (B.1.26) B-156 (I) (D.1.3)

B-73 (I) (A.3.36) B-115 (I) (B.1.27) B-157 (I) (D.1.4)

B-74 (I) (A.3.37) B-116 (I) (B.1.28) B-158 (I) (D.1.5)

B-75 (I) (A.3.38) B-117 (I) (B.1.29) B-159 (I) (D.1.6)

B-76 (I) (A.3.39) B-118 (I) (B.1.30) B-160 (I) (D.2.1)

B-77 (I) (A.4.1) B-119 (I) (B.1.34) B-161 (I) (D.2.2)

B-78 (I) (A.4.2) B-120 (I) (B.1.37) B-162 (I) (D.2.3) Mixt. Co.1 Co. 2 Mixt. Co.1 Co. 2 Mixt. Co.1 Co. 2

B-163 (I) (D.2.4) B-205 (I) (G.5.1 ) B-247 (I) (I.2.2)

B-164 (I) (D.2.5) B-206 (I) (G.5.2) B-248 (I) (I.2.3)

B-165 (I) (D.2.6) B-207 (I) (G.5.3) B-249 (I) (I.2.4)

B-166 (I) (D.2.7) B-208 (I) (H.1.1 ) B-250 (I) (I.2.5)

B-167 (I) (E.1 .1 ) B-209 (I) (H.1.2) B-251 (I) (J.1 .1 )

B-168 (I) (E.1 .2) B-210 (I) (H.1.3) B-252 (I) (J.1 .2)

B-169 (I) (E.1 .3) B-21 1 (I) (H.1.4) B-253 (I) (J.1 .3)

B-170 (I) (E.2.1 ) B-212 (I) (H.1.5) B-254 (I) (J.1 .4)

B-171 (I) (E.2.2) B-213 (I) (H.1.6) B-255 (I) (J.1 .5)

B-172 (I) (E.2.3) B-214 (I) (H.2.1 ) B-256 (I) (J.1 .6)

B-173 (I) (E.2.4) B-215 (I) (H.2.2) B-257 (I) (J.1 .7)

B-174 (I) (E.2.5) B-216 (I) (H.2.3) B-258 (I) (J.1 .8)

B-175 (I) (E.2.6) B-217 (I) (H.2.4) B-259 (I) (J.1 .9)

B-176 (I) (E.2.7) B-218 (I) (H.2.5) B-260 (I) (J.1.10)

B-177 (I) (E.2.8) B-219 (I) (H.2.6) B-261 (I) (K.1 .1 )

B-178 (I) (F.1.1 ) B-220 (I) (H.2.7) B-262 (I) (K.1 .2)

B-179 (I) (F.1.2) B-221 (I) (H.2.8) B-263 (I) (K.1 .3)

B-180 (I) (F.1.3) B-222 (I) (H.2.9) B-264 (I) (K.1 .4)

B-181 (I) (F.1.4) B-223 (I) (H.3.1 ) B-265 (I) (K.1 .5)

B-182 (I) (F.1.5) B-224 (I) (H.3.2) B-266 (I) (K.1 .6)

B-183 (I) (F.1.6) B-225 (I) (H.3.3) B-267 (I) (K.1 .7)

B-184 (I) (F.2.1 ) B-226 (I) (H.3.4) B-268 (I) (K.1 .8)

B-185 (I) (G.1.1 ) B-227 (I) (H.3.5) B-269 (I) (K.1 .9)

B-186 (I) (G.1.2) B-228 (I) (H.3.6) B-270 (I) (K.1.10)

B-187 (I) (G.1.3) B-229 (I) (H.3.7) B-271 (I) (K.1.1 1 )

B-188 (I) (G.1.4) B-230 (I) (H.3.8) B-272 (I) (K.1.12)

B-189 (I) (G.2.1 ) B-231 (I) (H.3.9) B-273 (I) (K.1.13)

B-190 (I) (G.2.2) B-232 (I) (H.3.10) B-274 (I) (K.1.14)

B-191 (I) (G.2.3) B-233 (I) (H.3.11 ) B-275 (I) (K.1.15)

B-192 (I) (G.2.4) B-234 (I) (H.4.1 ) B-276 (I) (K.1.16)

B-193 (I) (G.2.5) B-235 (I) (H.4.2) B-277 (I) (K.1.17)

B-194 (I) (G.2.6) B-236 (I) (H.4.3) B-278 (I) (K.1.18)

B-195 (I) (G.2.7) B-237 (I) (H.4.4) B-279 (I) (K.1.19)

B-196 (I) (G.3.1 ) B-238 (I) (H.4.5) B-280 (I) (K.1.20)

B-197 (I) (G.3.2) B-239 (I) (H.4.6) B-281 (I) (K.1.21 )

B-198 (I) (G.3.3) B-240 (I) (H.4.7) B-282 (I) (K.1.22)

B-199 (I) (G.3.4) B-241 (I) (H.4.8) B-283 (I) (K.1.23)

B-200 (I) (G.3.5) B-242 (I) (H.4.9) B-284 (I) (K.1.24)

B-201 (I) (G.3.6) B-243 (I) (H.4.10) B-285 (I) (K.1.25)

B-202 (I) (G.3.7) B-244 (I) (1.1 .1 ) B-286 (I) (K.1.26)

B-203 (I) (G.3.8) B-245 (I) (1.1 .2) B-287 (I) (K.1.27)

B-204 (I) (G.4.1 ) B-246 (I) (1.2.1 ) B-288 (I) (K.1.28) Mixt. Co.1 Co.2 Mixt. Co.1 Co.2 Mixt. Co.1 Co.2

B-289 (I) (K.1.29) B-331 (I) (M.1.25) B-373 (I) (N.6.3)

B-290 (I) (K.1.30) B-332 (I) (M.1.26) B-374 (I) (N.6.4)

B-291 (I) (K.1.31) B-333 (I) (M.1.27) B-375 (I) (N.6.5)

B-292 (I) (K.1.32) B-334 (I) (M.1.28) B-376 (I) (N.7.1)

B-293 (I) (K.1.33) B-335 (I) (M.1.29) B-377 (I) (N.7.2)

B-294 (I) (K.1.34) B-336 (I) (M.1.30) B-378 (I) (N.7.3)

B-295 (I) (K.1.35) B-337 (I) (M.1.31) B-379 (I) (N.8.1)

B-296 (I) (K.1.36) B-338 (I) (M.1.32) B-380 (I) (N.9.1)

B-297 (I) (K.1.37) B-339 (I) (M.1.33) B-381 (I) (N.10.1)

B-298 (I) (K.1.38) B-340 (I) (M.1.34) B-382 (I) (N.10.2)

B-299 (I) (K.1.39) B-341 (I) (M.1.35) B-383 (I) (N.10.3)

B-300 (I) (K.1.40) B-342 (I) (M.1.36) B-384 (I) (N.10.4)

B-301 (I) (K.1.41) B-343 (I) (M.1.37) B-385 (I) (N.10.5)

B-302 (I) (K.1.42) B-344 (I) (M.1.38) B-386 (I) (N.11.1)

B-303 (I) (K.1.43) B-345 (I) (M.1.39) B-387 (I) (N.12.1)

B-304 (I) (K.1.44) B-346 (I) (M.1.40) B-388 (I) (N.12.2)

B-305 (I) (K.1.45) B-347 (I) (M.1.41) B-389 (I) (N.12.3)

B-306 (I) (K.1.47) B-348 (I) (M.1.42) B-390 (I) (N.12.4)

B-307 (I) (M.1.1) B-349 (I) (M.1.43) B-391 (I) (N.13.1)

B-308 (I) (M.1.2) B-350 (I) (M.1.44) B-392 (I) (N.13.2)

B-309 (I) (M.1.3) B-351 (I) (M.1.45) B-393 (I) (N.13.3)

B-310 (I) (M.1.4) B-352 (I) (M.1.46) B-394 (I) (N.13.4)

B-311 (I) (M.1.5) B-353 (I) (M.1.47) B-395 (I) (N.13.5)

B-312 (I) (M.1.6) B-354 (I) (M.1.48) B-396 (I) (N.13.6)

B-313 (I) (M.1.7) B-355 (I) (M.1.49) B-397 (I) (N.13.7)

B-314 (I) (M.1.8) B-356 (I) (M.1.50) B-398 (I) (N.13.8)

B-315 (I) (M.1.9) B-357 (I) (N.1.1) B-399 (I) (N.13.9)

B-316 (I) (M.1.10) B-358 (I) (N.1.2) B-400 (I) (N.14.1)

B-317 (I) (M.1.11) B-359 (I) (N.1.3) B-401 (I) (N.14.2)

B-318 (I) (M.1.12) B-360 (I) (N.1.4) B-402 (I) (N.14.3)

B-319 (I) (M.1.13) B-361 (I) (N.1.5) B-403 (I) (N.15.1)

B-320 (I) (M.1.14) B-362 (I) (N.2.1) B-404 (I) (N.16.1)

B-321 (I) (M.1.15) B-363 (I) (N.2.2) B-405 (I) (N.16.2)

B-322 (I) (M.1.16) B-364 (I) (N.2.3) B-406 (I) (N.17.1)

B-323 (I) (M.1.17) B-365 (I) (N.3.1) B-407 (I) (N.17.2)

B-324 (I) (M.1.18) B-366 (I) (N.3.2) B-408 (I) (N.17.3)

B-325 (I) (M.1.19) B-367 (I) (N.3.3) B-409 (I) (N.17.4)

B-326 (I) (M.1.20) B-368 (I) (N.3.4) B-410 (I) (N.17.5)

B-327 (I) (M.1.21) B-369 (I) (N.4.1) B-411 (I) (N.17.6)

B-328 (I) (M.1.22) B-370 (I) (N.5.1) B-412 (I) (N.17.7)

B-329 (I) (M.1.23) B-371 (I) (N.6.1) B-413 (I) (N.17.8)

B-330 (I) (M.1.24) B-372 (I) (N.6.2) B-414 (I) (N.17.9) Mixt. Co.1 Co. 2 Mixt. Co.1 Co. 2 Mixt. Co.1 Co. 2

B-415 (I) (N.17.10) B-457 (I) (0.2.2) B-499 (I) (0.4.1 )

B-416 (I) (N.17.1 1 ) B-458 (I) (0.2.3) B-500 (I) (0.4.2)

B-417 (I) (N.17.12) B-459 (I) (0.2.4) B-501 (I) (0.4.3)

B-418 (I) (0.1.1 ) B-460 (I) (0.2.5) B-502 (I) (0.4.4)

B-419 (I) (0.1.2) B-461 (I) (0.2.6) B-503 (I) (0.4.5)

B-420 (I) (0.1.3) B-462 (I) (0.2.7) B-504 (I) (0.4.6)

B-421 (I) (0.1.4) B-463 (I) (0.2.8) B-505 (I) (0.4.7)

B-422 (I) (0.1.5) B-464 (I) (0.2.9) B-506 (I) (0.4.8)

B-423 (I) (0.1.6) B-465 (I) (O.2.10) B-507 (I) (0.4.9)

B-424 (I) (0.1.7) B-466 (I) (0.2.11 ) B-508 (I) (0.4.10)

B-425 (I) (0.1.8) B-467 (I) (0.2.12) B-509 (I) (0.4.1 1 )

B-426 (I) (0.1.9) B-468 (I) (0.2.13) B-510 (I) (0.4.12)

B-427 (I) (0.1.10) B-469 (I) (0.2.14) B-51 1 (I) (0.4.13)

B-428 (I) (0.1.1 1 ) B-470 (I) (0.2.15) B-512 (I) (0.4.14)

B-429 (I) (0.1.12) B-471 (I) (0.2.16) B-513 (I) (0.4.15)

B-430 (I) (0.1.13) B-472 (I) (0.3.1 ) B-514 (I) (0.4.16)

B-431 (I) (0.1.14) B-473 (I) (0.3.2) B-515 (I) (0.4.17)

B-432 (I) (0.1.15) B-474 (I) (0.3.3) B-516 (I) (0.4.18)

B-433 (I) (0.1.16) B-475 (I) (0.3.4) B-517 (I) (0.4.19)

B-434 (I) (0.1.17) B-476 (I) (0.3.5) B-518 (I) (O.4.20)

B-435 (I) (0.1.18) B-477 (I) (0.3.6) B-519 (I) (0.4.21 )

B-436 (I) (0.1.19) B-478 (I) (0.3.7) B-520 (I) (0.4.22)

B-437 (I) (0.1.20) B-479 (I) (0.3.8) B-521 (I) (0.4.23)

B-438 (I) (0.1.21 ) B-480 (I) (0.3.9) B-522 (I) (0.4.24)

B-439 (I) (0.1.22) B-481 (I) (O.3.10) B-523 (I) (0.5.1 )

B-440 (I) (0.1.23) B-482 (I) (0.3.11 ) B-524 (I) (0.5.2)

B-441 (I) (0.1.24) B-483 (I) (0.3.12) B-525 (I) (0.5.3)

B-442 (I) (0.1.25) B-484 (I) (0.3.13) B-526 (I) (0.5.4)

B-443 (I) (0.1.26) B-485 (I) (0.3.14) B-527 (I) (0.5.5)

B-444 (I) (0.1.27) B-486 (I) (0.3.15) B-528 (I) (0.5.6)

B-445 (I) (0.1.28) B-487 (I) (0.3.16) B-529 (I) (0.5.7)

B-446 (I) (0.1.29) B-488 (I) (0.3.17) B-530 (I) (0.5.8)

B-447 (I) (0.1.30) B-489 (I) (0.3.18) B-531 (I) (0.5.9)

B-448 (I) (0.1.31 ) B-490 (I) (0.3.19) B-532 (I) (0.6.1 )

B-449 (I) (0.1.32) B-491 (I) (O.3.20) B-533 (I) (0.6.2)

B-450 (I) (0.1.33) B-492 (I) (0.3.21 ) B-534 (I) (0.6.3)

B-451 (I) (0.1.34) B-493 (I) (0.3.22) B-535 (I) (0.6.4)

B-452 (I) (0.1.35) B-494 (I) (0.3.23) B-536 (I) (0.6.5)

B-453 (I) (0.1.36) B-495 (I) (0.3.24) B-537 (I) (0.6.6)

B-454 (I) (0.1.37) B-496 (I) (0.3.25) B-538 (I) (0.6.7)

B-455 (I) (0.1.38) B-497 (I) (0.3.26) B-539 (I) (0.7.1 )

B-456 (I) (0.2.1 ) B-498 (I) (0.3.27) B-540 (I) (0.7.2) Mixt. Co.1 Co. 2 Mixt. Co.1 Co. 2 Mixt. Co.1 Co. 2

B-541 (I) (0.7.3) B-583 (I) (0.18.4) B-625 (I) (0.26.16)

B-542 (I) (0.7.4) B-584 (I) (0.18.5) B-626 (I) (0.26.17)

B-543 (I) (0.7.5) B-585 (I) (0.19.1 ) B-627 (I) (0.26.18)

B-544 (I) (0.7.6) B-586 (I) (O.20.1 ) B-628 (I) (0.27.1 )

B-545 (I) (0.8.1 ) B-587 (I) (O.20.2) B-629 (I) (0.27.2)

B-546 (I) (0.8.2) B-588 (I) (O.20.3) B-630 (I) (0.27.3)

B-547 (I) (0.8.3) B-589 (I) (0.21.1 ) B-631 (I) (0.27.4)

B-548 (I) (0.8.4) B-590 (I) (0.21.2) B-632 (I) (0.27.5)

B-549 (I) (0.8.5) B-591 (I) (0.21.3) B-633 (I) (0.27.6)

B-550 (I) (0.9.1 ) B-592 (I) (0.21.4) B-634 (I) (0.27.7)

B-551 (I) (0.9.2) B-593 (I) (0.21.5) B-635 (I) (0.27.8)

B-552 (I) (0.9.3) B-594 (I) (0.21.6) B-636 (I) (0.27.9)

B-553 (I) (O.10.1 ) B-595 (I) (0.21.7) B-637 (I) (O.27.10)

B-554 (I) (0.1 1 .1 ) B-596 (I) (0.22.1 ) B-638 (I) (0.27.1 1 )

B-555 (I) (0.1 1 .2) B-597 (I) (0.22.2) B-639 (I) (0.27.12)

B-556 (I) (0.1 1 .3) B-598 (I) (0.22.3) B-640 (I) (0.27.13)

B-557 (I) (0.1 1 .4) B-599 (I) (0.22.4) B-641 (I) (0.27.14)

B-558 (I) (0.12.1 ) B-600 (I) (0.23.1 ) B-642 (I) (0.27.15)

B-559 (I) (0.13.1 ) B-601 (I) (0.23.2) B-643 (I) (0.27.16)

B-560 (I) (0.14.1 ) B-602 (I) (0.23.3) B-644 (I) (0.27.17)

B-561 (I) (0.14.2) B-603 (I) (0.24.1 ) B-645 (I) (0.27.18)

B-562 (I) (0.15.1 ) B-604 (I) (0.24.2) B-646 (I) (0.27.19)

B-563 (I) (0.15.2) B-605 (I) (0.24.3) B-647 (I) (O.27.20)

B-564 (I) (0.15.3) B-606 (I) (0.24.4) B-648 (I) (0.27.21 )

B-565 (I) (0.15.4) B-607 (I) (0.24.5) B-649 (I) (0.27.22)

B-566 (I) (0.15.5) B-608 (I) (0.25.1 ) B-650 (I) (0.27.23)

B-567 (I) (0.15.6) B-609 (I) (0.25.2) B-651 (I) (0.27.24)

B-568 (I) (0.15.7) B-610 (I) (0.26.1 ) B-652 (I) (0.27.25)

B-569 (I) (0.15.8) B-61 1 (I) (0.26.2) B-653 (I) (0.27.26)

B-570 (I) (0.15.9) B-612 (I) (0.26.3) B-654 (I) (0.27.27)

B-571 (I) (O.15.10) B-613 (I) (0.26.4) B-655 (I) (0.27.28)

B-572 (I) (0.15.1 1 ) B-614 (I) (0.26.5) B-656 (I) (0.27.29)

B-573 (I) (0.16.1 ) B-615 (I) (0.26.6) B-657 (I) (O.27.30)

B-574 (I) (0.16.2) B-616 (I) (0.26.7) B-658 (I) (0.27.31 )

B-575 (I) (0.16.3) B-617 (I) (0.26.8) B-659 (I) (0.27.32)

B-576 (I) (0.16.4) B-618 (I) (0.26.9) B-660 (I) (0.27.33)

B-577 (I) (0.16.5) B-619 (I) (0.26.10) B-661 (I) (0.27.34)

B-578 (I) (0.16.6) B-620 (I) (0.26.1 1 ) B-662 (I) (0.27.35)

B-579 (I) (0.17.1 ) B-621 (I) (0.26.12) B-663 (I) (0.27.36)

B-580 (I) (0.18.1 ) B-622 (I) (0.26.13) B-664 (I) (0.27.37)

B-581 (I) (0.18.2) B-623 (I) (0.26.14) B-665 (I) (0.27.38)

B-582 (I) (0.18.3) B-624 (I) (0.26.15) B-666 (I) (0.27.39) Mixt. Co.1 Co. 2 Mixt. Co.1 Co. 2 Mixt. Co.1 Co. 2

B-667 (I) (O.27.40) B-688 (I) (0.27.61 ) B-709 (I) (0.27.82)

B-668 (I) (0.27.41 ) B-689 (I) (0.27.62) B-710 (I) (0.27.83)

B-669 (I) (0.27.42) B-690 (I) (0.27.63) B-71 1 (I) (0.27.84)

B-670 (I) (0.27.43) B-691 (I) (0.27.64) B-712 (I) (0.27.85)

B-671 (I) (0.27.44) B-692 (I) (0.27.65) B-713 (I) (0.27.86)

B-672 (I) (0.27.45) B-693 (I) (0.27.66) B-714 (I) (0.27.87)

B-673 (I) (0.27.46) B-694 (I) (0.27.67) B-715 (I) (0.27.88)

B-674 (I) (0.27.47) B-695 (I) (0.27.68) B-716 (I) (0.27.89)

B-675 (I) (0.27.48) B-696 (I) (0.27.69) B-717 (I) (O.27.90)

B-676 (I) (0.27.49) B-697 (I) (O.27.70) B-718 (I) (0.27.91 )

B-677 (I) (O.27.50) B-698 (I) (0.27.71 ) B-719 (I) (0.27.92)

B-678 (I) (0.27.51 ) B-699 (I) (0.27.72) B-720 (I) (0.27.93)

B-679 (I) (0.27.52) B-700 (I) (0.27.73) B-721 (I) (0.27.94)

B-680 (I) (0.27.53) B-701 (I) (0.27.74) B-722 (I) (0.27.95)

B-681 (I) (0.27.54) B-702 (I) (0.27.75) B-723 (I) (0.27.96)

B-682 (I) (0.27.55) B-703 (I) (0.27.76) B-724 (I) (0.27.97)

B-683 (I) (0.27.56) B-704 (I) (0.27.77) B-725 (I) (0.27.98)

B-684 (I) (0.27.57) B-705 (I) (0.27.78) B-726 (I) (0.27.99)

B-685 (I) (0.27.58) B-706 (I) (0.27.79) B-727 (I) (0.27.100)

B-686 (I) (0.27.59) B-707 (I) (O.27.80)

B-687 (I) (O.27.60) B-708 (I) (0.27.81 )

The mixtures of active substances can be prepared as compositions comprising besides the active ingredients at least one inert ingredient (auxiliary) by usual means, e. g. by the means given for the compositions of compounds I.

Concerning usual ingredients of such compositions reference is made to the explanations given for the compositions containing compounds I.

The mixtures of active substances according to the present invention are suitable as fungicides, as are the compounds of formula I. They are distinguished by an outstanding effectiveness against a broad spectrum of phytopathogenic fungi, especially from the classes of the

Ascomycetes, Basidiomycetes, Deuteromycetes and Peronosporomycetes (syn. Oomycetes). In addition, it is refered to the explanations regarding the fungicidal activity of the compounds and the compositions containing compounds I, respectively.

I. Synthesis examples

The compounds of formula I can be prepared according to the methods outlined below.

1.1 ) Preparation of 4-(1 -aminocyclopropyl)benzonitrile

To a solution of 1 ,4-dicyano benzene (100 g) in CH ₂ CI ₂ (3.5 L) was added Ti(0/Pr) ₄ (229 ml_, 1.0 eq) followed by EtMgBr (3 M in Et ₂ 0, 470 ml_, 1 .4 eq) dropwise at -70 °C. The reaction mixture was warmed slowly to 20 °C and stirred for 3.5 hours. BF3 Et ₂ 0 (173 ml_, 1 .4 eq) was added and the mixture was stirred at 20 °C for 24 hours. The reaction was quenched with water (2 L), followed by the addition of 1 N aqueous HCI (200 mL) and separated. The aqueous layer was washed once with CH2CI2 (1 L), then adjusted to pH ~ 10 with aq. NaOH (10 N). The suspension was filtered through Celite and the filtrate cake was washed with water and EtOAc. The aqueous phase was extracted with EtOAc. The organic layers were combined, washed with brine, dried over Na2S0 ₄ , filtered and concentrated. The residue was purified by silica gel chromatography (CH ₂ CI ₂ : MeOH = 20:1 ) to yield the title compound (16.8 g, 14%) as yellow solid.

H NMR (400 MHz, DMSO-d^, 298 K): δ [ppm] = 0.99-1.03 (m, 2H), 1 .05-1.10 (m, 2H), 2.40 (br. s, 2H), 7.45-7.50 (m, 2H), 7.68 - 7.73 (m, 2 H).

1.2) Preparation of N[1 -(4-cyanophenyl)cyclopropyl]acetamide

A solution of the amine obtained in step 1.1 ) (1.5 g) in AC2O (30 mL) was stirred at 60 °C for 12 hours. TLC showed complete consumption of the starting material and the reaction was concentrated to afford the respective acetamide (1 .8 g, 89%) as yellow solid.

H NMR (400 MHz, DMSO-0 ⁶ , 298 K): δ [ppm] = 1 .18-1.23 (m, 2H), 1 .25-1.30 (m, 2H), 1.87 (s, 3H), 7.26 (d, 2H), 7.72 (d, 2H), 8.64 (s, 1 H).

1.3) Preparation of /V-[1-[4-(/V-hydroxycarbamimidoyl)phenyl]cyclopropyl]acetami de

A mixture of the acetate obtained in step 1.2) (2.0 g, 1.0 eq), NH?OH HCI (1 .74 g, 2.5 eq) and a2COs (2.6 g, 2.5 eq) in EtOH (50 mL) and H2O (10 mL) was stirred at reflux at 80 C for 12 hours. The solvent was evaporated to dryness and the residue was washed with water (3 * 30 mL). The resulting precipitate was collected and dried under reduced pressure to afford the title compound (1.8 g, 77%) as yellow solid.

1H NMR (400 MHz, DMSO-0 ⁶ , 298 K): δ [ppm] = 1.10-1.13 (m, 2H), 1 .15 (m, 2H), 1.84 (s, 3H), 5.72 (br. s, 2H), 7.04-7.13 (m, 2 H), 7.50-7.60 (m, 2H), 8.55 (s, 1 H), 9.53 (s, 1 H).

1.4) Preparation of /V-[1-[4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl]- cyclopropyl]acetamide

To a solution of amidine as obtained in step 1.3) (1.8 g, 1 .0 eq) in CHCI3 (200 mL) and pyridine (3 mL) was added trifluoroacetic anhydride (3.0 g in 2 mL CHCI3) at ambient temperature. After 4 hours, LCMS showed complete conversion of the starting material, and the mixture was poured into H2O (50 mL). The aqueous phase was adjusted to pH ~ 4-5 by adding aqueous HCI (3 N), and the mixture was extracted with CH2CI2 (30 mL). The organic phase was dried over Na2S0 ₄ , filtered and concentrated. The crude product was suspended in petrol ether and filtered to furnish the target compound (1 .8 g, 79%) as white solid.

H NMR (400 MHz, DMSO-0 ⁶ , 298 K): δ [ppm] = 1 .17-1.24 (m, 2 H), 1 .25-1.35 (m, 2H), 1.88 (s, 3H), 7.30-7.35 (m, 2H), 7.92-7.98 (m, 2H), 8.65 (s, 1 H). The compounds listed in Table I were prepared in an analogous manner. Table I : Compounds Ex-1 to Ex-9 of the formula I.A, wherein the meaning of R ¹ and R ² are as defined in each line.

* HPLC: High Performance Liquid Chromatography; HPLC-column Kinetex XB C18 1 ,7μ (50 x 2, 1 mm); eluent: acetonitrile / water + 0.1 % trifluoroacetic acid (gradient from 5:95 to 100 : 0 in 1 .5 min at 60°C, flow gradient from 0.8 to 1 .0 ml/min in 1 .5 min). MS: Quadrupol Electrospray lonisation, 80 V (positive mode). Rt: retention time in minutes.

II . Biological examples for fungicidal activity

The fungicidal action of the compounds of formula I was demonstrated by the following experiments:

Glass house trials

The spray solutions were prepared in several steps: the stock solutions were prepared: a mixture of acetone and/or dimethylsulfoxide and the wetting agent/emulsifier Wettol, which is based on ethoxylated alkylphenoles, in a relation (volume) solvent-emulsifier of 99 to 1 was added to 25 mg of the compound to give a total of 5 ml. Water was then added to total volume of 100 ml. This stock solution was diluted with the described solvent-emulsifier-water mixture to the given concentration. Use example 11.1 : Curative control of soy bean rust on soy beans caused by Phakopsora pachyrhizi

Leaves of pot-grown soy bean seedlings were inoculated with spores of Phakopsora pachyrhizi . To ensure the success of the artificial inoculation, the plants were transferred to a humid chamber with a relative humidity of about 95 % and 20 to 24 °C for 24 hours. The next day the plants were sprayed to run-off with an aqueous suspension, containing the concentration of active ingredient or their mixture as described below. The plants were allowed to air-dry. Then the trial plants were cultivated for 14 days in a greenhouse chamber at 23 to 27 °C and a relative humidity between 60 and 80 %. The extent of fungal attack on the leaves was visually assessed as % diseased leaf area.

In this test, the plants which had been treated with 32 ppm of the active compound Ex-2, Ex-3 showed a diseased leaf area of at most 2 %, whereas the untreated plants showed 100 % diseased leaf area. Use example II.2. Protective control of soy bean rust on soy beans caused by Phakopsora pachyrhizi

Leaves of pot-grown soy bean seedlings were sprayed to run-off with an aqueous suspension, containing the concentration of active ingredient or their mixture as described below. The plants were allowed to air-dry. The trial plants were cultivated for 2 day in a greenhouse chamber at 23 to 27 °C and a relative humidity between 60 and 80 %.Then the plants were inoculated with spores of Phakopsora pachyrhizi. To ensure the success the artificial inoculation, the plants were transferred to a humid chamber with a relative humidity of about 95 % and 20 to 24 °C for 24 hours. The trial plants were cultivated for fourteen days in a greenhouse chamber at 23 to 27 °C and a relative humidity between 60 and 80 %. The extent of fungal attack on the leaves was visually assessed as % diseased leaf area.

In this test, the plants which had been treated with 32 ppm of the active compound Ex-2, Ex-3, Ex-6 showed a diseased leaf area of at most 7 %, whereas the untreated plants showed 90 % diseased leaf area. Use example 11.3: Curative control of brown rust on wheat caused by Puccinia recondita

The first two developed leaves of pot-grown wheat seedling were dusted with spores of Puccinia recondita. To ensure the success the artificial inoculation, the plants were transferred to a humid chamber without light and a relative humidity of 95 to 99 % and 20 to 24 °C for 24 hours. The next day the plants were cultivated for 3 days in a greenhouse chamber at 20 to 24 °C and a relative humidity between 65 and 70 %. Then the plants were sprayed to run-off with an aqueous suspension, containing the concentration of active ingredient or their mixture as described below. The plants were allowed to air-dry. Then the trial plants were cultivated for 8 days in a greenhouse chamber at 20 to 24 °C and a relative humidity between 65 and 70 %. The extent of fungal attack on the leaves was visually assessed as % diseased leaf area.

In this test, the plants which had been treated with 63 ppm of the active compound Ex-2 showed a diseased leaf area of 1 %, whereas the untreated plants showed 90 % diseased leaf area.

Use example 11.4: Preventative control of brown rust on wheat caused by Puccinia recondita The first two developed leaves of pot-grown wheat seedling were sprayed to run-off with an aqueous suspension, containing the concentration of active ingredient or their mixture as described below. The next day the plants were inoculated with spores of Puccinia recondita. To ensure the success the artificial inoculation, the plants were transferred to a humid chamber without light and a relative humidity of 95 to 99 % and 20 to 24 °C for 24 hours. Then the trial plants were cultivated for 6 days in a greenhouse chamber at 20 to 24 °C and a relative humidity between 65 and 70 %. The extent of fungal attack on the leaves was visually assessed as % diseased leaf area.

In this test, the plants which had been treated with 63 ppm of the active compound Ex-2 showed a diseased leaf area of 2 %, whereas the untreated plants showed 90 % diseased leaf area.